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Interactions between five different cardiac glycosides, digitoxin, 
cymarol, convallatoxol, digoxin and ouabain, and Na+K+-ATPase from 
guinea pig heart, kidney, brain and rat heart and brain have been 
studied. Concentrations of glycosides required for 50% inhibition of 
the enzyme (ISO) have been determined at various concentrations of K+. 
The binding of the glycosides to the enzyme preparations was studied 
using tritiated glycosides. ATP, Mg2+, and Na+ were required for 
specific binding. Through the use of Scatchard plots, a high affinity 
binding site was demonstrated for each guinea pig enzyme preparation, 
and the association constants CKa) were measured for each of the 
glycosides. 
Although rat brain was demonstrated to have Na+K+-ATPase with a 
high affinity binding site for glycosides, this was not found to be 
true of rat heart Na+K+-ATPase. 
The initial concentration of each glycoside required to half 
saturate the high affinity site (BSO) was calculated. The effects of 
varying the concentration of K+ on Ka and BSO was ascertained. In the 
presence of a low concentration of K+ (0.625 roM), binding and inhibi-
tion were studied under identical conditions. The B50 and ISO values 
were similar to each other for each guinea pig enzyme and each 
glycoside. This established that with the guinea pig enzymes the 
binding observed was to the inhibitory site on the enzyme. Digitoxin, 
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cymarol and convallatoxol were bound more tightly and were more potent 
inhibitors than digoxin and ouabain with all enzyme preparations. The 
enzymes from the three guinea pig organs did not differ appreciably in 
their interactions with the glycosides. 
Inorganic phosphate plus Mg2+ could replace ATP, Mg2+ plus Na+ in 
supporting the binding of the glycosides, but in this case Na+ as well 
as K+ inhibited the binding. These data support the concept that Na+-
K+-ATPase is the receptor for cardiac glycosides in the guinea pig and 
that the binding occurs reversibly to the inhibitory site on the enzyme 
when it is phosphorylated. The data also support the concept that the 
binding process and the hydrolytic reaction, promoted by K+, compete 
for the phosphorylated enzyme in guinea pig Na+K+-ATPase. 
The BSO and ISO values for rat brain ATPase were different, with 
50% inhibition requiring 100 fold more glycoside than the amount 
required to obtain 50% saturation of the high affinity site. The BSO 
concentrations were consistent with guinea pig brain BSO concentrations 
not only in terms of relative order but also in magnitude. Since 50% 
saturation of this binding site was at a much lower cardiac glycoside 
concentration than the ISO concentration, it appears that this binding 
site is not related directly to the inhibitory site. 
Rat heart Na+K+-ATPase was inhibited by glycosides, but the ISO 
concentrations required were 30-1000 fold greater than those required 
with guinea pig heart ATPase. This observation, coupled with the fact 
that no high affinity binding to this enzyme could be demonstrated, 
indicates that the rat heart contains a Na+K+-ATPase which is extremely 
glycoside insensitive (lacks a high affinity inhibitory site). This 
may explain the relative lack of pharmacological action of glycosides 
3 
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INTRODUCTION 
The enzyme Na+K+-ATPase (EC: 3.6.1.3), was first recognized by 
Skou in 1957 (1). He suggested that this enzyme was responsible for 
transmembrane transport of sodium and potassium coupled to the hy-
drolysis of ATP. It was subsequently shown that hydrolysis of ATP as 
catalyzed by this enzyme is inhibited by cardiotonic steroids (2,3), 
and that these steroids also inhibit Na+ and K+ transport (4). These 
findings strengthened the hypothesis that Na+K+-ATPase is part of the 
Na+, K+-transport mechanism. Repke and Portius (5,6) investigated 
the possibility that Na+K+-ATPase of myocardial cells might be the 
"receptor" involved in the action of cardiac glycosides on the heart. 
The interrelationships among cardiac glycosides, Na+K+-ATPase and 
Na+, K+-transport have interested many biochemists, physiologists and 
pharmacologists, an interest that has.led to a very large volume of 
literature on the subject. 
The following discussion will touch on a few of the high points 
of this voluminous literature, especially as is deemed important to 
r' 
the research described in this dissertation. Numerous reviews of the 
relationship of Na+K+ -ATPase to the "Na pump" as well as detailed 
reviews and chapters on specific aspects of the enzyme system have 
been compiled (7-17). It is therefore not the objective of this In-
traduction to provide a complete review work on the subject. 
The "Na pump" is of prime importance to the functioning of 
specific cells (nerve, muscle), to the maintenance of osmotic pressure 
of all cells and to the ability of various tissues and organs (kidney, 
intestinal mucosa, secretory glands) to carry out their particular 
functions. The pump has many features that parallel those of Na+K+-
ATPase. These have been reviewed concisely by Hokin in Metabolic 
Transport (7). The common features are: both require the simulta-
neous presence of Na+ and K+ in approximately equivalent half-maximal 
activation concentrations; both are inhibited by cardiac glycosides 
with approximately the same concentrations for half-maximal inhibi-
tion; the quantitative distributions of both are in good agreement; 
both seem to display sidedness in the membrane with Na+ activating on 
the inside and K+ activating on the outside; both the pump (18) and 
Na+K+-ATPase have been driven backwards to produce ATP-y_32p from 
32Pi and ADP (19). With these common features in mind it is diffi-
cult to overestimate the importance of Na+K+-KfPase to cell and 
tissue function. 
Na+K+-ATPase appears to be an enzyme system which is an integra.l 
part of the plasma membrane. This has been most clearly demonstrated 
in the red blood cell (7). It can be characterized as an enzyme 
which has at least two types of subunits. One subunit appears to be 
a glycopolypeptide with a molecular weight of 55,000 and the other, 
a polypeptide associated with phospholipid with an estimated molecu-
lar weight of 84-105,000 (7,20). The subunits, even in the enzyme's 
most purified form, tend to cluster in vesicles similar to those seen 
in crude preparations of plasma membranes (20,21). The catalytic 
subunit of Na+K+-ATPase has been identified by labeling the aspartyl 
residue at the active site with ATP-y_32p in the presence of Na+ and 
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Mg2+ (7,22). The molecular weight of the catalytic subunit is esti-
mated to be 100,000, and it is probably the phospholipid containing 
subunit (7). As might be expected, the molecular weight of the en-
zyme system reported depends upon the methods used to purify the 
enzyme, the source of the enzyme and the method of determination. 
Since Na+K+-ATPase is an integral part of the plasma membrane, 
there is some question as to whether the enzyme will ever be purified 
into discrete protein components that will show activity. There is 
also a distinct possibility that the enzyme system cannot be truly 
solubilized except in association with detergents. Determination of 
the physical properties of the enzyme often depend upon its solubili-
zation, but the bound detergents will significantly alter any results 
obtained on such a preparation. Even without the involvement of 
detergents, associated carbohydrates and phospholipids will distinct-
ly alter the properties of the enzyme in solution (23). To compli-
cate matters further it has not been established that there is a 
constant carbohydrate composition of the Na+K+-ATPase. The estimates 
of the percentage of the total ATPase protein represented by the 
protein of the glycopolypeptide varies from 19 to 28% (21). It 
appears, on the basis of phospholipase treatment and phospholipid 
replacement, that a constant ratio of phospholipid is not necessary 
for enzymatic activity (24). Whether a parallel can be drawn, from 
these observations to the phospholipid and carbohydrate requirements 
in the membrane for Na+K+-ATPase activity, is not clear. Thus it is 
apparent that, although work on the purified enzyme \'1ill anS\ier many 
important questions, methods devised to elicit· information from the 
"membrane bound" enzyme will also prove invaluable. To this end it 
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is interesting to note that kinetic properties of the impure membrane 
bound enzyme are very similar to those for a highly purified Na+K+-
ATPase (25). 
4 
In the isolation of Na+K+-ATPase there is always an associated 
activity of Mg2+-dependent ATPase which is usually separated from Na+-
K+-ATPase by differential centrifugation and deoxycholate treatment 
(7). The purification of Na+K+-ATPase has taken many routes (pro-
tease treatment, phospholipase treatment, physical disruption, deter-
gent solubilization, salt fractionation) but most follow a general 
scheme. A typical scheme for the purification of Na+K+-ATPase is 
found in Table 1. Chaotropic agents such as NaI (7) are thought to 
extract some protein from microsome fractions; for example, the almost 
complete removal of Mg2+-ATPase has been claimed by this method (7, 
27). Deoxycholate, an anionic detergent, is often used in sub-solu-
bilizing concentrations to remove inert protein, reduce the level of 
Mg2+-ATPase and activate Na+K+-ATPase (7). Lubrol and SDS are also 
claimed to activate the enzyme; it appears that this is accomplished 
at critical micelle concentrations of the detergents. Other steps 
used in various procedures include ammonium sulfate fractionation, 
agarose chromatography, sephadex chromatography; CMe (carboxymethyl 
cellulose) chromatography, DEAE-cellulose chromatography, sucrose 
density gradient centrifugation, and g~ycerol gradient centrifugation. 
Standard methods for the determination of the molecular weight 
have not usually been employed because of the lipid and carbohydrate 
contributions to the subunits. SDS polyacrylamide gel electrophor-
esis has been used most often to estimate the subunit molecular 
weights, although the same problem exists~ Because of the considerable 
TABLE 1 


















a from Kahlenburg et a1., 1969 (26). 
Total Activity Total Protein 





1,560 13 .. 4 
1,150 7.5 
b transparent, colorless, gelatinous pellet was obtained after 
centrifugation at 115,000 x g for 18 hr. It readily redissolved 
in bqffer. 
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inhomogeneity of most preparations prior to the last year or two, the 
use of radiation inactivation and gel filtration were often used to 
determine the molecular weight of the enzyme (7). The former method 
has yielded a molecular weight of 250,000 for Na+K+-ATPase derived 
from human red blood cell, guinea pig kidney cortex and crayfish 
nerve cord plasma membranes (7). Lubrol and DOC treated rnicrosomes 
quite regularly give a molecular weight between 500,000 and 700,000 
as measured by gel filtration chromatography (7). Using the constant 
protein content observed throughout their preparation, Uesugi et al. 
(27) made corrections on the molecular weight of detergent isolated 
enzymes which accounted for the bound detergent, carbohydrate, chol-
esterol and non-phospholipid. When such corrections were made on a 
molecular weight determined by gel filtration of a detergent isolated 
enzyme, the calculated protein molecular weight was approximately 
260,000 (based on a protein content of 55%). 
As mentioned earlier the purified enzyme system apparently con-
tains carbohydrate and phospholipid. Carbohydrate has been identi-
fied by use of the periodic acid-Schiff reagent (20), but not quanti-
fied. According to Simpkins and Hokin (21) the purified enzyme from 
the rectal salt gland of Squalus acanthias contains protein and 
phospholipid in a ratio of 2:1, but data are not given. Other 
reports of lipid content are variable, .dependent upon the mode of 
isolation. A major question arises: Are carbohydrates and phospho-
lipids necessary and functional components of the ATPase system? The 
role of carbohydrate has not been thoroughly investigated and is not 
as yet clear. The function of phospholipids on the other hand has 
been studied by many research groups (7,9,12,13). Most of the work 
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to date has consisted of phospholipid removal with solvents (7), 
detergents (28,29) or phospholipases (14,15). The resultant inactive 
Na+K+-ATPase then is treated with various phospholipid preparation~ 
and individual phospholipids (phosphatidyl ethanolamine, phosphatidyl 
serine, phosphatidyl choline) in an attempt to restore activity. 
Variations in time of extraction, time of reactivation treatment, 
purity of the particular phospholipid used for reactivation treatment 
and purity of the particular phospholipid used for reactivation and 
inhibition by released fatty acids (30,31) have led to conflicting 
results. Several claims have been made that phosphatidyl serine is 
the activating lipid (7,32,33), but a systematic investigation (35) 
of Na+K+-ATPase phospholipid requirements revealed that a minimum 
structure of a phosphate plus two fatty acyl residues is required. 
It appears that phosphatidyl ethanolamine, phosphatidic acid and 
phosphatidyl inositol will reactivate as well as phosphatidy1 serine 
(7). It has been suggested that phospholipid reactivation may be the 
result of replacement of detergent and lyso-derivatives which can in-
activate the enzyme (31). Recent work employing spin-labeling tech-
niques and x-ray diffraction studies indicate that the phospholipid 
in highly purified Na+K+-ATPase possesses bilayer character. Inacti-
vation experiments with phospholipase A using N-ethylmaleimide spin-
labeled enzyme indicated that a conformational change in protein 
occurs as the result of disruption of the lipid bilayer. It can now 
be concluded that the role of phospholipids is not well defined, but 
that the evidence points towards a role in the maintenance of the 
protein in an appropriate conformation (7,30~35). 
Na+K+-ATPase hydrolyzes ATP to yield ADP plus Pi- This process 
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requires Na+, Mg2+, and K+. Several enzyme sites have been charac-
terized for Na+K+-ATPase. When the enzyme system is considered in the 
RBC membrane, it displays sidedness; therefore, the sites can be 
oriented in relation to the intra- and extra-cellular fluids. It 
appears that the ATP site is on the inside of the cell membrane along 
with a site having an affinity for Na+ which is 4-6 times the affinity 
for K+ (13,35). There is a monovalent cation site on the outside of 
the membrane which has an affinity for K+ that is 60-100 fold that 
for Na+, but that wi1l·accept other ions (i.e. K+>Rb+>NH
4
+>Cs+>Li+) 
(13,35). The requirement for Na+ and Mg2+ are absolute, if overall 
enzymatic activity is to be observed. The interrelationships of Na+ 
and K+ especially are very complicated as numerous kinetic studies 
have pointed out (10). In a system with at least four required com-
ponents (excluding the enzyme itself) the smallest changes in concen-
tration of any or all can have considerable effect on the .enzymatic 
activity. Mg2+ may have more than one role, in that the enzyme may 
have sites requiring Mg2+, besides the site which binds Mg2+-ATP. It 
appears now, after considerable study into the reaction mechanism, 
that the enzyme acts in a multistep manner with several steps defining 
the "phosphorylation phase" of the enzymatic activity and at least one 
step involved in the "dephosphorylation phase" (7,36-41). There is 
not a complete solution to the exact reaction mechanism for Na+K+-
ATPase, but from many approaches to the problem the following simpli-
fied picture arises (see Figure 1). There have been many imaginative 
approaches taken to elucidate the experimental evidence for the reac-
tion sequence of the hydrolysis of ATP by Na+K+-ATPase; but, of the 
numerous studies done, several stand out. In support of a phosphory-
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Figure 1. 
Proposed Enzyme Form Involved in the Interactions 
of Na+K+-ATPase with ATP and Cardiac Glycosides 
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E2 - P + H2O 1: ) E2 
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lated intermediate a Mg2+-dependent ATP-ADP exchange was described 
(7). Furthermore many researchers (7) reported a very rapid Na+-
dependent incorporation of 32p from ATP_y_32 p in the presence of r..fg2+ , 
the 32p remaining bound to the protein even after TeA precipitation. 
K+ included in the above experiments greatly diminished the level of 
32p in the TeA precipitated protein (7). In conflict with the ADP-
ATP exchange data of Skou were several pieces of evidence that the 
bulk of the exchange could apparently be separated from Na+K+-ATPase 
hydrolytic activity (7). 
Pursuant to these studies were those that provided evidence that 
there is more than one phosphorylated form of Na+K+-ATPase. Several 
groups of researchers (37-40) demonstrated at low Mg2+ concentrations 
(as compared to those required for hydrolysis) an exchange activity 
which has an absolute specificity for Na+ and ATP, a non-dependence 
on K+, and is inhibited by cardiac glycosides. It was postulated that 
one phosphorylated form of the enzyme~ El~P, was converted to another 
conformation, E2-P, via Mg2+, an essentially irreversible reaction, 
and that the E2-P form could not react with ADP. Therefore, under 
conditions leading to hydrolysis, namely at high magnesium levels!' 
the form El~P would be but a fleeting intermediate. 
Another approach to the problem of defining discrete partial 
reactions in the overall enzyme mechanism has been the use of 
inhibitors. Most inhibitors function after the phosphorylation 
partial reaction, most likely at the step where El is converted" to E2 -
The exception to this is that at high concentrations of glycosides and 
in the absence of Na+ an inhibition of the ATP-ADP exchange reaction 
is observed (7). 
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Support for the existence of the two phosphorylated enzyme forms 
El~P and E2-P arises from studies with various inhibitors (N-ethyl-
maleimide~ oligomycin, arsenite and 2,3-dimercaptoethanol) which block 
E-P hydrolysis (10,39,41). In the blocked enzyme there appear to be 
two phosphorylated forms of the enzyme with differing sensitivities 
to several ligands. A comparison of the phosphorylated forms of the 
enzyme in the native and NEM-treated states leads to the following 
observations: the native phosphorylated enzyme is hydrolyzed in 
response to K+ but not ADP, whereas the NEM-treated phosphorylated 
enzyme is dephosphorylated in response to ADP but not K+ (7,37-39). 
Peptide digests of these phosphorylated forms of the enzyme display 
no differences. It has been concluded from this type of study that 
the change in phosphorylated forms may simply represent a conforma-
tional change (7,36). 
An alternate sequence of partial reactions has been proposed for 
the mechanism of Na+K+-ATPase (42). In a recent paper Fukushima and 
Tonomura (43) have elaborated on the earlier proposed mechansim and 
have provided additional evidence to support the modified K.S.T. 
(Kanazawa, Saito, Tonomura) mechanism. The major differences between 
the K.S.T. mechanism and that prop.osed by Fahn, Albers, Post and 
coworkers (37,38) (F.A.P. mechanism) are (see Figure 2): 1) the 
existence of a high energy intermediate (in the presence of high Mg2+ 
concentrations) which will lead to the formation of ATP upon the 
addition of K+ in addition to the expected breakdown of high energy 
intermediate to yield _ Pi; 2) the existence, in the presence of IOlv 
Mg2+ concentrations and in an NEM-treated enzyme, of two high energy 
phosphorylated intermediates, with and without bound ADP. Using a 
a 
F .. A.P. 
b 
R.S .. T. 
Figure 2 .. 
Postulated Reaction Mechanisms 
for Na+K+-ATPase 
, E + ATP ... , __ _ 2 
NEM 
M + 
E·ATP - .... ~ El~P + ADP g b , iii . ;y 
K+ 
E2 - P + ADP---"')E + Pi 
• E + ATP ~ ... - -......-
ADP 
E'\JP + ADP 
p 
a Scheme of Fahn, Albers and Post (37,38). 
b Scheme of Kanazawa, Saito and Tonomura (42) .. 
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special apparatus that allowed for split second reaction times, good 
evidence was provided to demonstrate that one intermediate was 
sensitive and the other insensitive to the addition of AUP. 
In support of the F.A.P. model, Arrhenius profiles have been 
used to support possible conformational changes in Na+K+-ATPase. Two 
distinct discontinuities appeared at 6° and 20° in the Arrhenius plot 
of rat brain Na+K+-ATPase (44). 
Another approach to the detection of conformational changes has 
been the use of fluorescence probes. l-Anilino-8-napthalenesulfonic 
acid has been used for such studies, since it responds to increased 
hydrophobicity in its environment by a decrease in the wavelength of 
its maximum emission (7). The results are cloudy~ since it now 
appears that many of the observed effects are nonspecific (7); 
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thermal inactivation of the enzyme did not affect the fluorescence 
changes observed with the ligands ATP, Na+, and K+. Hellebrigenin-
1,4-sulfonaphthyl-hydrazone and the corresponding strophanthidin 
derivative were used in attempts to find a site specific probe (45). 
Both were biologically active as cardiotonic steroids and displayed 
some interesting ligand effects. Na+ enhanced the fluorescence while 
K+ and other monovalent cations which substitute for K+ suppressed 
it. The order of effectiveness of the suppressing ions (K+>Rb+>Li+> 
CS+>Tl+>NH4+) paralleled the order of affinities for the K+ site. 
Other effects were observed with various combinations of ATP, Mg2+, Pi 
and monovalent cations which all lead to the notion that there are 
conformational changes induced by these ligands for the enzyme. The 
effects could be abolished by 10\'1 pH denaturation or interaction with 
the inhibitor DFP, and, most importantly, were antagonized by 
14 
competition with hellebrigenin for the active site. 
The phosphorylated residue appears by recent evidence to be the 
beta carboxyl of an aspartic acid residue (46). It had previously been 
reported by Trevor~ Rodnight, and Schwartz in 1965 (47) that a serine 
residue was the amino acid phosphory1"ated during ATP hydrolysis, and 
more recent1yby Kahlenburg et al. (48) that it was the gannna carboxyl 
of a glutamate r~sidue. A recent paper employing the use of 3H_ 
borohydride reduction of the acyl phosphate linkage and identification 
of the resulting 3H-w-hydroxyamino acid formed confirms (Post et al.) 
the observations that the a-carboxyl/group of an aspartic acid residue 
is phosphorylated (49). 
B. Cardiac Glycosides. 
The cardiotonic steroids (also called cardiac glycosides or 
'digitalis') are powerful inhibitors of Na+K+-ATPase (50). They have 
been isolated from a wide variety of plants (leaves, flowers, seeds, 
stems, roots, and bark all serve as the source) and from the secre-
tions of toads (51). The cardiotonic steroids have served as 
medicines and as arrow poisons for centuries. The Scottish physician 
William Withering introduced the use of digitalis~ an extract from 
the dried seeds and leaves of purple foxglove, in the late 1700's for 
the treatment of "dropsy" (17,51). His careful study of over 200 
," 
patients set the stage for continued use of digitalis drugs in the 
treatment of cardiac patients. Although Withering recognized the 
powerful action of the drugs on the contraction of the heart, 
enlightenment as to the drugs' actual function has only occurred in 
the mid-1900's. Their specific pharmacologic activity is to increase 
the force of contraction of the heart muscle, diminish the heart rate 
and improve cardiac efficiency. Even today the mechanism by which 
the cardiotonic steroids increase the force of contraction of the 
heart is hotly debated. Recently the use of radio-labelled cardiac 
glycosides has made feasible the study of the distribution of the 
drug in various tissues of the body_ Short term exposure to the drug 
doesn't show a favored uptake by the'heart, but in six hours the 
heart (of a sensitive species) has retained most or all of the 
glycoside taken up (17) while blood levels have dropped drastically. 
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It is accepted by most workers in the field that the specific receptor 
for glycosides in most tissues studied is Na+K+-ATPase; the controversy 
arises over heart tissue for which there are factions divided over the 
mode of action of cardiac glycosides. One group postulates that Na+K+-
ATPase is the primary receptor for the cardiotonic steroids (52) and 
that their mode of action in increasing force of heart muscle 
contraction is through ionic changes caused by inhibiting the "Na 
pump". This inhibition'leads to increased intracellular Na+ which 
causes changes in the distribution of Ca2+ within the cell. Another 
view is that the Ca2+ redistribution ~s a more direct effect of a 
conformational change of Na+K+-ATPase in the membrane upon the binding 
of cardiac glycosides independent of the Na+ effects (53-55). Finally, 
it is postulated that cardiac glycosides bind to other receptors in 
addition to Na+K+-ATPase and this binding influences the contractile 
process (17). 
The basis for the research described here stems from the above 
controversy. The objective was to compare a drug-sensitive species, 
guinea pig, with an insensitive species, rat, in terms of the inter-
actions, of Na+K+-ATPase with cardiotonic steroids. Further, the goal 
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was to characterize Na+K+-ATPase from several tissues of the sensitive 
and insensitive species in terms of their binding and inhibition 
parameters for various cardiac glycosides. 
In addition to the study of the mode of action of cardiac 
glycosides in terms of their positive inotropic effects, cardiac 
glycoside/Na+K+-ATPase interactions have been used in experiments on 
the partial reactions of ATP hydrolysis (see earlier discussion). 
These studies are of particular interest to the biochemist-pharmacolo-
gist as a model for drug-receptor interactions. 
Many interesting observations have been made on structure-
activity relationships (SAR) between cardiac glycosides and Na+K+-
ATPase. The cardiac glycosides fall into two groups, the cardenolides 
and the bufadienolides (see Table 2), with the latter being generally 
more potent inhibitors. Structural features required for binding and 
inhibitory activity are: 1) an unsaturated lactone ring in the beta 
configuration at C-17 of the steroid nucleus; 2) a cis ring juncture 
between the A and B rings of the steroid nucleus; 3) a beta-hydroxyl 
at C-14; and 4) a beta-hydroxyl or beta-glycosidic linkage at the C-3 
position (7,55,60). The cardiac glycosides presented in this disser-
tation are listed in Table 2. 
Until very recently the best SAR studies made On cardiotonic 
steroids were done by toxicity assay .(8,58,64) or inhibition-toxicity 
comparison studies. In 1966, Repke and Portius (64) reported SAR 
studies for a la!ge number of cardiotonic compounds based on their 
inhibitio~ of Na+K+-ATPase. They pointed out the requirement of a 
carbonyl function conjugated with a double 1Jond for inhibitory activity. 
The erythrophleum alkaloid, cassaine, neither possesses a steroid 
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TABLE 2 
Cardiac glycosides of two classes 
cardenolide (c) bufadienolides (b) 
RO 
Steroid R Substitution Class 
Conval1atoxol L-rharnnosy1 CHZOH SS-OH c 
Cymarol D-cymarosyl CH20H SS-OH c 
Digitoxin (3)D-digitoxosyl CH3 c 
Digoxin (3)D-digitoxosyl CH3 12f3-0H c 
Hellebrin D-rhamnosyl + 
D-glucosyl CHO Sf3-0H b 
Ouabain D-rhamnosyl CH20H lS,Sf3,lla.-OH c 
Strophanthidin H CHO Sf3-0H c 
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nucleus nor an unsaturated lactone (as do cardiac glycosides) yet it 
inhibits Na+K+-ATPase (ISO = 0.5 l1r.rO; however, it does have a carbonyl 
conjugated with a double bond in its side chain. They also point out 
that the oxygen function at C-3 is important to inhibitory activity, 
but that the sugar component doesn't appear to be crucial. 
When approaches were developed to study the mechanism of the 
cardiac glycoside/enzyme interaction, hypotheses were advanced to 
explain the SAR. In 1970 Wilson et ala (56) postulated a binding site 
model for cardiac glycoside/Na+K+-ATPase interactions which was 
comprised of three components. The A component reacted optimally with 
the sugar portion of an aglycone monosaccharide; the B component 
interacted with the l4-hydroxyl group on the steroid nucleus; and the 
C component interacted with the lactone ring with preference for the 
bufadienolide type. Applying Wilson's model, Yoda in 1973 studied the 
SAR involved in the dissociation rates of various cardiac glycoside/ 
enzyme complexes (57). He found that the dissociation rate of the 
complex was dependent upon the sugar portion of the cardiac glycoside 
and temperature, but was independent of the aglycone. He suggested 
from his data that the rate determining step of the dissociation 
might be a conformational change that occurred accompanying the 
dissociation of the sugar portion but prior to the dissociation of the 
steroid. In a subsequent paper Yoda.and coworkers (65) described SAR 
studies employing association rates. It was concluded from these 
experiments that the steroid portion of the cardiac glycoside binds 
first and determines the ka - A conformational change following steroid 
binding and preceding sugar binding was proposed. Differences between 
monoglycosides and oligosaccharides of the same steroid are explained 
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by the effect of differences in the bulk effect of the sugar moiety. 
c. Na+K+-ATPase/Cardiac Glycoside Interactions--Inhibition. 
Cardiac glycosides inhibit the hydrolysis of ATP by Na+K+-ATPase. 
The rate of such hydrolysis and consequently the degree of inhibition 
can be measured by determining the rate of release of Pi from ATP 
under suitable conditions. Ten millimolar glycoside will totally 
inhibit all known Na+K+-ATPases. Some preparations are fully inhibi-
ted by concentrations as low as 1 x 10-4 M. Concentrations of 
glycoside lower than the fully-inhibitory ones bring about degrees of 
inhibition that are related to the concentration. Within the r~nge 
of inhibitory concentrations the degree of inhibition is proportional 
to the logarithm of the glycoside concentration. Cardiac glycosides 
interact with Na+K+-ATPase at a site which is specific for cardiotonic 
steroids and is thought to be located on a hydrophobic protein, 
possibly the glycoprotein subunit (66). Most of the knowledge on this 
interaction has been elucidated, up until fairly recently, by studying 
the inhibitory effects of cardiac glycosides on Na+K+-ATPase. 
Inhibition is time~ temperature, glycoside concentration, ligand 
concentration, tissue and species dependent. This complexity, in all 
probability, explains the diversity of the experimental observations--
large variations in observed ISO val~es, claims of irreversibility 
versus reversibility of the enzyme glycoside interaction, the questioned 
necessity of a pho'sphorylated form of the enzyme to which the glycoside 
binds, whether K+ and glycosides compete for the same binding site. 
It has generally been accepted that in the assay of Na+K+-ATPase 
the Na+/K+ ratio should be between 5/1 (67) and 10/1 (1) with the Na+ 
level at 100 mM~ and that the-Mg 2+ concentration should be at least 
tlvice that of ATP (7,68). It would appear, though, that the maximum 
inhibition by cardiotonic steroids occurs at Na+/K+ ratios much 
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higher, i.e. 100/1 (69). If the concentration of potassium is reduced> 
the ISO value is also reduced (8,67,70). Sodium increases at constant 
K+ concentrations also lead to an increase of the ISO value (69). 
Matsui and Schwartz (69) concluded from their kinetic studies of the 
effects of Na+ and K+ on the inhibition that it was impossible to 
separate the two effects and that the Na+/K+ ratio was the important 
determinant. The K+ effect is not thought to be a competition between 
cardiac glycoside and K+ for a particular site as was earlier 
postulated (67). It has more recently been postulated by Wolf and 
Peter (71) that the binding of K+ induces a conformational change 
which decreases the binding of ouabain. This conclusion was arrived 
at on the basis of an observed partial competition between K+ and 
ouabain and the assumption that the relative degree of ouabain 
inhibition is independent of the Na+ concentration. The differences 
in ISO values for various enzyme preparations reported in the litera-
ture may be a result of not only differing affinities for various 
glycosides, but also the result of different affinities of the enzyme 
for K+ and/or Na+ (71). 
Further evidence of the occurrence of a conformational change as 
the result of K+ binding to the enzyme is provided in studies employing 
F- as an inhibitor (72). The fluoride-inhibited enzyme can be 
reactivated at a much faster rate than K+-complexed fluoride 
inactivated enzyme, which suggests that a change in conformation 
occurs when the inhibited enzyme is exposed to K+. 
An unusual phenomenon which has been observed is the stimulation 
of Na+K+-ATPase by cardiac glycosides at low concentrations (usually 
less than 1 x 10- 8M) (8,11). This stimulation is not altered by 
varying the K+ concentration from 0.01 - 25 mM (11). It has been 
suggested, as an explanation, that low ouabain concentration affects 
the conformation of the enzyme in a way dependent upon pre~reaction 
conditions (11). 
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An interesting observation lias made by Godfraind and DePover (73) 
when ISO values for guinea pig heart ATPase (0.22 ~M) were compared to 
the values for half saturation of the atria (0.21 ~), fifty percent 
inhibition of K+ uptake (0.24 ~M), and fifty percent inotropic effect 
(0.28 ~M) caused by digitoxin. The authors suggest that these results 
are indicative of at least a superficial relationship between Na+K+-
ATPase inhibition and the cardiotonic effects of the glycosides. 
There is great variation in species sensitivity to cardiac glyco-
side inhibition (74). At divergent ends are the rat and toad 
(insensitive species) as compared to the guinea pig, dog, cat, frog, 
pigeon and human (sensitive species)~ The ISO values for the rat and 
toad cardiac Na+K+-ATPases are in the range of 0.7 - 1.0 x 10-4 M 
ouabain (74). The corresponding values for the sensitive species are 
as lo\v as 5 x 10-8 M and as high as 7 x· 10-7 (74). Repke demonstrated 
a 100 fold difference in the inhibitory concentrations for rat and 
guinea pig cardiac Na+K+-ATPases (70,74). Allen and Schwartz (75) 
offered as a possible explanation that the glycoside-enzyme complex 
formed by Na+K+-ATPase from a sensitive species was more stable than 
the complex formed by the enzyme from an insensitive species. Since 
this conclusion was drawn from binding studies which were carried out 
under high concentrations of glycoside there is some question as to 
validity. 
D. Binding Methods and Experimental Data Interpretation. 
Binding of a ligand by a protein can be measured in many 
different Ways. The choice of the method is dependent upon the 
chemical and physical characteristics of not only the binding protein 
but also of the ligand. Several generally used methods cited in 
Edsall and Wyman (76) are: equilibrium dialysis~ ultrafiltration 7 
spectroscopic measurements, electrophoretic mobility studies, and pH 
changes associated with binding. The list given is by no means all~ 
inclusive. The list does leave out a distinctly useful method which 
is dependent upon an easily pelletable protein and a radioactively 
labelled ligand. The latter method allows quantification of the 
bound species by radioisotopic detection and is dependent upon 
separation of the bound ligand from the unbound ligand by centrifuga-
tion of the pelletable protein followed by physical separation of the 
two phases. Since the studies herein were carried out on a partially 
purified membranous protein, the latter method proved the most con-
venient to use for the study of the binding of cardiac glycosides-3H 
by ATPase. Large numbers of samples could be handled simultaneously. 
This allowed the study of not only several glycosides under a 
multiplicity of conditions but also the comparison of ATPase from 
several tissue sources under various conditions. 
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For a binding process, the association constant (Ka), is obtained 
from the expression, Ka = (n-:)[u] , where b = bound ligand, n = 
number of binding sites and [ul = concentration of free ligand. 
The analysis of experimental binding. data obtained using one of 
the above methods can be accomplished by the use of one of the follow-
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ing methods of plotting the data. Each of these approaches \vill allow 
the determination of at least two binding parameters, i.e. the affinity 
constant (Ka) and the number of moles ligand bound per mole of protein 
(n). The methods and their axis determinants are; direct plot, b vs 
[u]; logarithmic plot, b vs log [u]; reciprocal plot, lib vs l/[u]; 
Scatchard plot b/[u] vs h. 
The "direct plot" (76) (see Figure 3a) is the simplist way to 
analyze experimental binding data for a single set of binding sites 
(76). It is represented by the following formula: b = nKa[u] , 
1 + Ka[u] 
and appears as a rectanglular hyperbola for a single set of binding 
sites. The curve asymptotically approaches the horizontal where b=n 
is the limiting case. Thus Ka can be determined from the unbound 
concentration at b = n/2. If there is more than one set of binding 
sites the curve does not follow the "ideal" rectangular hyperberola, 
but instead approaches the horizontal much more gradually (see 
Figure 3a). This makes the determination of the line b = n difficult 
and therefore the values for nand Ka quite inaccurate. This is the 
actual case in most attempts to use this method, and therefore highly 
accurate values are usually not obtained. 
The logarithmic plot (76) (see Figure 3b) is simply a titration 
curve where a wide range of unbound ligand ([ul) may be plotted. For 
a single set of equivalent sites the following equation expresses the 
logarithmic plot: log Ka + log [u] = log b The Ka is obtained 
n-b 
from the value of log [u] when b = n/2 and is expressed in the equation 
as -log Ka- n is not accurately obtained by this method; therefore, 
if the n value is not already known, the Ka cannot be accurately 
obtained either. The method may be used to determine \ihether one, or 
Figure 3. A graphical display of three methods for plotting experi-
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more than one, class of binding sites is represented by particular 
data, and an approximate n may be determined for such data from the 
shape of the curve~ 
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The reciprocal plot (76) (see Figure 3c) is another method of 
plotting binding data which best deals with single sets of equivalent 
binding sites. From the equation for the reciprocal plot, lib = lIn + 
lIn Ka [u], it is seen that both nand Ka may be determined directly 
where lin is the intercept on the try" axis and the slope is given by 
I/Kan. If an attempt is made to use this plot on data which arises 
from two sets of equivalent sites, interpretation becomes difficult. 
It is only at high unbound concentrations that a marked deviation from 
l~nearity should be observed. This is an area of the plot where it is 
difficult to differentiate normal data scatter from the deviation from 
linearity that should be observed as a result of a second set of 
equivalent binding sites. Therefore, in practice, it is difficult to 
know \vhether the deviation from linearity is actually present. 
The last method to be·considered is the Scatchard plot (76) (see 
Figure 4), which can be represented by the following expression, 
b/[u] = Ka (n-b). The Scatchard plot was chosen to represent the 
experimental binding data in this work since it yields the best 
estimates of the affinity constant, Ka, and the number of binding sites, 
n, where more than one class of binding sites exists. This mode of 
expressing the data places less emphasis, than the reciprocal plot, on 
values of b obtained at very low [u] values and more evenly weights 
different portions of the curve (76).. Therefore, even though there 
may be some difficulty in extrapolating from a conspicuously non-linear 
curve, the Scatchard plot still allows good approximations of nand Ka 
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Figure 4. Example of Scatchard plot: Binding of convallatoxol-3H to 
Na+K+-ATPase. 
The number beside each set of data points refers to the total 
molar concentration of convallatoxol. The dashed line (-~~) is drawn 
from the value n/2 up to the curve; from this intercept the BSO con-
centration can be calculated using the Scatchard relationship. n, 
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to be made from non-linear curves. 
In the present work n (Figure 4) is taken to be a relative value 
describing the number of binding sites per mg protein, and nKa divided 
by n yields Ka , the affinity constant or "intrinsic association 
constant" (76) for the binding site. The association constant, Ka , 
then describes the affinity of the ATPase binding site for the ligand, 
CG. Therefore, comparisons between Ka values for different cardiac 
glycosides should yield the relative affinity of the enzyme, Na+K+-
ATPase, for these glycosides. 
If n is the amount of CG bound at full saturation of a specific 
set of binding sites, then n/2 describes the amount of CG bound at 
half saturation. In the Scatchard plot shown (Figure 4), it is 
apparent that the value of n/2 is achieved by a total CG concentration 
near 3 x 10-8 M. This CG concentration may be calculated from the 
Scatchard relationship. When b = n/2, the following substitutions 
into the Scatchard equation will give the unbound CG concentration: 
n/2 · l/[u] = Ka (n - n/2) 
[u] = l/Ka 
Therefore, the free or unbound CG at n/2 can be determined directly 
from the slope of the Scatchard plot. the value for b at n/2 can also 
be obtained directly from the Scatchard relationship. This can be 
converted to concentration units. If [u] and [b] (for n/2) are summed 
the total concentration of CG can be obtained which SO% saturates the 
high affinity site (designated BSO) 
E. Na+K+-ATPase/Cardiac Glycoside Interactions --Binding. 
Several groups have shown that there is a parallel relationship 
between the degree of binding of glycosides and the extent of 
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inhibition caused by glycosides under like conditions (11,75,77-79). 
Under conditions similar to those which lead to the phosphorylation 
of the enzyme (either in the presence of ATP, Mg2+ and Na+, or in the 
presence of Mg2+ and Pi) maximal binding is observed for any given set 
of time and temperature conditions (75,77-80). It has been reported 
that the number of "high affinity binding sites closely approximates 
the number of sites phosphorylated (77,81). This supports the postu-
late that a phospho-enzyme is the binding form of Na+K+-ATPase. It 
has been suggested that some binding does occur in the presence of 
Mg2+ only (78), but it is not of the magnitude observed if a phosphate 
source is present. 
An interesting experiment supports the need for a phosphorylated 
form of the enzyme as the one to which the glycoside binds. Tobinet 
al. (80) demonstrated that an analogue of ATP, S,y-methylene ATP, 
bound to the enzyme in such a fashion as to compete with ATP binding. 
The analogue is not hydrolyzed by the enzyme. In the presence of 
S,y-methylene ATP, Na+, and Mg2+ there was only one percent of the 
ouabain binding observed in the presence of ATP, Mg2+, and Na+. If 
both ATP and S,y-methylene ATP were added, there was only 66% of the 
ouabain binding observed when ATP was present alone. 
Although there is much to learn about the form of the enzyme 
which binds cardiac glycosides, the following summarizes the known 
ligand effects on this binding. Microsomal eel electroplax Na+K+-
ATPase binds ouabain in~a slow "reaction (82) the rate of which can be 
modified by the following ligands: ATP, orthophosphate~ Mg2+, Na+ and 
K+. Two alternate path\~ays are observed: 1) Na+ stimulated, ATP-
dependent glycoside binding and 2) Na+-inhibited Pi-dependent 
glycoside binding (82). The first pathway can utilize numerous 
organic phosphate ligands as magnesium complexes (80), while the 
second is MgHP04 or Mg2+ dependent. The' first pathway is inhibited 
by K+ while the second is inhibited by Na+ and K+ (82-85,79). The 
free phospho-ligands are found to be inhibitory thus making Mg2+ an 
obligatory ligand (82). 
It can be concluded that cardiac glycosides bind preferentially 
31 
to the E2-P form of the enzyme (see Figure 1) and may also bind to the 
E2 form at a much slower rate (36). It is proposed that the ability 
of Na+K+-ATPase to bind glycosides in the presence of Mg2+ and Pi may 
be related to the E2 form of the enzyme. This latter postulate arises 
from the small amount of binding which is observed in the presence of 
Mg2+ but in the absence of a phosphate source (86). The binding may 
be through the E2 form of the enzyme or a similar form which is slowly 
formed in the presence of high concentrations of Mg2+. 
As mentioned previously the enzyme system has several features 
which may be related to its binding of cardiac glycosides. First, 
Na+K+-ATPase is most probably composed of at least two subunits, one 
a phospholipid containing protein. Second, the system appears to have 
ligand sites separated by the width of the membrane, i.e. Na+ and ATP 
sites on the inside and K+ and cardiac glycoside sites on the outside 
of the membrane. Third, although a good relationship between the 
binding of glycosides and the specific activity of the enzyme has been 
established in several cases (79,87), binding has been observed under 
certain conditions that is unrelated to the enzymatic ability to carry 
out the hydrolysis reaction (88). It is of interest to relate these 
facts to the observation of Rivas et ala (66) that 3H-ouabain binds to 
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a hydrophobic protein different from the one which is labelled with 
32p in phosphorylation experiments. The latter observation correlates 
with the RBC membrane work which demonstrates separation of the 
various ligand sites, some being on the inner surfa~e and some on the 
outer surface of the membrane. 
The role of phospholipids in Na+K+-ATPase binding of ouabain has 
been thoroughly studied by Taniguchi and Iida (81). They observed 
that ouabain binding rates were unaltered in the presence of either 
Mg2+ and ATP or Mg2+, Na+ and ATP after phospholipase A treatment. 
The rates were, however, altered in the presence of Mg2+, K+ and ATP, 
Mg2+ and Pi, or Mg2+ alone after phospholipase A treatment. This 
s~ggested that there are at least two binding conformations, one in 
which phospholipids play a role and the other where they are not 
involved. As would be expected, the Kd's were unaffected for the 
first set of conditions and were increased for the second set. 
Of great interest is the controversy over the reversibility of 
the Na+K+-ATPase/glycoside complex. Reports of reversibility of 
binding (50,57,89-95» binding difficult to reverse (96), and virtually 
irreversible complexes (77,97) are scattered throughout the literature. 
It would appear that several factors enter into the problem. Species 
differences appear to be the determining factor, although improper 
experimental conditions can lead to the false conclusion of irreversi-
bility. The latter situation was pointed out in a paper by Allen, 
Harris and Schwartz (98). They demonstrated that K+ would interfere 
with the reversibility of 3H-ouabain binding in the presence of Mg2+, 
+ ATP and Na. This most certainly explained the irreversibility 
reported by Yoda and Hokin (99) in calf brain dissociation experiments 
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where they added K+ to their dissociation medium. Numerous papers 
have dealt with this problem, but the most complete study was described 
in two papers by Yoda and coworkers (57,65). Both association and 
dissociation rate constants were measured for beef brain Na+K+-ATPase 
glycoside interactions. The ka (for the complex formed in the presence 
2+ + 2+ -of either ATP, Mg and Na or Mg and Pi) was dependent upon the 
nature of the steroid moiety (aglyconE0. The rank order of the 
cardiac glycosides was the same when based on either ka or ISO. The 
kd for the complex formed in the presence of Mg2+ and Pi was dependent 
upon the nature of the sugar and the temperature but not upon the 
steroid. Erdmann and Schoner (95) have demonstrated graphically the 
effect of temperature on the dissociation rates. At 0° ouabain-enzyme 
complexes of beef kidney, heart and brain as well as dog heart are· 
stable for hours, losing less than 10% bound glycoside in 9 hours. At 
37°C 50% of the ouabain has dissociated in less than 2 hours. The 
same effect has been noted for guinea pig kidney (92) where the 
binding appeared irreversible at O°C and was completely reversible at 
37°C (see Table 3). The Yoda papers (57,65) did not include 
bufadienolides or an enzyme which appears, to date, to bind 'irrevers-
ibly', Electrophorous electric organ Na+K+-ATPase (77). It would seem 
that the condition of irreversibility of the ATPase/glycoside complex 
is more a problem of experimental conditions than fact. Since time, 
temperature, pH, species, glycoside and ligand composition all 
contribute to the stability of the ATPase/glycoside complex, it is not 
surprising that confusion prevailed in the past. There is no indica-
tion that a covalent bond is formed in the process, and therefore 
there is no reason to expect that, under proper conditions, an 
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equilibrium cannot be reached. 
Table 3 is a compendium of various equilibrium and rate constants 
for the glycoside/enzyme complexes of several species. The Ka values 
were approximated from literature data for comparison with the values 
given in this dissertation. Of particular interest to this dissertation 
are the values given for the various 'guinea pig and rat tissues. It 
" appears that these tissues have Na+K+-ATPases that are readily 
reversible. 
In 1969, Allen and Schwartz (75) advanced the idea that the reason 
the rat was insensitive to cardiac glycosides involved Na+K+-ATPases 
(from rat kidney and heart) that were temperature and time independent; 
they also suggested that the enzyme/glycoside complex was much less 
stable than those derived from the enzymes of sensitive species. They 
claimed maximal binding to rat Na+K+-ATPase occurred in less than 
three minutes. They also reported removal of the ligand by simple 
washing of the enzyme pellets. Their method for expressing the 
experimental binding data was the 'direct plot' (see earlier discussion). 
The use of this method could have led .the authors to draw the 
possibly false conclusion that they were observing a specific binding 
of glycoside by Na+K+-ATPase from the rat heart. It seems ~ighly 
questionable whether the observed binding was specific or non-
specific. 
The present study undertook the task of invest.igati!lg various 
guinea pig and rat Na+K+-ATPases in terms of their ability to bind 
several glycosides specifically. The Scatchard plot was chosen as the 
most sensitive method to analyze the experimental binding data. 




















Binding constants for Na+K+-ATPase from various sources 
glycosidea 
ouabain 
2.5 x 10-7 M 
ouabain 
1 x 10-7 M 
~ 1 x 10-6 M 
ouabain 








1.7 x 10-7 M 
ka 
°c Ka ,10-7M-l Kd,108M ~M-lmin-l 
assoc t~ 
min 





37 4.0 2.5 
37 2.5 




















+ + Na K -ATPase 
Source ref. glycosidea 
dog kidney (101) ouabain 
1 x 10-6 M 
beef brain (92) ouabain 
beef brain (81) ouabain 







lamb brain (89) ouabain 
5 x 10- 7 M 
electrophorus (82) ouabain 
electricus 1 x 10-5 M 
calf brain (83) ouabain 
1 x 10-6 M 
TABLE 3 (continue~) 
ka 




ATP,Mg2+ and Na+ 
37 71.4 0.14 0.3 
37 0 .. 56 18.0 
37 0.83 12.0 
37 
37 >4.35 2.61 

















TABLE 3 ( continued) 
Na+K+-ATPase k assoc t~ kd dissoc t~ a 
Source ref. glycosidea °c K lO-7M- 1 Kd,108M 11M-lrnin -1 mln 10-4s- 1 min a' 
Pi and Mg2+ 
beef brain (81) ouabain 37 0.91 11.0 
beef kidney (95) ouabain 37 21.3 0.47 1.11 0.94 
beef heart 32.2 0.31 2.17 0.99 
beef br.ain 35.7 0.28 2.78 1.33 
dog heart 23.2 0.43 3.27 2.31 
guinea pig 
kidney 0.62 16.2 1.05 24.5 




guinea pig (102) ouabain 37 
kidney 1.6 2.5 
heart 1.6 2.0 
brain 1.6 'V20 
a glycoside concentration given is that used either to saturate enzyme prior to dissociation studies or 
to estimate association times and Kd values. 
b estimated from data given. 










The labelled cardiac glycosides convallatoxol-3H (441 mCi/mmole) 
and cymarol- 3H (498 mCi/mmole) were prepared in this laboratory by the 
reduction of convallatoxin and cymarin-with-NaB3H4 respecti~elyl. 
Ouabain- 3H, (1080 mCi/mmole), digoxin- 3H (827 rnCi/mmole) and digitoxin-
3H (533 rnCi/mmole) were obtained from New England Nuclear Corporation. 
Some of the unlabelled glycosides were purchased from Mann Research 
L~boratories (ouabain), Pfaltz and Bauer, Inc. (digoxin), S. B. Penick 
and Co. (digitoxin), Fluka AG (cymarin), and L. Light and Co., Ltd. 
(convallatoxin). Cymarol and convallatoxol were prepared by NaBH4 
reduction of cymarin and convallatoxin respectively. Hellebrin was 
kindly donated by Dr. W. E. Scott of Hoffmann-LaRoche, Inc. Purity 
of these compounds was established by thin layer chromatography'. Tris-
ATP was purchased from Sigma Chemical Co. All other chemicals were 
obtained from commercial sources, were of reagent quality, and were 
used without further purification. Deionized water that was subsequently 
glass distille~ was used in all aqueous solutions. 
B. ATPase Preparation. 
In all cases both fresh and frozenCPel Freeze, Rogers, Arkansas) 
guinea pig and rat tissues have been used in preparing the enzymes. 
Equivalent results were obtained \'1ith fresh and frozen tissues. Each 
preparation yielded enough enzyme to carry out a complete set of 
binding and inhibition experiments. The guinea pig heart enzyme was 
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studied with respect to variations among identically prepared batches. 
Each preparation was carried out entirely at 0-4°C. The volumes 
for homogenization and resuspension of the pellets are based on weight 
of the original tissue. The Na+K+-specific activities of the enzyme 
preparations are reported as ~moles Pi released per mg of protein per 
hour. 
Guinea Pig and Rat Ventricle ATPase: A modification of the 
method of Matsui and Schwartz (105) was used to prepare ventricle 
Na+K+-ATPase. Approximately 30-40 hearts (30-50 g ventricular tissue) 
were trimmed, chopped and homogenized in a Sorvall Omni-Mixer for 40 
sec at medium speed in 9 volumes of 0.25 M sucrose-I.O roM EDTA 
(adjusted to pH 7.4 with Tris). The homogenate was filtered through 
cheese cloth and centrifuged in a Sorvall RC2-B centrifuge at 1020 x £ 
(Sorva11 GSA - 2500 rpm) for 10 min. The resulting pellet was resus-
pended in 8 volumes of 0.25 M sucrose-l.O ruM EDTA (pH 7.4), rehomogen-
ized for 30 sec at low speed, and an appropriate amount of 10% sodium 
deoxycholate (DOC) was added to yield a 0.1% DOC solution which was 
then homogenized for 2.5 min at low speed. The DOC treated solution 
was centrifuged at 23,300 x g (Sarva!l GSA - l2~OOO rpm) for one hour 
yielding a pellet which again was treated with 0.1% DOC in 7 volumes 
of 0.25 M sucrose - 1.0 roM EDTA (pH 7.4). The two supernatants were 
combined to give a solution which was centrifuged at 68,000 x g 
(Beckman 42 - 28,500 rpm) in a Beckman L2-6s ultracentrifuge for one 
hour. The 68,000 x g pellet was resuspended in 1.1 volumes of 1.0 mM 
EDTA (adjusted to pH 7.4 with Tris) with a Dua11 glass homogenizer 
using a Teflon pestle. The final suspensions had protein concentra-
tions of 0.12 -0.15 mg protein/SO 1-11. The specific activities of the 
ventricle Na+K+-ATPase preparations were 8-14 and were stable at this 
level for approximately one month at -20°C. 
Guinea Pig Kidney Cortex ATPase: The method of preparation of 
kidney cortex ATPase was essentially the same as for the ventricle 
ATPase with the exception. that the original centrifugation step \vas 
carried out at 4900 x g (Sarvall GSA - 5500 rpm) for 15 min. The 
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final 68, 000 x g pellet was resuspended in 1.1 volumes of 1. a JIli\1 EDTA 
(pH 7.4) yielding a protein concentration of 0.22 mg/50 ~l. The enzyme 
suspensions had Na+K+-ATPase specific activities of 8-12. The enzymic 
activity was stable for at least 6 months. 
Guinea Pig and Rat Brain ATPase: A slight modification of the 
method of Uesugi et ale (106) was used to prepare brain ATPase. The 
grey matter was aspirated from approximately 3S brains yielding about 
100 g of tissue. Cold 0.9% saline was used to wash the aspirated 
tissue into a collection flask~ The suspension of grey matter was 
centrifuged at 650 x g (SoTvall GSA - 2000 rpm) as it was obtained. 
The supernatant was reused for collecting additional grey matter. In 
this way the total volume of saline required was kept to a minimum, 
2 1. Finally centrifugation at 1465 x g (Sorvall GSA - 3000 rpm) for 
15 min was carried out and the recovered tissue weighed. The resulting 
pe1letwas resuspended in 8.5 volumes of 0.32 M sucrose - 1.0 ruM EDTA 
(adjusted to pH 7.4 with Tris), homogenized in a Sorval1 Omni-Mixer 
for 40 sec at medium speed, and centrifuged at 10,400 x £ (Sorvall GSA 
- 8000 rpm) for 20 min. The resulting supernatant was centrifuged in 
a Beckman 42 or International A-l47 rotor at 27,500 x R (19,000 rpm) 
for 3 hr in either a Beckman L2-65 or an International Model 60B 
ultracentrifuge. This pellet was resuspended in one volume of 
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distilled water (pH adjusted to 7.4 with Tris), and treated with an 
equal volume of 4 M NaT. The 27,500 x g pellet obtained following NaI 
treatment was washed three times by suspension in 0.8 volume of 
distilled H20, adjusted with Tris to pH 7.4, followed by centrifugation 
at 27,000 x g (Sorva1l SS-34 15,000 rpm). The final suspension of 
this NaI treated enzyme was in 0.8 volume Tris distilled water (pH 7.4), 
yielding a protein concentration of O.lS mg/50 ~1 with a Na+K+-ATPase 
specific activity of 24-35. The original specific activity was· 
retained for a month and a specific activity of at least 16 was main-
tained for approximately 3 months. 
c. ATPase Assay_ 
ATPase was assayed by a modification of the method of Matsui and 
Schwartz (105). The reaction mixture contained a total volume of O.S 
ml SO ~l of 20 roM ATP ,(Tris salt); 50 III of a combined 0.5 M Tris, 
10 roM EDTA, SO roM MgC12 solution; SO III of a combined 1 M NaCl, 0.2 M 
KCl solution; made up to 0.45 ml with an appropriate amount of cardiac 
glycoside solution and/or water. The assay components were preincu-
bated for 5 min at 37°C and SO ~1 of the ATPase suspension (0.07 -
0.22 rug protein) was added to start the reaction. The incubation was 
carried out for 10 min at 37°C on sample and control tubes. The 
reaction was stopped by the addition of 2.1 ml of cold 5% TeA to the 
assay mixture. This TeA treated solution was centrifuged in an lEe 
model UV centrifuge at 1500 rpm for 10 min. A 2.0 ml aliquot of the 
supernatant was used t.o measure liberated Pi by the method of Fiske 
and SubbaRow (107). Na+K+-ATPase activity was calculated by the 
difference in activity with and without complete inhibition by ouabain 
(5 x 10-4 M). Protein was determined by the.method of Lowry et al. 
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(108). 
D. Inhibition Studies. 
Experiments to determine 50% inhibition of the enzyme were carried 
out under assay conditions as stated above with varying amounts of 
cardiac glycoside (1 x 10-8 to 2 x 10-2 M) and varYl~g amounts of K+ 
(0.16 - 20.0 ruM). The concentration of glycoside required for 50% 
inhibition of the Na+K+-ATPase activity is referred to as ISO. 
E. Binding Studies. 
Experiments carried out to determine the binding parameters were 
done in a total volume of 0.25 ml, containing all the substances in 
identical concentrations as in the assay with the exception of KCl. 
KCI was omitted in order to obtain optimum binding conditions, and 
0.625 roM KCl was used in experiments designed to yield binding para-
meters which could be compared with inhibition values. Preincubation 
at 37°C for 5 min preceded the start of the reaction by the addition 
of SO ~l of the same enzyme suspension. Incubation at 37°C for 10 min 
was terminated by cooling the tubes on ice. The reaction mixture was 
centrifuged at 27,000 x g (Sorvall SS-34, 15,000 rpm) for 30 min. 
This centrifugation was sufficient to sediment essentially all of the 
ATPase activity. A 200 ~1 aliquot of the supernatant was pipetted 
into a counting vial, followed' by 0.5 rol of water and 10 m! of 
Triton-toluene scintillation solution (109). This supernatant aliquot 
was then counted to determine unbound cardiac glycoside. The excess 
supernatant was removed from the pellet with a pipet, the tube 
swabbed and the pellet resuspended in 0.5 m! water. The tubes were 
kept on ice until this process was complete. A 400 ~l aliquot of the 
resuspended pellet was pipetted into a counting vial, and 0.3 ml of 
water was added follo\ved by the Triton-toluene scintillation mixture. 
This aliquot of the resuspended pellet was counted to yield the value 
for bound cardiac glycoside. All samples were counted on a Packard 
Tricarb 3320 and in all cases at least 5000 counts were accumulated. 
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The final form of the data was in pmoles cardiac glycoside/mg protein 
for the bound portion. The unbound fraction \vas expressed as molar 
concentration. A full binding study utilized a concentration range 
fr'o"in 1 x' 10- 8 to 3 x 10-5 M cardiac "glycoside with a specific activity 
range from 2.5 to 666 mCi/mmole (see Table 4). Several experiments 
employing 1 x 10-9 M cardiac glycoside solutions did not yield 
consistently higher bound/unbound cardiac glycoside ratios. From this 
it was assumed that a concentration of 1 x 10-8 M was closely 
approaching the limiting value of nKa (see discussion of the Scatchard 
plot)~ and therefore concentrations of less than I ~ 10-8 M were not 
regularly used in binding studies. 
The experimental binding data in this dissertation were treated 
so as to. yield values which could be plotted by the Scatchard method 
(see earlier discussion). The radioactivity of the supernatant was 
used to calculate pmoles of cardiac glycoside unbound, and the pellet 
values to calculate pmoles cardiac glycoside bound. From these 
results the bound to unbound ratio was calculated. An extrapolation 
was carried out for each plot to yield the binding parameters·n, nKa 
and Ka. The n values are given in units of pmoles CG bound/mg protein; 
the Ka va1ues'are expressed as reciprocal molar concentrations. 
The binding experiments were carried out in total volumes of 0.25 
rul whereas the inhibition studies were in 0.5 mI. The amount of 
protein was the same in both cases. Therefore, the BSO values have been 
TABLE 4 
Specific activities of glycosides used in binding studies 
The tritiated glycosides ,~ere diluted with appropriate amounts 
'of'the corresponding unlabeled compounds to yield the 'indicated 
specific activities, which were suitable for accurate estimates of 
binding at the various stated concentrations. 
~101ar Specific Activity in m~i/mmole 
Concentration 
of Glycoside Convallatoxol Cymarol Digoxin Digitoxin Ouabain 
1 & 3 x 10-8 441.0 401.0 665.0 666.0 665.0 
1 & 3 x 10-7 263.0 211.0 33.2 33.2 $3.3 
1 & 3 x ,10-
6 26.3 21.1 3.3 3.3 3.3 
1 & 3 x 10-5 19.8 15.8 2.5 2.5 2.5 
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calculated to yield the or,iginal concentration of cardiac glycoside' 
required to give half saturation of the binding site had 0.5 ml, 
rather than 0.25 ml, been used. 
To establish that a condition of equilibrium existed between 
glycoside- 3H and ATPase, incubations were carried out under standard 
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binding conditions plus a second incubation that employed a replacement 
of glycoside- 3H with cold glycoside. A fixed amoUnt, of enzyme and 
tritiated cardiac, glycoside (1 x 10"",8 M) were allowed to" interact at 
37°C for a fixed time interval. This incubation was terminated by 
cooling on ice as usual. The samples were then centrifuged as usual. 
The supernatant-A (see Figure ~) was totally removed and an aliquot 
counted. The pellet-B was resuspended in the same reaction medium 
with the substitution of 1 x 10-5 M cold glycoside for the glycoside-
3H. The resuspended pellet including any enzyrne-glycoside- 3H complex 
was incubated for varying time periods (2.5-60 minutes) at 37°C and 
the incubation was again terminated, the contents centrifuged, and 
the prot,ein and supernatant assayed for tritium. Counts from the 
pellet-D plus the second supernatant-C represent those counts that 
were present in the original pellet-B. The data therefore contains 
an expression of the original equilibrium (original bound = C + D; 
original unbound = A; and the original b/u ratio = C + D and the 
, A, 
degree of dissociation (bound = D; unbound = C; and blu = Die) at 
various times. 
Figure S. A protocol for the binding studies used to determine 
dissociation data. 
Samples A, C, D were counted to yield the experimental binding 
data; C and D are representative of the unbound and bound for the 
dissociation phase of the experiment. 
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A. Guinea Pig Brain, Kidney and Heart Na+K+-ATPase. 
ATPase Assay: The assay of Na+K+-ATPase consists of two steps, 
"'-
the first of which is the enzymatic cleavage of the y-phosphate from 
ATP under the appropriate conditions (see Experimental Methods) either 
in the p~esence or absence of 1 x 10-3 M ouabain. In the absence of 
ouabain both Mg2+ and Na+K+-dependent~ ATPase activities are expressed, 
yielding a total production of Pi that is higher than the value 
obtained in the presence of ouabain. In the latter case the Na+K+-
ATPase activity is inhibited, and therefore the production of Pi 
under these conditions is an expression of Mg2+-dependent ATPase. The 
+ + Na K -ATPase activity is obtained as the difference between the two 
values. The second step of the assay is a colorimetric determination 
of the Pi produced in the enzymatic incubation. Typical data for a 
K2HP04 standard curve are shown in Table S. From such data was 
obtained the value A660 units/~mole Pi that was used to convert 
absorbance readings into units of enzyme activity. This value is 
given in each assay or inhibition table (s~e Appendix Tables 1-10). 
Also included in Table 5 are example enzyme assay data like those used 
to calculate the Na+K+-ATPase specific activities cited for each table 
of assay or inhibition data. 
Each guinea pig Na+K+-ATPase displayed a linear production of Pi 
over the time period in which all assays were carried out. There was 
also, a linear increase in the rate of production of Pi with a 
TABLE 5 
An example set of data for the enzymatic assay of Na+K+-ATPase, 
including the standard curve for phosphate determination 
so 
Guinea pig heart Na+K+-ATPase (4.4 mg protein/ml) was assayed 
under the conditions described in Experimental Methods at a K+ concen-
tration of 0.625 roM for 10 minutes; the value obtained from the 
phosphate standard curve, 1.27 A660 ~its/~mole Pi, was used to con-
vert the assay absorbance values into activity values. 














1.27 A660 units/~mo1e Pi 
Enzyme Assay at 0.625 roM K+ 
Enzyme A660 Activitya 
1 .164 22.4 
2 .152 20.7 
3 .151 20.6 
4 .163 22.2 
Enzyme + Ouabain 
1 .085 11.'6 
2 .094 12.8 
3 .075 10.2 
aEnzyme -(Enzyme + Ouabain)= 
Na+K+-ATPase Activity 
(10.0 llmo1es Pi/mg Pro/hr) 
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progressive increase in enzyme concentration (see Appendix Table 1). 
ATPase Activity as a Function of K+ Concentration: Figure 6 
demonstrates that the activity of preparations from all three guinea 
pig organs varies with K+ concentration. It can be seen that 0.625 ruM 
K+ gives adequate ATPase activity to allow activity measurements for 
all three ATPase preparations. This concentration of K+ is also 
sufficiently low for binding studies, as discussed below. Although 
heart and kidn·ey·preparations have approximately the same specific 
activity, the activity measured for heart ATPase at 0.625 mM K+ is 
only 45% of its maximal act~vity whereas kidney is at least 95% of its 
maximal activity. 
ATPase Inhibition as a Function of K+ Concentration: Figure 7 
demonstrates that the effective concentration of CG required to cause 
50% inhibition occurs at a much lower glycoside concentration in the 
presence of 0.625 mM K+ than in the presence of 20.0 rnM K+. This 
dramatic difference (Table 6) is evident in the inhibition studies 
of each of the enzyme preparations, i.e. guinea pig heart, kidney, 
and brain (data for the determination of ISO values, Appendix Tables 
5-9). Differences are about 30-200 fold for brain, 20-80 fold for 
kidney and 25-250 fold for heart ATPase. 
Na+K+-ATPase Relationship to High Affinity Binding: Full binding 
studies on all the cardiac glycosides yield high affinity and low 
affinity portions of the curve when a Scatchard plot is applied to the 
binding data (all data cited in Appendix Tables 10-30). The high 
affinity region is that portion of the curve which encompasses data 
points described by relatively small amounts of ligand bound at a 
high blu ratio, while the low affinity region includes data points 
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Figure 6. Effect of varying K+ concentration on Na+K+-ATPase activity 
from three guinea pig organs. 
The assays were carried out as described under Experimental 
Methods except the K+ concentrations were varied as indicated. Spec-
ific activities (20 mM K+) of the enzyme preparations were: heart-





















Figure 7. Effect of K+ concentration on ISO determination with 
guinea pig kidney Na+K+-ATPase. 
Assays of ATPase activity were carried out as described under 
Experimental Methods in the presence of either 0.625 ruM K+ (~) or 
20.0 mM K+ (0). The dashed lines (---) show the ISO values (see 











Inhibition studies: ISO determination at two K+ concentrations 
Na+K+-ATPase from guinea pig brain (specific activity 30.1), 
kidney (specific activity 12.0), and heart (specific activity 10.0) 
were assayed as described under Experimental Methods with concentra-
tions of glycosides varying from 1 x 10-8 to 1 x 10-4 M in the pres-
ence of either 0.625 mM K+ or 20.0 roM K+. The ISO values were estima-
ted graphically as indicated in Figure 7. 
ISO (lM) 
G.P. Brainb G~P. Kidneyc 
0.62Sa 20 .. 0 0.625 20.0 
Digitoxin 0.03 1.9 0.13 4.8 
Cymarol 0.04 3.7 0.22 8.4 
Conva11atoxo1 0.09 2.8 0.16 5.3 
Digoxin 0.03 7.1 0.27 22.0 
Ouabain 0.12 7.1 0.57 13.0 
Hellebrin 0.02 1.2 0.13 3.0 
a Potassium chloride concentration, (ruM). 
b see Appendix Tables 6 ..... 7. 
C see Appendix Tables 8-9. 








described by low b/u ratios and relatively large amounts of ligand 
bound (Figure 4)w In view of the dependence of binding of the 
tritiated glycoside to Na+K+-ATPase upon the phosphorylation of the 
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enzyme by ATP and the further dependence of phosphorylation on the 
presence of Mg2+ and Na+ (7,36-41), it can be predicted that specific 
binding of the tritiated glycoside to Na+K+-ATPase will not occur in 
the absence of ATP, Mg2+, or Na+. Furthermore, ~igh affinity binding 
cannot be detected in the presence of high concentrations of K+, since 
this ion causes the breakdown of the phosphorylated form of the enzyme 
(7). Experiments were done to relat&'Na+K+-ATPase activity to the 
high affinity portion of the Scatchard plot. Maximum high affinity 
binding of tritiated cardiac glycoside to enzyme occurred in the 
presence of ATP, Mg2+, and Na+. Omission of anyone of these greatly 
reduced the slope of the high affinity binding portion of the curve 
(see Appendix Table 10). 
Binding as a Function of Enzyme Concentration: Using a fixed 
glycoside concentration and increasing amounts of protein (Table 7), 
several observations can be made on the binding of glycosides by 
Na+K+-ATPase. It binds convallatoxol-3H with a higher affinity than 
it binds either digoxin- 3H or ouabain-3H, a finding consistent with 
the Scatchard data. At low protein concentrations the b/u ratio 
, . 
increases linearly, while at higher protein concentrations the ratio 
asymptotically approaches a limiting value of infinity. This 
correlates with the approach to infinity of the blu ratio along the 
y-axis of a Scatchard plot as the glycoside concentration decreases 
at constant protein concentration. 
TABLE 7 
Experimental binding data for guinea pig heart Na+K+-ATPase 
as a function of protein concentration 
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The binding studies were carried out with guinea pig heart Na+K+-
ATPase (specific activity 8.5; 2.3 mg protein/ml) and either 1 x 10-8 
M convallatoxol-3H, digoxin-3H or ouabain_3H as described under 
Experimental Methods' at the specified enzyme concentrations (see 
Appendix Table 11). 
Expt. 1 Expt. 2 Expt. 3 
111 
Enzyme 
Solution bound b/u bound 'b/u bound blu 
Convallatoxo1 
25 2.21 0.219 1.91 0.216 2 .. 6 1.01 
2.81 0.308 2.39 0.269 2.3 0.88 
50 5.45 0.658 4.68 0.609 5.0 2.07 
5.36 0.612 5.22 0.656 4.9 2.09 
100 7.95 1.12 7.65 1.22 7.6 3.79 
7.88 1.10 7.40 1.18 7.9 4.12· 
150 9.74 1.53 9.38 1 .. 68 10.4 6.04 
10.0 1.57 8.96 1.57 9.7 5.64 
Digoxin 
25 0.70 0.078 1.02 0.131 0.9 0.38 
0.72 0.080 0.96 0.119 0.9 0.38 
50 1.75 0.200 1.96 0.262 2.1 0.97 
1.90 0.229 1.99 0.262 1.7 0.76 
100 3.41 0 .. 418 3.57 0.554 3.6 1 .. 69 
3.73 0.496 3.22 0.485 3.2 1.56 
150 4.90 0.692 5.22 0.821 4.5 2.27 
4.55 0.643 4.84 0.752 4.3 2.20 
Ouabain 
25 1.16 0.116 1.05 0.122 1.1 0.42 
1.17 0.120 1.01 0.117 1.1 0.45 
50 2.57 0.260 2.28 0.260 2.3 0.90 
2.41 0.252 2.14 0.254 2.2· 0.87 
100 3.89 0.229 4.01 0.530 3.5 1 .. 54 
3.82 0.220 4.04 0.555 3.9 1.79 
150 5.60 0.376 5.09 0.766 5.2 2.45 
5.08 0.353 4.97 0.718 5.2 2.45 
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ATPase Binding as a Function of K+ Concentration: A sharp 
decline in the b/u ratio at a fixed total concentration of glycoside 
occurs with increasing concentration of K+ for all three enzyme 
preparations (see Appendix Tables l2-l3)~ Relatively high b/u ratios 
are still obtained at 0.625 mM K+; this concentration can therefore be 
used satisfactorily for BSO determinations. 
Figure 8 demonstrates the effect of increasing K+ concentration 
on the Scatchard plot of the high affinity bindi.ng curve of guinea pig 
heart ATPase with convallato~ol ... 3H (see'Appendi~ Tables 12). It is 
apparent from this study and similar experiments on brain and kidney 
.-
ATPase that increasing K+ (Appendix Table 13) interferes with binding 
to all three enzymes. With increases in K+ concentration, the affinity 
constant and the number of high affinity binding sites are reduced. 
When the B50 values are calculated, there is a corresponding increase 
in the cardiac glycoside concentration necessary to obtain 50% 
saturation of the high affinity site (Table 8) as the K+ concentration 
is increased. At high concentrations of K+, the BSO values cannot be 
estimated since any specific binding would occur only at cardiac 
glycoside concentrations in the range where non-specific binding also 
occurs. 
Binding Parameters of Three Tissue ATPase Preparations at 0.0 
and 0.625 mM K+ with Various Cardiac Glycosides: The BSO values 
(Table 9) for all three preparations show no great differences when 
studied under optimum conditions in the absence of K+ and in the 
presence of 0.625 mM K+. The latter concentration of K+ supports 
ATPase activity adequate for estimation of the ISO. Although theo-
retically the BSO values at 0.0 K+ should be lo\ver than at 0.625 mM K+, 
Figure 8. Effect of various K+ concentrations on the high affinity 
binding of convallatoxol-3H to guinea pig heart Na+K+-ATPase~ 
Binding studies were carried out with guinea pig Na+K+-ATPase 
(specific activity 9.5) and convallatoxol-3H as described under 
Experimental Methods in the presence of various KCl concentrations 
(.G 0 K+) • 0.155 mM K+, II 0.625 roM K+, 0 20.0 roM K+) (see 








Ka and BsO values' as a function of K+ concentration 
The Ka and BsO values of guinea pig brain ATPase (specific activ-· 
ity 20.0) with convallatoxol- 3H \'lere calculated from Scatchard plots 




0.0 3.55 0.039 
0.625 2.57 0.050 
1.25 2.13 0.057 
2.50 1.42 0.080 
TABLE 9 
Binding parameters for various glycosides in three 
guinea pig tissues at 0 K+ and 0.625 roM K+ 
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The binding parameters were determined as described in Experimen-
tal Methods for each" of the tritiated glycosides with brain (specific 
activity 21.9), kidney (specific activity 11.5), and heart (specific 
activity 10.2) Na+K+-ATPase in the absence of K+ and the presence of 
0.625 mM K+. Each value in the table is the mean from several experi-
ments except those with heart and kidney Na+K+-ATPase, under conditions 
















B50 K 10- 7 M-1 a' 
0.04 140 7.22 
0.03 130 12.49 
0.08 147 1.95 
0.09 165 1.82 
0.09 83 1.50 
0.10 105 1.28 
0.10 101 1.24 
0.18 76 0.64 
0.21 109 0.54 
0.625 roM K+ 
0.04 146 4.76 
0.04 133 3.75 
0.03 130 5.64 
0.08 125 1.44 
0.12 157 1.00 
0.12 69 0.97 
0 .. 20 93 0.55 
, 
0.22 100 0.50 
0.36 80 0.30 
0.61 108 0.17 
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TABLE 9 (continued) 
0 K+ 0.625 mM K+ 
Cardiac 
Glycoside B50 n Ka , 10-7 M-l B50 n Ka, 10-! M- 1 . 
Heart: e 
. 
Digitoxin 0.04 35 2.68 0.06 35 1.95 
Cymarol 0.06 41 1.98 0.05 29 2.00 
Convallatoxol 0.08 48 1.40 0.09 39 1.18 
Digoxin 0.13 37 0.83 0.10 2S 1.08 
Ouabain 0.17 SO 0.61 0.16 31 0.65 
a The BSO values are micromolar. 
b The values of n are expressed as pmoles cardiac glycoside bound/mg 
protein 
c see Appendix Tables lS-20~ 
d see Appendix Tables 21-23. 
e see Appendix Tables 24~29~ 
this was not consistently observed except in the case of the kidney. 
This may reflect a variation in purity of the preparations as well as 
error in the measurement, since the measurements were made on 
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different preparations at different times. The n values (amount bound 
per mg protein at saturation of the high affinity site) tend to reflect 
the differences in Na+K+-ATPase specific activities among the various 
tissues, although there is not a constant relationship. As the 
specific activity decreases with age for a given preparation the n 
value decreases at a slower rate (Table 10). 
The differences dependent upon K+ concentration observed in brain 
and kidney Ka values are greater than those differences observed for 
heart (Table 9). This indicates a greater effect of K+ on the apparent 
binding affinity of brain and kidney ATPase for cardia~ glycosides. 
There is a consistent trend toward digoxin and ouabain being bound 
less tightly as evidenced by the lower Ka values and higher BSO values 
for these two compounds. The data for digitoxin binding to brain 
ATPase in the absence of K+ were much more variable than those for 
the other glycosides and are therefore not included in Table 9 (see 
Appendix Tables 14-19). 
Comparison of ISO and B50 Values at 0.625 roM K+ from 3 Tissue 
ATPase Preparations: Optimum binding conditions (i.e. without K+) 
give BSO values that show 50-300 fold differences from the ISO values 
determined under normal assay conditions (20.0 mM K+) (Tables 6 and 9). 
If both binding and inhibition are carried out at 0.625 roM K+, the 
BSO and ISO values (Table 11) then fall within the same range. The 
agreement between individual values is reasonably good when the 
. possible sources of error are considered. Both ouabain and digoxin 
TABLE 10 
Changes in specific activity and n values 
of guinea pig heart ATPase with time 
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Assays and binding studies with convallatoxol ·were carried·out on 
guinea pig heart ATPase at various times after its preparation. The 
























Comparison of ISO and B50 values at 0.625 roM K+ for 
Na+K+-ATPase from tfiree guinea pig tissues 
This table compares selected data from Tables 6 and 9. 
G .. P. Brain G.P. Kidney ·G.P. 
Glycoside ISO BSO ISO BSO ISO 
11M llM ]JM l-lM llM 
Digitoxin 0.03 0.04 0.13 0.12 0.13 
Cymarol 0.04 0.04 0.22 0.20 0.06 
Conval1atoxo1 0.09 0.03 0.16 0.22 0.12 
Digoxin 0.03 0.08 0.27 0.36 0.12 










appear to be bound less tightly by brain and kidney Na+K+-ATPase 
when both ISO and BSO values are considered~ The binding of ouabain 
and digoxin by heart Na+K+-ATPase appears to be comparable to that of 
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the other three glycosides. The overall range of glycoside concentra-
tion required to half-saturate or half-inhibit the enzyme is 3-61 x 
10- 8 M. Most of the variation is in "kidney Na+K+ -ATPase interactions 
" " with the glycosides. If kidney is excluded, the range narrows 
considerably, 3-16 x 10-8 M. 
ATPase Biilding'of'Cardiac'Glycosides in the Presence 'of Pi and 
Mg2+: One millimolar Pi used in the presence of Mg2+ will support 
binding which yields Scatchard plots similar to those for binding in 
the presence of ATP, Mg2+ and Na+ (see Appendi~ Table 29). If either 
4.0 mM K+ or 100 roM Na+ is included, the maximal b/u ratio is dras-
tica11y decreased (Table 12). This inhibitory effect has been seen 
with as little as 2 roM Na+. When the incubation is carried out in 
the presence of Pi alone, or with Pi and Na+, there is no observable 
high affinity binding (i.e. the blu ratio is very low). 
B~ Rat Brain Na+K+-ATPase. 
Rat Brain Assay: The enzyme was assayed over a thirty minute 
period (Figure 9) and displayed a linear production of Pi over the 
time span in which all assay and inhibitio!) studies were carried out 
(10 minutes). There also was a linear increase in the production of 
Pi with increasing enzyme concentration (Figure 10). When enzyme 
activity was studied (at a fixed time interval and at fixed reactant 
concentrations) as a function of K+ concentration (Figure 11), the 
maximum Na+K+ -ATPase activity (as \vell as total ATPase activity) was 
seen at 2.5 ~f K+, with relatively high activity maintained over a K+ 
TABLE 12 
The effect of ionic variations on the binding of glycoside 
to guinea pig Na+K+ ~,ATPase in the presence of Pi 
. All tubes contained 50 ~l enzyme suspension and 1 x 10-8 M con-
vallatoxol-3H and, where indicated, 2 roM ATP(Tris), 1 mM H3P04' 5 roM 
MgC12, 100 mM NaC1, 4 mM KCl in 0.25 ml at pH 7 .. 4. The binding ex-
periments were carried out as described under Experimental Methods. 
Relative b/u 
Brain Kidney 
ATP, Mg2+, Na+ 100 100 
p. 
1 1 
Pi, Na+ <1 
Pi' Mg2+ 76 109 
Pi, Mg2+, Na+ 1 
Pi' Mg2+, Na+ , K+ <1 1 
Pi' Mg2+, K+ 1 
69 
Figure 9. Hydrolysis of ATP by rat brain Na+K+-ATPase as a function 
of.time. 
The assay of rat brain Na+K+-ATPase (specific activity 33.2) was 
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Figure 10. Rat brain Na+K+-ATPase activity as a function of enzyme 
concentration. 
The assay of rat brain Na+K+-ATPase (specific activity 24.0; 
0.90 mg protein/ml) was carried out as described under Experimental 
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Figure 11. The effect of varying K+ concentration on two rat Na+K+-
ATPases. 
The assays were carried out as described under Experimental 
Methods except the K+ concentrations were varied as indicated. 
Specific activities were: brain - 30.3 (0), heart - 13.2 ( +) 





























concentration range of 1-20 mf'4. 
Inhibition of Rat Brain Na+K+-ATPase by Various Cardiac Glycosides 
at 0.625 and 20.0 roM K+: The ISO values (Table 13) for rat brain are 
in the micromolar range with little difference found between those at 
low K+ concentration (0.625 ~1) and those at high K+ concentration 
(20 m!v1). It can also be seen from Table 13 that there is little 
difference among ISO values for the various glycosides. While digoxin 
and ouabain appear to be required in higher concentrations than the 
others to effect 50% inhibition at 20 mM K+, this does not seem to be 
the case at 0.625 roM K+. These ISO values at 0.625 mM are 60-,100 
fold greater than those observed with the. guinea pig brain enzyme (see 
Table 6) and 10-30 fold greater than for guinea pig kidney or heart 
enzyme. 
Binding Parameters of Rat Brain Na+K+-ATPase for Various Cardiac 
Glycosides: From Table 14 it can be seen that the BSO values fall in 
the 1 x 10-8 M range. The BSO values (Table 14, Preparation 1) for 
digitoxin, cymarol and conval1atoxol in the presence of 0.625 roM K+ 
fall in the range of 2.2-3.6 x 10-8 M while those for digoxin and 
ouabain are considerably higher 8.4 and 7.3 x 10-8 M. These values 
for BSO are slightly higher than the BSO values at 0 K+ Cfable 14). 
Preparation 2 demonstrates that a decrease in affinity and increase in 
n markedly affect B50 values. These data are similar to the data 
obtained for guinea pig brain (Table 9) not only in terms of relative 
order but also in magnitude. The Ka values (Table 14-Preparation 1) 
for digitoxin, cymarol and conva11atoxol in the presence of 0.625 mM K+ 
fall within the range of 4.8-7.6 x 107M-I, while digoxin and ouabain 
have Ka values of 1.4 and 1.6 x 107M- l respectively. As would be 
TABLE 13 
Rat Brain Inhibition Studies: 
150 determination at two K+ concentrations 
. ATPase from rat brain (specific activity 16.0-24.0) was assayed 
as described under Experimental Methods with concentrations ofglyco-
sides varying from 1 x 10-8 M to 5 x 10-4 M in the presence of either 
0.625 mM K+ or 20 mM K+. The ISO values were estimated graphically 
as indicated· in Figure 7 (see Appendix Table: 34). 
0.625* 20.0* 
Digitoxin 2.1 1.6 
Cymarol 3.2 1.1 
Convallatoxo1 1.7 2.2 
Digoxin 1.6 3.2 
Ouabain 3.2 3.8 
Hellebrin 4.3 1.7 
* Potassium chloride concentration, mM 
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TABLE 14 
Binding parameters for various glycosides in rat brain 
at a K+ and 0.625 ~~ K+ 
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The binding parameters were determined as described in Experimen-
tal Methods for each of the tritiated glycosides with rat brain Na+KT-
ATPase (specific activity 30.3, preparation 1, and 37.0, preparation 
2) in the absence of K+ and in the presence of 0.625 roM K+ (see 
Appendix Tables 35-37). 
0 K+ 0.625 mM K+ 
Cardiac a b Ka,lO-7M-1 
a b K 10-7M- 1 Glycoside BSO n BsO n a' 
Preparation 1 
Digitoxin 0.019 79 6.5 0.036 80 4.8 
Cymarol 0.019 64 6.3 0.028 57 5.4 
Conval1atoxo1 0.017 81 7.7 0.022 71 7.6 
Digoxin 0.090 83 1.2 0.084 64 1.4 
Ouabain. 0.051 75 2.1 0.073 66 1.6 
Preparation 2 
Digitoxin 0.064 192 3.0~ 
Cymaro1 0.044 139 4.6 
Conva11atoxol 0.034 123 7.1 
Digoxin 0.092 125 1.4 
Ouabain 0.093 135 1.4 
a 
the BSO values are given in micrornoles/liter. 
b the n values are expressed as pmoles cardiac. glycoside 
per mg protein. 
expected, the Ka values in the presence of 0.625 mM K+ are slightly 
lower than those obtained in the absence of K+. These values corres-
pond well> as do the BSO values, with those for guinea pig brain in 
terms of both relative order and magnitude. The n values~ at both 0 
and 0.625 ~~ K+ are in the range of 47-83 pmoles/mg protein. The n 
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values~ as given in Table 14-Preparation 1, are approximately one-half 
those determined for guinea pig brain~ although the specific activities 
of the two enzymes are similar. The n values for Preparation 2 more 
closely approximate those for guinea pig brain. 
The ISO concentrations are up to 100 times higher than those 
concentrations required for BSO (Table lS)~ This descrepancy could 
not be eliminated by pre-incubating the enzyme with glycoside, in 
normal medium, and then starting the reaction by the addition of K+. 
It thus did not appear to be a problem of reaching equilibrium between 
the enzyme and glycoside. 
When the effect of various K+ concentrations on Ka and BSO values 
was studied (Figure 12 and Table 16) (see Appendix Tables 38-39) the 
results directly parallel those for g~inea pig brains (Table 8). The 
Ka values decreased (21.2 -+- O. S6 x 10-7 M-1) \vith increasing K+ 
concentration (0-20 ruM) and the BSO values increased (0.9 -+- 18.0 x 
10-8 M) over the same K+ concentration range. 
," 
To determine whether or not an equilibrium had been reached in 
the time period of the binding experiments and to ensure further that 
the binding was reversibl~studies of association and dissociation of 
cardiac glycosides to and from rat brain ATPase \vere carried out. A 
constant b/u ratio (Figure 13) was obtained for convallatoxol-3H at 
1 x 10-8 M by five minutes and \vas maintained up to thirty minutes. 
TABLE 15 
A comparison of ISO and BSO values, Rat Brain* 
This table compares selected data from Tables 13 and 14. 
ISO 
llM l-lM 
Digitoxin 2.1 .036 
Cymarol 3.2 .028 
Conval1atoxol 1.'7 .022 
Digoxin 1.6 .084 
Ouabain 3.2 .073 
* [KCl], 0.625 roM 
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Figure 12. The effect of various K+ concentrations on the high 
affinity binding of convallatoxol-3H to rat brain Na+K+-ATPase. 
81 
Binding studies were carried out with rat brain Na+K+-ATPase 
(specific activity 24.0) and convallatoxol-3H as described under 
Experimental Methods in the presence of various KCl concentrations 
( 0 0 K+, -.D 0.625 roM K+, + 2.5 Illivf K+, II s. a ruM K+, e 20 Illl\1 K+) 
(see Appendix Table 39). 
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TABLE 16 
Ka and BSO values of rat brain Na+K+-ATPase 
as a function of K+ concentration 
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The Ka and BsO values of rat brain Na+K+-ATPase (specific activi-
ty 24.0) with conval1atoxol-3H were calculated from Scatchard plots of 
data obtained at the stated concentrations (see Appendix Table 38). 
BSO 
mM 
0.0 21.2 0.0094 
0.625 7.67 0.0184 
2.50 1.65 0.0664 
5.00 1.43 0.0730 
20.00 0.56 0.180 
Figure 13. The rate of association of 3H-g1ycoside to rat brain 
Na+K+-ATPase. 
The association studies were carried out with rat brain'Na+K+-
ATPase {specific activity 29.4) and either conva11atoxol-3H ( tt ) 
or digoxin- 3H (Ct ) as described under Experimental Methods for 








































A relatively constant blu ratio was obtained for digoxin- 3H at 
1 x 10-8 M by thirty minutes and was maintained for another thirty 
minutes (Figure 13). When dissociation of glycoside- 3H from ATPase 
(Figure 14) in the presence of incubation medium with 1 x 10-5 M 
unlabeled glycoside was studied~ a new b/u equilibrium value was 
reached in 30 minutes for both convallatoxol and digoxin with a major 
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portion of the dissociation occurring by fifteen minutes. This 
dissociation represented 70 and 40%, respectively, of that glycoside .... 3H 
which was bound in the presence of 1 ~ 10~8 M conval1ato~ol and digoxin. 
This is in comparison to all three guinea pig Na+K+ -.ATPases which 
maintained a constant blu ratio for convallato~ol ..... 3H from 2~30 minutes. 
c. Rat Heart N.a+K+ ~ATPase. 
Rat Heart Assay: As described for the rat brain, a linear 
production of Pi was observed (Figure IS) well past the time required 
for the assay and inhibition studies, as well as a linear increase in 
Pi production with increasing amounts of enzyme (Figure 16). A study 
of enzyme activity versus K+ concentration (Figure 11) revealed that 
maximum Na+K+-ATPase activity occurred at 1.25 mM K+ and that this 
activity was maintained up to 20 roM K+. 
Inhibition of Rat Heart Na+K+-ATPase by Various Cardiac 
+ Glycosides at 0.625 and 20 mM K: The concentration of glycoside 
which will yield 50% inhibition (Table 17) for 20 ruM K+ is 3-20 fold 
greater than the required glycoside concentration at 0.625 ~~ K+. 
From these data it would appear that rat heart ATPase is least 
inhibited by convallatoxol and most inhibited by hellebrin at both K+ 
concentrations. However, if these concentrations of glycoside (at 
0.625 mM K+) are compared with those required to obtain half-inhibition 
Figure 14. The rate of dissociation of 3H-glycoside from rat brain 
Na+K+-ATPase. 
The dissociation studies were carried out for the specified 
times with. rat brain Na+K+-ATPase (specific activity 29.4) and either 
convallatoxol-3H ( +, .,) or digoxin- 3H ( 0 ) as described under 
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figure IS,! Hydrolysis of ATP by rat h'eart Na +K+ -ATPase as a function 
of time. 
The assay of rat heart Na+K+-ATPase (specific activity 9.2) was 





















Figure 16. Rat heart Na+K+-ATPase activity as a function of enzyme 
concentration. 
The assay of rat heart Na+K+-ATPase (specific activity 13.2; 
2.0 mg protein/ml) was carried out as described under Experimental 
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TABLE 18 
A comparison between the binding of 1 x 10-8 ~'1 
convallatoxol- 3H by rat heart and rat brain Na+K+-ATPase 
The binding studies were carried out as described under"Experi-
mental Methods (Appendix Tables 48-52). 
Heart Brain 
b/u 0.027 21.0 
mg/Protein 0.165 0.050 
S.A. l1moles 
Pi/hr/mgProtein- 9.0 38.3 
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DISCUSSION 
In order to better understand the interrelationships between the 
important group of drugs, the cardiac glycosides, and Na+K+-ATPase, 
there are several questions of a quantitative nature which must be 
answered. They are: (1) Can the inhibition of guinea pig and rat 
Na+K+-ATPases by cardiac glycosides and the binding of glycosides be 
T'elated quantitatively? In other words, under identical conditions 
does 50% inhibition occur when a recognizable binding site is 50% 
saturated? (2) Are there fundamental differences in the sensitivi-
ties of Na+K+-ATPases from different organs and species to inhibition 
by the glycosides and do these different Na+K+-ATPases bind glycosides 
with different affinities? (3) Do glycosides with differing physical, 
chemical and pharmacologic properties bind to Na+K+-ATPase with 
different affinities? (4) Can the binding-affinities be related to 
pharmacologic potencies or onsets and durations of action? The 
results described in this dissertation bear on this series of ques-
tions. 
Discussion of Guinea Pig ATPases: The Na+K+-ATPase activity for 
guinea pig heart, kidney and brain was dependent upon ligand concen-
trations, time and temperature. Under the" conditions used, the 
e~zymes displayed linear production of Pi over the time period 
employed in the inhibition and binding studies. With all other 
ligands at constant concentrations, changes in K+ concentration 
produced changes in enzymatic activity of all three enzymes. It was 
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demonstrated that at 0.625 mM K+ there was sufficient activity in each 
enzyme to carry out the inhibition studies. This was important in 
that the inhibition studies were to be compared to binding studies at 
the same K+ concentrations and the normal K+ concentrations prevented 
binding. It should be noted that the activity for heart ATPase at 
this low K+ concentration was only 45% of its maximal activity. As a 
result of the decreased activity of the heart ATPase at 0.625 ~~ K+ 
there isa probable increased error in the estimation of the ISO. 
This could explain some of the variability seen in comparisons of the 
ISO values and BSO values determined at this K+ concentration (Table 
10). 
The effect of K+ on ATPase inhibition by cardiac glycosides is 
dramatic. ISO values are 30-200 fold lower for brain, 20-80 fold 
lower for kidney, and 25-250 fold lower for heart Na+K+-ATPase when 
the K+ concentration is decreased from 20 mM to 0.625 mM (Table 5). 
Repke (8) showed some decrease in the ISO for ouabain with guinea pig 
heart Na+K+-ATPase when K+ concentration was reduced from 25 mM to 
2.5 mM. The observations herein are also consistent with those made 
by Akera (110) where the ISO value for ouabain was lower when 15 mM K+ 
was added at the end of a preincubation period rather than with the 
glycoside. The relative order of ISO values among the various cardiac 
glycosides was essentially the same for each Na+K+-ATPase at 0.625 mM 
K+. Kidney ATPase had ISO values which were 5 to 9 fold larger than 
the values for the same glycoside inhibition of brain or heart. 
Binding experimental data can be treated in numerous ways (see 
earlier discussion). The Scatchard method was chosen to plot the 
experimental data because it best deals with _data containing multiple 
sets of binding sites. The Scatchard plot places nearly equal 
emphasis on the binding parameters of all sets of sites. When using 
the Scatchard plot the experimental data of the binding of various 
glycosides to Na+K+-ATPase can be discussed in terms of three 
parameters the affinity constant,Ka ; the concentration at which 
the high affinity site is half-saturated, BSO; and the maximum number 
of pmoles CG bound/mg protein, n (see earlier discussion). Since the 
Scatchard method is dependent upon the-existence of an equilibrium, -
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it is important to note that maximum binding to the guinea pig enzymes 
(heart, brain and kidney) is reached by 200 seconds (102), well within 
the time period of the binding experiments. 
It was demonstrated that the binding of cardiac glycosides to 
Na+K+-ATPase of all three guinea pig tissues was dependent upon well 
established requirements for ATP, Mg2+ and Na+ (1,7,10-13). It was 
shown that the slope of the high "affinity portion of the Scatchard 
plot \vas greatly reduced when anyone of the above ligands was omitted. 
Furthermore, the inclusion of K+ had the same effect. This latter was 
to be expected, since it has been clearly demonstrated that K+ 
enhances the hydrolysis of the phosphorylated enzyme, the form of the 
enzyme to which glycosides normally bind (7,9,35,83,84,98). 
In order to compare inhibition and binding data under equivalent 
conditions, it was necessary to do the binding studies in the presence 
of the same K+ concentration as used in the inhibition studies. A 
concentration of K+ which allowed for both enzymatic activity and 
+ significant high affinity binding was arrived at, 0.625 roM K . 
To delineate further the effect of K+ on the binding of cardiac 
glycosides by Na+K+-ATPase from the three guinea pig tissues, two 
99 
studies were carried out. The first demonstrated a marked decline 
in the blu ratio at a fixed glycoside concentration (1 x 10-8 M) when 
the K+ levels were increased from 0 to 20 m~ (Appendix Table 14). It 
was noted that there were still relatively high blu ratios at 0.625 mM 
K+, indicating that it should be possible to do binding studies at 
this K+ concentration. The second study yielded a family of curves 
obtained from Scatchard plots of binding studies done in the absence 
of K+ and in the presence of various K+ concentrations (Figure 8). It 
was observed from these curves that increasing K+ concentration 
reduced Ka values and in turn produced an increase in the BSOvalues; 
i.e. when the 'apparent affinity' was reduced, a higher concentration 
of glycoside was required to half-saturate the high affinity site. 
This most probably is a result of the stimulatory effect of K+ on the 
dephosphorylation reaction which leads to the breakdown of the active 
binding species of the enzyme. In the absence of K+ all the enzyme 
species presumably exist in an equilibrium situation; in the presence 
of excess ATP and the absence of K+, the enzyme should exist primarily 
ATP CG 
'--E ~ ~E - P 
ADP 
--\.a...-~t CG - E - P 
p 
E 
in two forms, E - P and CG E - P,which are in equilibrium with each 
other. This is consistent with the fact that at a fixed glycoside 
concentration (1 x 10-8 M) the blu ratio does not change over an 
extended time interval (2-30 min.) (Appendix Tables 42-45). When K+ 
is added, the enzyme is partially dephosphorylated; this may lead to 
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the existence of a significant amount of the enzyme in the free form. 
Thus, in the presence of K+ there exist three enzyme forms, E, E - P, 
and CG - E - P; there also exists a new set of conditions where the 
phosphorylated form of the enzyme no longer exists in a true equilih-
rium condition but in a quasi-equilibrium or steady state, since the 
phosphorylated form is being continually hydrolyzed and rephosphory-
lated. The fact that there is good agreement between the equilibrium 
binding data (B50) and the kinetic inhibition data (ISO) at 0.625 ~~ 
K+ indicates that a steady state does exist (Table 11). As the 
concentration of K+ is increased a corresponding decrease in the 
steady state level of the phosphorylated enzyme species occurs, . 
accounting for the diminished n values of the Scatchard plot (Figure 
8). Under the above conditions it is expected that n should decrease 
in the presence of K+, but that the affinity for the remaining sites 
should remain the same as in the absence of K+. The. 'apparent Ka' 
decreases in the presence of K+ (Figure 8). This may reflect a true 
decrease in the affinity of the enzyme for the glycoside but more 
probably results from the n value being influenced by the competition 
between the glycoside and K+ for the phosphorylated enzyme, E - P. 
As the concentration of glycoside is increased at constant K+ concen-
tration the concentration of the CG - E - P form of the enzyme will 
increase leading to a concomitant decrease in E - P and E, establish-
ing a new steady state condition. The greater the concentration of 
glycoside, in the presence of K+, the greater will be the amount of 
enzyme in the CG - E - P plus E - P forms as compared to the E form. 
Thus, the higher the glycoside concentration, the closer the value of 
+ 
n in the presence of K+ approaches the value of n in the absence of K . 
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Therefore the Scatchard plot of glycoside binding to Na+K+-ATPase in 
the presence of K+ will reflect a slope change CKa change) due to the 
variable effect of glycoside/K+ competition in the steady state on 
the value of n. In other \vords, the high K+ concentration reduces 
the apparent affinity of the ATPase for the glycosides, by diminishing 
the 'steady state' concentration of the enzyme form to which the 
tritiated cardiac glycoside binds. Therefore, in the presence of X+ 
the apparent Ka is a measure of more than the affinity constant of the 
cardiac glycoside binding reaction. 
With all of this in mind, it is still possible to make comparisons 
of the interactions of the various glycosides with a specific Na+K+-
ATPase and also relative comparisons among enzyme preparations in 
terms of the interactions with the glycosides employing-the binding 
parameters Ka' nand BsO. The affinity constants, Ka' for the high 
affinity sites of guinea pig kidney and heart Na+K+-ATPase are quite 
similar in the absence of K+ and at 0.625 mM K+. This is true for 
all the glycosides. The Ka for guinea pig brain Na+K+-ATPase is 
somewhat higher, showing that the enzyme in this organ binds the 
glycoside more strongly. 
The affinity of Na+K+-ATPase for ouabain and digoxin is consis-
tently lower for all three tissues than the affinity for convallatoxol, 
cymarol and digitoxin in the absence of K+. In the presence of O~625 
roM K+ the difference between these two groups is less exaggerated, 
with heart ATPase displaying the least difference and brain the 
greatest. This suggests that the more active enzyme is more sensitive 
to small changes in K+ concentration. 
The number of binding sites per mg of enzyme protein roughly 
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correlates with the Na+K+-ATPase specific activities, being highest 
for brain and lowest for heart (Table 9). This suggests that the 
number of binding sites per molecule of enzyme may be similar for all 
three preparations but more precise studies with more highly purified 
enzyme preparations are needed to prove this point. As the specific 
activity of Na+K+-ATPase decreases with aging for a given preparation 
the n values also decrease, but at a slower rate (Table 10). It is 
possible that the binding capacity of the enzyme is not dependent upon 
the hydrolyzing capacity. In other words the ability to break down 
E - P does not appear to be required in order for binding to occur. 
Although the enzyme system may have to remain intact, the phospholipid 
subunit may not have to be entirely functional in order for the 
glycopolypeptide subunit to bind glycoside. 
Harris et al. (88,111) have demonstrated ouabain binding by a 
membrane fraction from beef brain that is low in ATPase activity. 
They suggested that this represented an inactive form of the enzyme 
resulting from a loss of phospholipid without concomitant loss of 
binding capacity. Taniguchi and Iida (112) have similarly suggested 
that phospholipid is necessary for ATPase activity but not for ouabain 
binding. 
The B50 values in the absence of K+ for all three tissues fall 
in the 3-21 x 10-8 M range. With the exception of four values, the 
values all fall in the 3-10 x 10-8 M range. The B50 values for 
ouabain and digoxin binding to kidney and heart ATPases are slightly 
higher than the values for the other glycosides. Upon the inclusion 
of 0.625 mMK+, the range of B50 values broadens to 3-61 x 10-8 M 
for all three organs. With·the exception of the kidney B50 values, 
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which appear quite sensitive to K+ change, the range is 3-16 x 10-8 M. 
The BSO values for kidney Na+K+-ATPase double or triple, while those 
for brain and heart are not significantly changed. The kidney is the 
only organ of the three that maintains the majority of its activity 
at this low K+ concentration (Figure 6). The greater effect of 0.625 
mM K+ on the binding, relative to that at 0 K+, is consisten~ with 
+ the fact that 0.625 mM K supports almost maximal activity of the 
kidney enzyme and not of the other two~ This concentration causes a 
greater reduction in the level of the phosphorylated form of the 
kidney enzyme and a resulting larger decrease in Ka and increase in 
BSO· 
The concentrations at which specific ouabain binding to guinea 
pig kidney enzyme occurs are similar to those reported by Tobin and 
Sen (92) and Erdmann and Schaner (95). The apparent ~ value reported 
by the former group, 1.8 x 10-7 M, compares with the BSO value found 
in this work of 2.1 x 10-7 M, and the value, Kd = 1.6 x 10-7"M of the 
latter group, compares with the Ka of 5.4 x 106 M- 1 (Kd = 1.8 x 10-7 M) 
found in this study. The Ka and n values for ouabain binding to 
guinea pig brain Na+K+-ATPase (Table 9) are in reasonably good agree-
ment with those reported by Taniguchi" and Iida (93) for ox brain 
Na+K+-ATPase~ Ka = 5.5 x 106 M- 1 , n = 119 pmo1es/mg protein. The Ka 
values found in the present study for kidney and heart ATPase bindi?g 
of ouabain are~ however, closer to the values of Taniguchi and Iida 
(93). These comparisons are made to point out the similarities 
between some species in terms of glycoside/Na+K+-ATPase interactions. 
When a 'comparison of individual ISO values with the corresponding 
BSO values is made for each of the preparati~ns, there is reasonably 
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good agreement (Table 11). When the possible sources of error are 
taken into account, it is probable that the majority of values are not 
significantly different in an ISO to BSO comparison. It is interesting 
to note that, the heart ISO/BSO ratios for a particular glycoside are 
not significantly different from those for the brain although the 
ratios for kidney do differ somewhat. The ISO/BSO values among the five 
glycosides do not differ significantly with the enzyme from brain or 
heart. The kidney preparation on the otber hand appears to have a 
somewhat lower affinity for the glycosides as a group and in particular 
for digoxin and ouabain. Even so, the agreement between tissue 
preparations is fairly good considering that each enzyme was not highly 
purified, but is simply a suspended membrane preparation. 
These data would suggest that the~e is a one to one relationship 
of the binding to the inhibition of guinea pig preparations. This 
could be interpreted to mean that the high affinity binding site is 
the inhibitory site of the enzyme.. Various studies have led to the 
conclusion that Na+K+-ATPase contains 1, 2 or even "more sites, 
dependent upon the enzyme source. These values have been surmised 
by comparing ouabain binding to specific activity (75,87) and to the 
number of phosphorylations (77); Scatchard plots of ouabain binding 
to ox brain ATPase have shown two binding sites, one with a Kd of 
0 .. 18 x 10-6 and the other Kd of 20 x 10-6 (81,93), while ox kidney 
on the other hand appears to have one high affinity receptor, Kd , 
0.47 x 10-8 M (95). Erdmann and Schoner (95) reported that guinea pig 
kidney has four ouabain sites per phosphorylated intermediate, 
although they point out that the ouabain receptor and the ATP 
lOS 
Inorganic phosphate, in the presence of Mg2+, will promote 
binding of cardiac glycosidesto much the same extent as does Mg2+, 
Na+ and ATP (Table 12). In our limited studies of this phenomenon 
we have found the binding to be similar under these quite different 
procedures; the high affinity binding parameters are similar. This 
binding is inhibited not only by K+ but also by Na+ at a concentration 
that is required for the ATP promoted binding. These results are 
consistent with those of other investigators (65,78,83,86,88,92,95;, 
103). All these results strongly suggest that a phosphorylated 
intermediate of the enzyme is formed in the presence of Pi and that 
this intermediate is similar, if not identical, to the glycoside 
binding intermediate formed \'1i th ATP. Tobin and Sen (92) reported 
ouabain_3H binding to guinea pig kidney Na+K+-ATPase in the presence 
of Mg2+ and Pi \'lhich was saturated at 1 x 10-5 M and was inhibited by 
Na+ and K+. Equilibrium was reached in three minutes at 37°C. Erdmann 
and Schoner (95) have reported a Kd of 1.62 x 10-7 M for guinea pig 
kidney Na+K+-ATPase at 37°C. 
Discussion of Rat ATPases: As was true with the guinea p1g 
Na+K+-ATPases, rat brain and heart Na+K+-ATPase activity is dependent 
on time, temperature and ligand concentration. The enzymes displayed 
linear Pi production over the times employed in the inhibition and 
binding studies. Keeping all other ligands at constant concentration, 
changes could be observed in enzymatic activity of both rat heart and 
brain ATPase when the K+ concentration was varied. The optimum K+ 
concentration for rat heart ATPase was 2.5 ~I and for brain 5.0 mM. 
It was shown that sufficient activity remained at 0.625 roM K+ for 
inhibition studies to be carried out. As with the guinea pig enzymes, 
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activity at this K+ concentration was important because of the compari-
son needed between inhibition and binding studies at the same K+ 
concentration. 
Lowering the K+ concentration from 2.5 to 0.625 mM has little 
effect on the ISO values for the enzyme from rat brain. The changes 
were negligible in comparison to the differences observed with the 
guinea pig enzymes. It appears that rat brain Na+K+-ATPase is 
insensitive to K+ concentration changes in terms of its inhibition by 
cardiac glycosides. The ISO values for rat brain are in the range of 
1-5 x 10-6 M; these values are consistent with the value of 1.6 x 10- 6 
M (in the presence of 15 roM KCl) reported for ouabain by Tobin and 
Brody (94). Shirachi, Allard and Trevor (104) reported 42% inhibition 
by 1 x 10-6 M ouabain in the presence of 20 roM K+ and 48% in the 
presence of 10 mM K+. 
A change in K+ concentration from 20 to 0.625 ~I caused a decrease 
in the ISO values for rat heart Na+K+-ATPase. The ISO range changed 
from 32-500 ~ to 3-190 ~M when the K+ concentration was lowered from 
20 to 0.625 mM (Table 17). The largest difference was approximately 
20 fold, for digoxin, and. the smallest was approximately five fold. 
Although these differences for rat heart are not as large as those 
observed for the guinea pig preparations, ,~hey are appreciable. The 
lack of a K+ effect distinguishes rat brain from rat heart Na+K+-
ATPase and from all of the guinea pig enzymes studied. Both rat heart 
and brain Na+K+-ATPase require more glycoside to attain ISO than do 
the guinea pig preparations with brain requiring 10 to 100 fold more 
glycoside and heart 300-1000 fold more glycoside. 
Does the binding of glycosides to the rat Na+K+-ATPase reflect 
these ISO values? The affinity constants for rat brain are very 
similar in the absence of K+ or in the presence of 0.625 mM K+. 
107 
They range from 1.4 to 7.6 x 107 M-l in the presence of 0.625 roM K+ 
which shows only a very small change from the values obtained in the 
absence of K+. These Ka values for rat brain (Table 14) are essen-
tially the same as those for guinea pig brain (Table 9). Of the other 
binding parameters, BSO values are also similar for rat brain and 
guinea pig brain enzyme. It is concluded that the high affinity 
sites of the two enzymes are similar with respect to their affinity 
for glycosides. The n values for rat brain are significantly lower 
than those for guinea pig brain, suggesting rat brain binds less 
glycoside per mg protein. This is in contrast to the fact that the 
specific activities of fresh preparations of each enzyme are approxi-
mately the same. 
A large discrepancy between ISO and BsO values is observed with 
the enzyme from rat brain. It requires 100 fold more glycoside to 
half-inhibit the enzyme than to half-saturate the high affinity site 
(Table IS). This is in marked contrast to the guinea pig enzymes, 
where under identical conditions the ISO and BSO values were compara-
ble. Preincubation of the rat brain enzyme with glycoside did not 
lower the ISO value. Thus it appears that failure for equilibrium to 
be reached does not explain this discrepancy. A further indication 
that the data cannot be explained by a lack of equilibrium is from 
the fact that the two glycosides which would be expected to take 
longest to reach equilibrium (Figure 13, Table 3), digoxin and ouabain3, 
show only 20 and 40 fold differences while the other three sho\v 
approximately 100 fold differences. It appears that a second site 
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of lower affinity (the inhibitory site) may be involved which has 
about the same affinity for all the glycosides. Two ouabain binding 
sites have been reported for ox brain by Taniguchi and Iida (93)--1) 
Kd = O. 18 11M, n = 119 pmoles/mg protein and 2) Kd = 20 }Jt.1, n = 104 
pmoles/mg protein. They found that ouabain binding to higher affinity 
site caused a marked reduction in Na+K+-ATPase activity (0.18 11M 
ouabain). Their experiments were done in the presence of 14 mM KC1 
and required 2 hours incubation before the binding reached a plateau. 
The number of lower affinity binding sites was reduced in half by 
. t th b 6 d· - t l.-n the absence of K+. carrylng ou e ln lng experlmen 5 Although 
these observations are interesting to note~ especially the existence 
of two distinguishable ouabain binding sites, it is difficult to 
correlate them with the results noted here for rat brain enzyme. To 
answer the question posed earlier, it is not clear that the explanation 
for low ouabain sensitivity to glycosides by rat brain enzyme can be 
explained in terms of its high affinity binding. The rat brain 
therefore presents a real enigma. Rat heart Na+K+-ATPase, on the 
other hand, presents a clearcut case. The rat heart simply does not 
possess a Na+K+-ATPase which can bind the glycosides at high affinity. 
Under various conditions, with and without K+ and over an extended 
time interval, no specific binding of cardiac glycosides could be 
demonstrated to rat heart Na+K+-ATPase. This would correspond well 
with the fact that at least 3 11M digoxin and up to 190 lJ!'t1 conval1atoxol 
were required to half-inhibit the enzyme. This concentration range 
is well out of the high affinity binding range observed for rat brain 
and all the guinea pig enzymes. Taniguchi and Iida (93) postulated 
that there was "cooperativity" between the two ouabain binding sites 
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In ox brain. It is possible that an analogollssituation exists in 
the rat brain, such that the inhibitory site (lower affinity site) may 
not bind without a binding to the higher affinity site occurring first. 
Thus, if the rat heart were considered in this light, it could be 
speculated that the high affinity site of the rat heart Na+K+-ATPase 
is functionally missing. Due to the absence of this site, the lower 
affinity site cannot interact cooperatively; therefore, the ISO 
concentrations are greater than those observed for rat brain Na+K+-
ATPase. 
CONCLUSIONS 
The results herein seem to be consistent with the generally 
accepted model for the interactions between Na+K+-ATPase, ATP and 
cardiac glycosides in a suitable ionic environment. Omission of ATP, 
Mg2+ or Na+ eliminates the high affinity binding. Inclusion of Mg2+ 
and Pi in the absence of ATP promotes binding. It appears that a 
phosphorylated form of the enzyme, produced by its interaction with 
ATP in the ·presence of Mg2+ and Na+ or Pi in the presence of Mg2+, 
is the binding species. The binding was ShOlffi to be freely reversible, 
in contrast to some of the results reported by others, who used ATPase 
preparations from other species. Tobin and Sen (92) also found the 
binding of ouabain to guinea pig kidney Na+K+-ATPase to be reversible. 
It would appear"that the inhibitory effect of K+ on binding 
results from its role in promoting the hydrolysis of the phosphorylated 
form of the enzyme. Similar observations have been made by Baker and 
Willis (113) on the binding of ouabain by He La cells. With increasing 
K+ concentrations there is a decrease in the steady state level of 
phosphorylated enzyme which is, in turn, in equilibrium with the form 
bound to the. glycoside. This leads to an apparent reduction of the 
+ values of nand Ka in the presence of 0.625 mM K and the complete 
disappearance of the high affinity binding at 20 ~4 K+. These results 
support other observations herein that the binding of Na+K+-ATPase to 
cardiac glycosides is freely reversible. If reversibility were not 
the case, th~ binding would represent a 'trap.' for the phosphorylated 
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enzyme and eventually all enzymatic activity could be abolished even 
at low glycoside concentrations (1 x 10-7 M). It is interesting to 
note that several groups have suggested that the extent of binding is 
not affected even in the presence of large K+ concentrations if enough 
time is allowed for an equilibrium to be established. 
By using the Scatchard method of analyzing the data~ with each 
glycoside and each guinea pig Na+K+-ATPase and rat brain preparation, 
it is possible to show a high affinity binding site which requires ATP, 
Mg2+ and Na+ and which is eliminated by high concentrations of K+. By 
selecting a low concentration of K+, we have found conditions under 
which both binding and Na+K+-ATPase inhibition can be studied. Under 
these conditions, 50% inhibition of the enzymic activity and 50% 
saturation of the high affinity binding site both occur at similar 
glycoside concentrations for all glycosides and all guinea pig enzyme 
preparations. This was not true for rat brain Na+K+~ATPase where the 
ISO val~es' were a hundred fold greater than the B50 values. No 
comparison can be made for rat heart since it displays no high affinity 
binding. This virtually established for the guinea pig enzymes that 
the binding of the glycosides is by the Na+K+-ATPase in the crude 
preparations and that the binding site is the inhibit~ry site. No 
contaminating substance in any of the preparations shows appreciable 
high affinity binding. It follows that the high uptake in vivo of 
glycosides by heart and kidney (36-38) is most probably a result of 
binding to the inhibitory site of Na+K+-ATPases. It thus appears 
warranted to consider this site on the enzyme as the receptor for 
cardiac glycosides. The uptake of glycosides by brain in vivo is 
quite low (17), presumably as a result of the blood-brain barrier, 
even though the enzyme from this source still has the capacity to 
bind glycosides. 
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The rat brain Na+K+-ATPase may have a requirement for more than 
one molecule of cardiac glycoside for inhibition. It might possess 
two binding sites for the glycoside, similar to the two sites reported 
for ox brain, one with an affinity 100 fold greater than the other. 
The lack of any apparent high affinity binding by rat heart Na+K+-
ATPase supports the role of Na+K+-ATPase as the receptor for and 
mediator of cardiac glycoside action, since the rat is a glycoside 
insensitive species. 
Comparisons among the five glycosides studied reveal no correla-
tions between any binding parameter and any parameter of pharmacologic 
activity. In general the compounds fall into two groups -- digitoxin, 
cymarol and conval1atoxol, which show relatively higher affinities 
than digoxin and ouabain. Ouabain, convallatoxol and cymarol are 
similar pharmacologically in that each has a very high potency and a 
rapid onset and short duration of ,action in vivo, whereas digitoxin 
is at the opposite extreme with respect to each of these properties. 
Digoxin is intermediate. No detailed correlation between chemical 
structure and binding affinity is made with this small number of 
compounds, although it should be noted that the two compounds with 
substituents on ring C, ouabain, with an lla-hydroxyl and digoxin, 
with a 12S-hydroxyl, are least tightly bound. Additional studies to 
determine whether this indicates that ring C is of particular 







Lefler, C. F. and B. Baggett, unpublished results. 
One preparation of rat heart ATPase did show a small amount of high 
affinity binding, with a Ka = 6.7 x 107M-I and an n value of 4 for 
convallatoxol (see Appendix Table 51). The hearts appeared engorged 
with blood; therefore, the observed high affinity binding may have 
been due to a small amount of RBC ATPase which remained during the 
ATPase isolation process. A Ka = 0.7 x I07M-l has been reported 
for human RBC Na+K+-ATPase (100). An alternate explanation may be 
that there is a very small but finite amount of glycoside sensitive 
Na+K+-ATPase in rat hearts, while the bulk of the ATPase is glyco-
side insensitive. 
From Figure 13 it can be seen that the rate of association of 
digoxin to Na+K+-ATPase is slower than that of convallatoxol. Data 
given in Table 3 for beef brain show that the rate of association 
of ouabain is half that for either convallatoxin, cymarin, or 
digitoxin. These data point out that digoxin and ouabain associate 
to ATPase at a slower rate than do the other glycosides mentioned. 
Since ATPase activity is measured over a ten minute period of time 
(starting at time = 0), a glycoside that binds slowly would exert 
a smaller inhibitory effect on ATPase than one that binds .rapidly, 
even though both are equally bound at equilibrium. Therefore, a 
glycoside with a low rate of association would show a higher IsO 
relative to BSO than one with a high rate of association. 
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TABLE 1 ~ Guinea Pig ATPase Activity 

































































a 1.25 A660 units/Jlmo1e Pi; Na+K+-ATPase S.A. - 11.1; 
.146 mg Pro/50 ~1. 
b 1.34 A660 units/~mo1e Pi; Na+K+-ATPaseS.A. - 37.2; 












TABLE 2. Guinea Pig Heart ATPase Activity 
as a Function of KCl concentration 
Total 
A660 Activitya A660 
.264 11.3 .223 
.268 11.4 .233 
.256 10.9 .225 
.258 11.0 .236 
.290 12.4 .220-
.247 10.6 .228 
.243 
.229 
.347 14.8 .220 
.330 13.7 .213 
.325 13.9 .207 
.329 14.1 .212 
.44 19.0 .223 
.41 17.5 .234 
.41 17.5 .21S 
.40 17.3 .225 
.51 21.7 .222 
.47 20.0 .216 
.48 20.4 .225 
.226 
.43 18.2 .189 
.44 18.7 .185 
.42 18.0 .189 
.187 
.41 17.4 .197 
.41 17.4 .197 
.40 17.2 .192 
.40 17.2 .199 
.397 17.0 .207 
.376 16.1 .197 
.. 382 16 .. 3 .202 
.368 15.7 .206 
a 1.25 A660 units/~mo1e Pi; Na+K+-ATPase S.A. - 11.1 
b inhibited with 5 x 10-4 M Ouabain. 
2 
Mg2+ 

































TABLE 3 . Guinea Pig Brain ATPase Activity 
as a Function of KC1 Concentration 
KC1 Total 
mM A660 Activitya A660 
Study 1 
0.155 .38 14.9 .170 
.37 14.6 .210 
.41 16.0 
.42 16.5 
0.310 .51 20.1 .150 
.52 20.0 .149 
.49 19.3 
.. 50 19.7 
0.625 1.01 39.7 .122 
1.01 39.7 .116 
1.09 42.9 
1.15 45.2 
1.25 .84 33.2 .115 
.86 33.8 .122 
.83 32.6 
.86 33.8 
2.50 .83 32.6 .137 
.82 32.4 .147 
.77 30.3 
.81 31.8 
5.0 .94 37.2 .139 
.94 37.2 .157 
.93 36.6 
.92 36.6 
10.0 1.01 39.7 .158 
1.02 40.1 .139 
1.00 39.3 
1.02 40.1 
20.0 1.00 39.0 .130 
1.00 39.0 .145 
1.00 39.0 
1.00 . 39.0 
a 1.34 A660 units/~mole Pi; Na+K+-ATPase S.A. - 37.2. 




















TABLE 3 (continued) 
KCl Total 
~1 A660 Activitya A660 
Study 2 
0.155 .245 9 .. 4 .110 
.229 8.7 .10S 
.302 11.S .. 110 
0.310 .. 314 12.0 .10S 
.311 11.9 .. 102 
.102 
0.625 .48 18.1 .099 
.50 19.1 .110 
.099 
1.25 .60 22.9 .105 
.62 23.7 .098 
.. 61 23.3 .101 
2.5 .67 25.6 .101 
.69 26 .. 3 .112 
.65 24.8 .116 
S.O .64 24.4 .. 120 
.65 24.8 .118 
.68 26.0 .120 
10.0 .57 21.8 .120 
.54 20.6 .118 
.56 21.4 .127 
20.0 .48 18.3 .119 
.50 19.1 .121 
.50 19.1 .126 
a 1.38 A660 units/~mole Pi; Na+K+-ATPase S.A .. - 21.4. 




























TABLE 4 Guinea Pig Kidney ATPase Activity 
as a Function of KCl Concentration 
KCl Total 
mM A660 Activitya A660 
0.625 .85 22.6 .192 
.86 22.9 .190 
.83 22.1 .193 
.86 22.9 .195 
1.25 .89 23.6 .178 
.86 22.9 .180 
.84 22.3 .176 
.85 22.6 .179 
2.50 .76 " 20.2 .175 " 
• 76 20.2 .178 
. 74 19.7 .175 
.75 19.9 .180 
5.0 .68 1B.1 .175 
.66 17.5 .180 
.65 17.3 .172 
.69 18.3 .174 
10.0 .60 16.0 .193 
.62 16.5 .191 
.61 16.2 .183 
.63 16.6 .188 
a 1.34 A660 units/]Jrnole Pi; Na+K+-ATPase"S.A. - 18.1 .. 

























TABLE s. Inhibition of Guinea Pig Heart ATPase by Various 
Cardiac Glycosides at Two K+ Concentrations 
CONVALLATOXOL DIGOXIN CYMAROL 
Glycoside % % % 
Molarity A660 Inhibition A660 Inhibition A660 inhibition 
20.0 mM K+ a 
1 x 10- 7 .306 -36 .270 - 4 
.315 -44 .345 -70 .270 - 4 
5 x 10- 7 .290 -22 .310 -40 .250 13 
.290 -22 .290 -22 .270 - 4 
1 x 10-6 .286 -18 .210 -39 .270 - 4 
.298 -29 .285 -18 .272 - 6 
5 x 10- 6 .265 0 .260 4 .245 17 
.260 4 .260 4 .248 15 
1 x 10-5 .230 30 .260 4 .231 30 
.245 17 .185 70 .. 222 37 
5 x 10- 5 .200 56 .. 195 61 .181 74 
.195 61 .200 56 .190 65 
1 x 10- 4 .180 74 .185 70 .175 78 
.180 74 .180 74 .168 84 
5 x 10-4 .160 91 .148 102 .161 90 
.175 78 .148 102 .167 85 
0.625 roM K+ b 
1 x 10-7 .352 13 .303 44 .293 50 
.368 3 .301 45 .284 56 
5 x 10- 7 .292 Sl .250 78 .251 77 
.. 306 42 .254 75 .273 63 
1 x 10- 6 .260 71 .247 80 .234 88 
.251 77 .251 77 .246 80 
5 x 10-6 .246 80 .238 85 .237 86 
.240 84 .234 88 .239 85 
1 x 10-5 .230 90 .236 87 .233 88 
.236 87 .240 84 .234 88 
5 x 10-5 .262 70 .218 98 .224 94 
x 10- 4 
.241 83 .218 98 .. 234 88 
1 .250 78 
.240 84 
5 x 10- 4 .213 101 
.226 93 
a 1.39 A660 units/~mo1e p .. Na+K+-ATPase S.A. 7.2; .265 A660 in absence 1" 
of glycoside. 
b 1.40 A660 units/~ole p .. Na+K+-ATPase S .. A. - 5.6; .372 A660 in absence 1" 
of glycoside. 
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TABLE 5 (continued) 
CONVALLATOXOL DIGOXIN CYMAROL 
Glycoside % % % 
Molarity A660 Inhibition A660 Inhibition A660 Inhibition 
20.0 ruM K+ 
1 x 10- 7 .263 2 .245 17 .292 -24 
.250 13 .245 17 .285 -18 
5 x 10- 7 .244 18 .245 17 .248 15 
.258 6 .245 17 .260 4 
1 x 10-6 .237 24 .245 17 .250 13 
.. 250 13 .235 26 .245 17 
5 x 10-6 .235 26 .212 46 .212 46 
.248 15 .210 48 .202 55 
1 x 10-5 .243 19 .195 61 .200 56 
.234 27 .195 61 .195 61 
5 x 10-5 .195 61 .176 77 .146 104 
.190 65 .157 94 .162 90 
1 x 10-4 .180 74 .146 103 .165 87 
.170 83 .141 108 .140 109 
5 x 10-4 .151 100 .130 .145 
.150 .130 .147 
0.625 mM K+ 
1 x 10- 7 .303 44 .301 45 .259 72 
.300 46 .309 40 .266 68 
5 x 10- 7 .255 74 .251 77 .229 91 
.258 73 .255 74 .228 92 
1 x 10- 6 .250 78 .240 84 .225 94 
.242 83 .245 81 .220 97 
5 x 10- 6 .265 68 .222 96 .219 97 
.229 91 .229 91 .235 87 
1 x 10-5 .219 97 .231 90 .212 102 
.222 96 .230 90 .222 96 
5 x 10- 5 .210 .218 98 .205 106 
.212 100 .228 92 .219 97 
1 x 10- 4 .218 .218 98 .214 100 
.217 .215 100 .206 106 
5 x 10-4 .220 .168 .. 199 
.230 .160 .199 
8 
TABLE 6. Inhibition of Guinea Pig Brain ATPase by Various 
Cardiac Glycosides at 20 roM K+ 
CONVALLATOXOL DIGOXIN CYMAROL 
Glycoside % % % 
Molarity A660 Inhibition A660 Inhibition A660 Inhibition 
Study 1 
a 
1 x 10- 7 1.15 - 6 .. 99 12 .99 12 
1.05 5 1 .. 00 11 .99 12 
5 x 10- 7 .94 17 .. 85 27 .. 86 26 
.95 16 .. 87 2S .. 89 23 
1 x 10-6 .80 33 .85 27 .. 79 34 
.77 36 .86 26 . 76 37 
5 x 10- 6 .46 70 .59 56 .46 70 
.44 72 .58 57 .46 70 
1 x 10- 5 .324 85 .50 66 .310 87 
.327 85 .48 68 .338 84 
5 x 10- 5 .200 99 .250 94 .219 97 
.208 98 .245 94 .204 98 
1 x 10- 4 .179 101 .141 106 .. 142 105 
.184 101 .159 104 .173 102 
5 x 10- 4 .186 101 
.176 102 
Studz: 2b 
1 x 10- 7 .92 7 .92 7 .95 3 
10~7 
.92 7 .93 6 .95 3 
5 x • 79 22 . 79 22 .. 83 18 
.80 21 .. 80 21 .82 19 
1 x 10-6 .65 39 .78 24 .76 26 
.64 40 .78 24 .. 74 28 
5 x 10-6 .358 74 .54 52 .48 59 
.391 70 .58 47~ .48 59 
1 x 10- 5 .311 79 .. 45 63 .. 361 73 
.293 81 .47 60 .366 73 
5 x 10-5 .203 92 .198 92 
.. 180 95 .210 91 .197 93 
1 ?C 10-
4 .. 146 99 .152 98 .IS0 98 
.138 100 .147 99 .159 97 
5 x 10-4 
a 
1.30 A660 units/~mole Pi; 
+ + - 24.2; 1.10 A660 in absence Na K -ATPase S .. A. 
b 
of glycoside. 
Na+K+-ATPase S.A. 1.34 A660 units/~mo1e p ... - 21.9; .98 A660 in absence l' 
of glycoside. 
9 
TABLE 6 (continued) 
OUABAIN DIGITOXIN HELLEBRIN 
Glycoside % % % 
Molarity A660 Inhibition A660 Inhibition A660 Inhibition 
Study 1 
1 x 10- 7 1.10 0 .95 16 .90 22 
1.00 11 .95 16 .90 22 
5 x 10- 7 .95 16 .78 35 .68 46 
.98 13 .81 32 .68 46 
1 x 10-6 .92 20 .67 47 .61 54 
.93 18 .69 45 .64 50 
5 x 10-6 .66 48 .354 82 .313 86 
.65 49 .357 82 .320 86 
1 x 10-5 .52 64 .264 92 .317 86 
.51 65 .251 93 .308 87 
5 x 10- 5 .289 89 .138 106 .183 101 
.303 88 .140 106 .195 100 
1 x 10-4 .232 96 .163 103 
.232 96 .158 104 
5 x 10-4 .189 100 
.195 
Study 2 
1 x 10- 7 .99 - 1 1.02 - 5 .86 14 
.98 - 2 .97 1 .87 13 
5 x 10- 7 .89 9 .80 21 .61 43 
.89 9 .82 19 .61 43 
1 x 10-6 .90 18 .62 42 .56 49 
.85 15 .61 43 .58 47 
5 x 10-6 .53 S3 .372 72 .283 82 
.55 50 .359 73 .291 81 
1 x 10-5 .48 S9 .276 83 
.50 S6 .291 81 
5 x 10-5 .250 86 .156 97 
.252 86 .159 97 
1 x 10-4 .204 91 .218 90 .141 99 
.202 92 .264 84 .131 100 
5 x 10-4 .131 100 .136 99 
.132 .130 100 
10 
TABLE 6 (continued) 
Glycoside % % % 
. Molarity A660 Inhibition A660 Inhibition A660 Inhibition 
Study 3a CONVALLATOXOL DIGOXIN CYMAROL 
1 x 10- 7 .73 11 .77 - 1 . 72 7 
.74 10 • 76 1 . 71 8 
5 x 10- 7 .68 13 .69 12 .61 24 
.64 20 .69 12 .63 21 
1 x 10-6 .55 34 .65 18 .58 29 
.57 31 .67 15 .60 26 
5 x 10- 6 .36 64 .50 42 .42 54 
.35 65 .49 43 .394 58 
1 x 10- 5 .268 78 .40 58 .323 70 
.276 77 .381 60 .. 318 70 
5 x 10-5 .174 93 .196 90 .182 92 
.172 94 .204 89 .182 92 
1 x 10-4 .142 98 .160 96 .155 96 
.136 99 .164 95 .143 98 
OUABAIN DIGITOXIN HELLEBRIN 
1 x 10- 7 .76 1 .. 70 10 .67 15 
. 76 1 .66 16 .66 16 
5 x 10- 7 .64 20 .59 27 .51 40 
• 66 16 .. 58 29 . .51 40 
1 x 10-6 .64 20 .50 42 .46 48 
.64 20 .52 38 .43 53 
5 x 10-6 .45 50 .317 71 .240 83 
.45 50 .307 72 .234 84 
1 x 10-5 .43 53 .230 84 .240 83 
.42 54 .227 85 .232 84 
5 x 10-5 .227 85 .117 102 .158 96 
.225 85 .115 103 .153 97 
1 x 10-4 .175 93 .126 101 
.183 92 .128 101 
5 x 10-4 .134 100 
.132 
a 1.35 A660 units/~mo1e Pi; Na+K+-ATPase S.A. - 16.4; .76 A660 in absence 
of glycoside. 
TABLE 7. Inhibition of Guinea Pig Brain ATPase by Various 
+ Cardiac G1ycosidesat 0.625 ruM K 
CONVALLATOXOL DIGOXIN CYMAROL 
Glycoside % % 
11 
% 
Molarity A660 Inhibition A660 Inhibition A660 Inhibition 
Studl la 
1 x 10- 8 .40 52 -.310 70 .310 70 
.41 SO .299 72 .323 67 
5 x 10- 8 .289 74 .206 91 .210 90 
.290 74 .221 88 
1 x 10- 7 .206 91 - .180 96 .202 92 
.201 92 .186 95 .202 92 
5 x 10- 7 .180 96 .171 98 .175 98 
.181 96 .167 99 .174 98 
1 x 10-6 .170 98 .159 101 - .161 100 
.168 99 .165 100 .168 99 
5 x 10-6 .180 96 .142 104 .159 101 
.172 98 .146 103 .158 101 
1 x 10-5 .165 100 .138 105 .148 103 
.155 102 .142 104 .143 104 
5 x 10-5 .154 102 
.159 101 
Study 2b 
1 x 10-8 ~ .359 6 .312 21 .326 16 
.352 8 .317 19 
5 x 10- 8 .259 38 .233 46 .253 40 
.273 33 .229 47 .252 40 
1 x 10- 7 .209 54 .193 59 .200 57 
.221 50 .191 60 .200 57 
5 x 10- 7 .131 79 .111 85 .112 85 
.131 79 .110 85 .121 82 
1 x 10- 6 .101 88 .093 91 .092 91 
.103 88 .090 92 .098 89 
5 x 10-6 .084 94 .076 96 .055 103 
.079 95 .066 99 .060 101 
1 x 10- 5 .072 98 .067 99 .052 104 
.079 95 .071 98 .057 102 
1 x 10-4 .067 99 .063 100 
.072 98 .060 101 
a 1.34 A660 units/~mo1e Pi; Na+K+-ATPase S.A. - 36.0; .66 A660 in absence 
of glycoside. 
b 1.41 A660 unitslvrno1e Pi; Na+K+-ATPase S.A. - 23.0; .378 A660 in 
absence of glycoside. 
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TABLE 7 (continued) 
OUBAIN DIGITOXIN HELLEBRIN 
Glycoside % % % 
Molarity A660 Inhibition A660 Inhibition A660 Inhibition 
Study 1 
1 x 10-8 .371 58 .298 72 .277 77 
.285 55 .295 73 .269 78 
5 x 10-8 .255 81 .201 92 .192 94 
.261 80 .202 92 .198 93 
1 x 10- 7 .282 76 .182 96 .198 93 
.230 86 .190 94 .190 94 
5 x 10- 7 .185 96 .155 102 .166 99 
.190 94 .160 101 .165 100 
1 x 10-6 .175 98 .148 103 .170 98 
.151 102 .168 99 
5 x 10- 6 .161 100 
.163 100 
1 x 10-5 .161 100 
.166 99 .149 103 .154 102 
5 x 10-5 .162 100 
.163 
Study 2 
1 x 10-8 .336 13 .327 16 .280 31 
.334 14 .342 11 .291 28 
5 x 10-8 .287 29 .218 51 .162 69 
.277 32 .213 52 .172 66 
1 x 10- 7 .252 40 .203 56 .132 78 
.247 42 .193 S9 .136 77 
5 x 10- 7 .156 71 .107 86 .090 92 
.176 64 .108 86 .088 92 
1 x 10-6 .125 80 .096 90 .082 94 
.120 82 .097 90 .083 94 
5 x 10-6 .077 96 .067 99 .060 101 
.082 94 .059 102 .061 101 
1 x 10- 5 .076 96 .062 101 
.078 96 .062 101 
1 x 10-4 .066 100 
.065 
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TABLE 7 (cont inued) 
Glycoside % % % 
Molarity A660 Inhibition A660 Inhibition A660 Inhibition 
Study 3c CONVALLATOXOL DIGOXIN CYMAROL 
1 x 10- 8 .261 6 .283 - 4 .249 11 
.260 6 .260 6 .241 15 
5 x 10-8 .200 33 .230 20 .201 32 
.200 33 .232 19 .203 32 
1 x 10- 7 .171 46 .221 24 .179 42 
.163 49 .206 30 .174 44 
5 x 10- 7 .098 78 .221 24 .114 71 
.092 81 .231 19 .110 73 
1 x 10- 6 .080 86 .097 78 .087 83 
.074 88 .091 81 .091 .81 
5 x 10-6 .058 96 .070 90 .072 89 
10-5 
.059 95 .062 94 .061 94 
1 x .054 97 .060 95 .061 94 
.054 97 .061 94 .060 95 
5 x 10- 5 .050 99 .050 99 .051 99 
.051 99 .050 99 .051 99 
5 x 10-4 .050 99 
.052 98 
OUBAIN DIGITOXIN HELLEBRIN 
1 x 10- 8 .257 8 .261 6 .238 16 
.257 8 .236 17 .247 12 
5 x 10- 8 .235 17 .190 37 .lS0 42 
.230 20 .157 52 .181 41 
1 x 10- 7 .200 33 .157 52 .156 S2 
.198 34 .161 SO .160 50 
5 x 10- 7 .127 65 .081 85 .102 76 
.123 67 .091 81 .100 77 
1 x 10-6 .099 78 .081 85 .082 85 
.107 74 .081 S5 .082 85 
5 x 10':"6- .068 91 .061 94 .060 95 
.070 90 .061 94 .068 91 
1 x 10-5 .067 92 .050 99 .053 98 
.073 89 .053 98 .056 96 
5 x 10-5 .057 96 .042 103 .049 100 
.050 99 .050 99 .057 96 
5 x 10-4 .047 100 
.049 
c 1.41 A660 units/~mole Pi; Na+K+-ATPase S.A. - 18.4; .304 A660 in 
absence of glycoside. 
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TABLE 8 . Inhibition of Guinea Pig Kidney ATPase by Various 
Cardiac Glycosides at 20 mM K+ 
CONVALLATOXOL DIGOXIN CYMAROL 
Glycoside % % % 
Molarity A660 Inhibition A660 Inhibition A660 Inhibition 
Study 1a 
1 x 10- 7 .48 - 4 .. 50 -12 .46 3 
.50 -12 .52 -20 .48 - 4 
5 x 10- 7 .48 - 4 .44 - 8 .45 7 
.49 - 8 .52 -20 .43 15 
1 x 10- 6 .44 9 .48 - 4 .42 18 
.45 7 .47 0 .45 7 
5 x 10- 6 .332 52 .393 29 .333 52 
.360 41 .387 31 .335 51 
1 x 10-5 .288 69 .337 SO .281 71 
.297 6S .351 4S .290 68 
5 x 10- 5 .230 91 .225 93 .216 96 
.231 90 .220 95 .225 93 
1 x 10-4 .217 96 .190 106 .197 103 
.230 91 .204 101 
5 x 10- 4 .198 103 
.183 109 
Study 2b 
1 x 10- 7 .51 7 .53 1 .51 7 
.55 - 4 .53 1 .53 1 
5 x 10- 7 .51 7 .53 1 .46 21 
.52 4 .54 - 2 .44 26 
1 x 10-6 .45 24 .56 - 7 .45 24 
.48 15 .52 4 .45 24 
5 x 10- 6 .376 44 .41 35 .363 48 
.360 49 .41 35 .358 SO 
1 x 10- 5 .295 67 .369 46 .310 63 
x 10- 5 
.298 66 .356 SO .298 66 
5 .228 86 .223 88 .216 90 
.224 87 .215 90 .208 92 
1 x 10- 4 .210 91 .184 98 .187 98 
.202 94 .181 99 .185 98 
5 'x 10- 4 .181 99 
.173 102 
a 
1.39 A660 units/~rnole Na+K+-ATPase Pi; S.A. 6.9; .47 A660 in absence 
b 
of glycoside. 
1.36 A660 units/~mole Pi; Na+K+-ATPase S.A. - 9.3; .53 A660 in absence 
of glycoside. 
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TABLE 8 (continued) 
CONVALLATOXOL DIGOXIN CYMAROL 
Glycoside % % % 
Molarity A660 Inhibition A660 Inhibition A660 Inhibition 
Study 1 
1 x 10- 7 .49 - 8 .45 7 .44 11 
.51 -16 .48 - 4 .44 11 _ 
5 x 10- 7 .50 -12 .43 15 .42 18 
.49 - 8 .44 - II .40 26 
1 x 10- 6 .48 - 4 .389 30 .355 43 
.48 - 4 .39 30 .386 31 
5 x 10-6 .41 22 .289 68 .280 72 
.41 22 .269 76 .263 78 
1 x 10- 5 .362 39 .144 124 .. 283 71 
.366 39 .147 122 .281 71 
5 x 10-5 .269 76 .213 97 
.262 79 .216 -96 
1 x 10- 4 .230 91 .221 94 .203 101 
.237 88 .221 94 
5 x 10-4 .205 100 
.207 
Study 2 
1 x 10- 7 .50 10 .52 4 .48 IS 
.49 12 .52 4 .50 10 
5 x 10- 7 .48 15 .48 15 .50 10 
.48 15 .48 15 .41 35 
1 x 10- 6 .43 29 .375 45 
.47 18 .43 29 .398 38 
5 x 10- 6 .40 38 .307 64 .254 79 
.41 35 .304 65 .260 78 
1 x 10-5 .354 S1 .249 80 .290 69 
.362 48 .250 80 .282 71 
5 x 10- 5 .234 84 .158 106 .200 94 
.242 82 .151 108 .201 94 
1 x 10-4 .217 89 .190 97 
.212 91 .182 99 
5 x 10-4 .182 100 
.176 
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TABLE 9. Inhibition of Guinea Pig Kidney ATPase by Various 
Cardiac G1ycosides at 0.625 mM K+. a 
Glycoside % % % 
Molarity A660 Inhibition A660 Inhibition A660 Inhibition 
CONVALLATOXOL DIGOXIN C)1.1AROL 
1 x 10- 8 .65 11 .51 38 .49 42 
.65 11 .54 32 .48 44 
5 x 10- 8 .60 21 .316 75 .304 77 
.62 17 .320 74 .289 80 
1 x 10- 7 .64 13 .275 83 .269 84 
.68 5 .. 280 82 .. 259 86 
5 x 10- 7 .51 38 .210 95 .194 98 
.50 40 .211 95 .204 96 
1 x 10- 6 .254 87 .195 98 .179 101 
.256 87 .190 99 .197 98 
5 x 10- 6 .210 95 .185 100 .184 100 
.208 96 .190 99 .179 101 
1 x 10- 5 .183 101 .168 103 .179 101 
.191 99 .180 101 .183 101 
5 x 10- 5 
.202 97 
5 x 10-4 .180 101 
.181 101 
OUABAIN DIGITOXIN HELLEBRIN 
1 x 10- 7 .62 17 .46 48 .303 78 
.60 21 .393 60 .303 78 
5 x 10- 7 .40 59 .241 89 .294 79 
.41 57 .233 91 .295 79 
1 x 10-6 .334 72 .205 96 .175 102 
.319 74 .213 95 .181 101 
5 x 10-6 .214 95 .174 102 .163 104 
.224 93 .172 103 .173 102 
1 x 10- 5. .197 98 .157 106 .173 102 
.217 94 .163 104 .163 104 
5 x 10- 5 .197 98 .155 106 
.204 96 .154 106 
1 x 10-4 .184 100 
.199 98 
5 x 10- 4 .189 100 
.186 
a 
1.30 A660 units/~mole Pi; Na+K+-ATPase S.A. 
of glycoside. 
- 14.4; A660 in absence 
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TABLE 10. Experimental data for the influence of various ligands on 
the binding of cardiac glycosides by guinea pig Na+K+-ATPase 
Glycoside 
Molarity 
1 x 10- 8 
1 x 10- 7 
1 x 10-6 
1 x 10-8 
3 x 10-8 
1 x 10-7 
3 x 10- 7 
1 x 10-8 
3 x 10-8 
1 x 10- 7 
, 3 x 10-7 




























b/u bound unbound b/u 
KIDNEY 
with 20 mM K+
a 
0.101 12.0 0.008 
0.101 11.6 0.009 
0.002 1.42 107. 0.013 
0.001 1.34 Ill. 0.012 
0.000 14.6 1164. 0.012 
18.7 1164. 0.016 
HEART 
with 20 roM K+
a 
0.006 0.54 10.3 0.052 
0.005 1.06 9.92 0.107 
0.004 1.43 31.2 0.046 
0.000 1.18 31.8 0 .. 037 
0.002 3.86 96.0 0.040 
0.003 3.69 98.4 0.038 
0.002 7.66 310. 0.025 
0.000 8.03 318. 0.025 
with 20 mM K 
+b 
0.318 0.28 9.00 0.031 
0.315 0.25 9.08 0.028 
0.243 0.73 29.3 0.025 
0.246 0.84 28.6 0.029 
0.180 2.00 87.2 0.023 
0.178 2.09 91.2 0.023 
0 .. 079 5.88 286. 0.020 
0.083 7.50 284. 0.026 
Glycoside 
Molarity 
1 x 10-8 
1 x 10-7 
1 x 10-6 
1 x 10-9 
3 x 10-9 
1 x 10-8 
TABLE 10 (continued) 
bound unbound b/u 
BRAIN 
without ATpa 
.098 9.30 0.010 
.057 9.33 0.006 
.988 81.6 0.012 
1.35 87.0 0.016 
11.8 873. 0.014 
9.88 853. 0.012 
without ATPb 
.019 1.14 0.017 
.018 1.29 0.014 
.049 3.93 0.012 
.048 3.99 0.012 
.130 14.2 0.009 
.142 14.1 0.010 
a conval1atoxo1 
b d· . 19oXl.n 
18 
bound unbound b/u 
with 20 JTh\l K+ 
a 
2.14 7.36 0.291 
2 .. 00 7.47 0.268 
15.3 70.2 0.218 
15.1 70.6 0.214 
74.3 797. 0.093 
74.9 809. 0.092 
a 
with 20 mM K+ 
.213 1.03 0.207 
.112 1.06 0.106 
.383 3.20 0.120 
.353 3.29 0.107 
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TABLE lL Experimental binding data for guinea pig kidney Na+K~-ATPase 
at various enzyme concentrations at fixed glycoside concentration 
III 




















mg protein/SO ~1. 


















b/u bound unbound b/u 
DIGOXINb 
0.725 2.2 7.72 0.285 
0.747 2.1 7.72 0.272 
1.42 3.6 6.56 0.549 
1.36 3.3 6.56 0.503 
2.50 4.5 3.40 1.32 
1.96 4.9 3.40 1 .. 44 
2.77 5.1 3 .. 24 1 .. 57 










TABLE 12. Experimental binding data for guinea pig brain Na+K+-ATPase 
































a mg prote~n/50 111 


























blu bound unbound b/u 
CYMAROL 
5.14 7.61 2.93 2.60 
6.22 7.06 2.80 2.52 
15.5 9.22 1.20 7.68 
15.4 8.77 1.35 6.50 
36.7 9.85 0.922 10.7 
39.2 9.76 0.666 14.6 
30.4 
31.1 
1.35 6.34 5.05 1.26 
1.15 5.89 5.62 1.05 
2.48 7.99 3.92 2.04 
2.44 8.22 4.90 1.68 
3.64 10.4 1.86 5.59 
3.46 9.95 2.28 4.36 
4.21 
4.07 
1.46 5.16 5.84 0.884 
1.38 4.81 5.75 0.836 
3.06 7.01 4.23 1.66 
2 .. 94 6.69 4.24 1.58 
6 .. 12 8.44 2.22 3.80 




TABLE 13. Experimental data for guinea pig heart Na+K+-ATPase/ 
convallatoxol binding in the presence of various concentrations of K+ 
Glycoside 
Molarity bound unbound blu bound unbound b/u 
0 K+ 0.155 mM K+ 
1 x 10-8 5.46 7.28 0.750 5.02 8.36 0.600 
5.41 7.08 0.764 3.75 8.64 0.434 
3 x 10-8 14.4 23.8 0.605 11.8 25.8 0.457 
13.4 24.1 0.556 12.5 25.0 0.500 
1 x 10- 7 26.4 85.2 0.310 23.5 94.0 0.250 
28.5 88.8 0.321 25.2 95.6 0.264 
3 x 10- 7 39.8 315. 0.126 33.9 310. 0.109 
39.2 316. 0.124 35.5 320. 0.111 
1 x 10-6 45.8 1072. 0.043 44.4 1148. 0.039 
46.5 1064. 0.044 43.5 1168. 0.037 
3 x 10-6 52.6 3376. 0.016 46.5 3288. 0.014 
42.4 3424. 0.012 57~O 3380. 0.017 
1 x 10-5 72.7 10688. 0.007 67 .. 1 11432. 0.006 
61.0 11136. 0.005 Ill .. 11744. 0.009 
3 x 10-5 
1.4 35840. 0.000 
0.625 roM K+ 20 roM K+ 
1 x 10-8 2.80 9.00 0.311 .23 9.04 0.025 
2.69 9.12 0.295 .. 25 10.1 0.025 
3 x 10-8 6.89 29.2 0.236 .78 36.0 0.022 
7.15 30.4 0.235 .72 35.5 0.020 
1 x 10-7 11.9 96.4 0.123 1.87 92.8 0.020 
14.3 101. 0.142 1.66 94.0 0.018 
3 x 10- 7 21.8 336. 0.065 5.38 343. 0.016 
22.1 337. 0.066 5.08 350. 0.014 
1 x 10-6 31.3 1112. 0.028 8.21 896. 0.009 
35.3 936. 0.038 10.5 932. 0.011 
3 x 10-6 43.9 3376. 0.013 72.6 3512. 0.021 
19.8 3468 .. 0.006 3484. 
1 x 10-5 73.7 10448. 0.007 17.0 9152. 0.002 
10-5 
49.7 11064. 0.004 12.5 9604. 0.001 
3 x 34696. 65.6 35740. 0.002 
35812. 36120. 
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TABLE 14. Experimental data for guinea pig brain Na+K+-ATPase/ 
conva11atoxol binding in the presence of various K+ concentrations 
Glycoside 
Molarity bound unbound b/u bound unbound b/u 
0 K+ O. 155 Jill.tl K+ 
1 x 10-8 27.3 1.44 19.0 27.5 1.68 16.4 
25.8 1.56 16.5 27.3 1.60 17.1 
3 x 10-8 76.3 8.04- 9.49 73.5 7.72 9 .. 52 
77.5 7.28 10.6 77.3 7.40 10.4 
1 x 10- 7 143. 59.6 2.40 135. 61.2 2.20 
10- 7 
152. 59.6 2.55 137. 65.2 2.10 
3 x 179. 282. 0.635 171. 273. 0.626 
176. 292. 0.603 174. 291. 0.598 
1 x 10-6 148. 1012. 0.146 202. 996. 0.203 
211 1032. 0.204 199. 1016. 0.196 
3 x 10- 6 272. 3276. 0.083 227 .. 3312. 0.068 
x 10-5 
259. 3316. 0.078 236. 3316. 0.071 
1 248. 11000. 0.022 204. 11032. 0 .. 018 
291. 11364. 0.026 249. 11704. 0.021 
3 x 10-5 243. 33752. 0.007 491. 33308. 0.015 
172. 35380. 0.005 582. 34612. 0.017 
0.625 rnM K+ 20 .. 0 Jlli\1 K+ 
1 x 10-8 25.6 2.32 11.0 6.78 9.12 0.743 
25.4 2.16 11.8 7.32 8.96 0.817 
3 x 10-8 70.3 10.6 6.63 18.8 28.1 0.669 
67.0 10.0 6.70 18.3 28.4 0.644 
1 x 10-7 129. 64.0 2.02 40.0 97.2 0.412 
132. 67.6 1.95 45.7 91.2 0.501 
3 x 10-7 157. 292. 0.538 78.8 307. 0.257 
153 .. 294. 0.520 78.8 324. 0.243 
1 x 10-6 196. 1036. 0.189 129. 1076. 0.120 
10- 6 
186. 1092. 0.170 136. 1020. 0.133 
3 x 218. 3232. 0.067 181. 3408. 0.053 
221. ·3268. 0.068 222. 3292. 0.067 
1 x 10-5 263. 11304. 0.023 500. 11088. 0;045 
10-5 
381. 11080. 0.034 360. 11492. 0.031 
3 x 867. 33732. 0.026 279. 34824. 0.008 
560. 33552. 0.017 442. 33264. 0.013 
TABLE 14. (continued) 
Glycoside 
Molaridy bound unbound' b/u bound unbound b/u 
0 K+ 0.625 ruM K+ 
1 x 10-8 20.6 1.09 18.9 17.2 1.30 13.2 
10- 8 
19.6 1.16 17 .. 0 17.0 1.35 12.7 
3 x 55.4 3.73 14.9 46.7 4.38 10.7 
50.9 4.06 12.6 48.7 4.23 11.5 
1 x 10-7 106. 19.7 5.40 91.8 20.8 4.46 
110. 19.4 5.68 92.7 20.7 4.46 
3 x 10- 7 149. 71.7 2.03 133. 73.0 1.76 
145. 72.0 2 .. 03 132. 73.0 1.76 
1.25 roM K+ 2.50 roM K+ 
1 x 10-8 15.4 1.45 10.6 11.6 1.76 6.59 
15.0 1.50 10 .. 0 11.2 1.78 6.29 
3 x 10-8 38.2 5.01 7.62 30.5 5 .. 58 5.46 
41.3 4.78 8.64 32.1 5.46 5.88 
1 x 10- 7 88.4 21.1 4.19 63.0 22.9 2.75 
87.6 21.1 4.15 64.6 22.8 2.83 
3 x 10-7 128. 73.3 1.75 110. 74.7 1.47 
118. 74.0 1.59 108. 74.8 1.44 
These values were derived from (total pmoles present-pmoles 
bound). This method is appropriate since in other experi-
ments the total pmoles added could be accounted for by pmoles 
bound + pmoles unbound within reasonable limits. 
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TABLE 15. Experimental binding data for guinea pig 
brain Na+K+-ATPase in the absence of K+ 
Glycoside 
~lo1arity 
1 x 10-8 
3 x 10-8 
5 x 10- 8 
1 x 10-7 
1 x 10-8 
3 x 10-8 
5 x 10~8 
1 x 10-7 
1 x 10-8 
3 x 10-8 
5 x 10-8 






















































b/u bound unbound 
CYMAROL 
16.0 12.7 1.21 
16.2 13.1 1.35 
11.8 3S .. 7 5.02 
11.4 40.8 5.20 
8.49 63.6 9.24 
7.28 65.1 10.0 
3.34 IDS. 33.5 
3.05 109. 32.8 
DIGITOXIN 
3.21 9.08 1.28 
2.97 8.16 1.42 
2.73 23.4 4.65 
2.55 27.7 4.21 
2.30 43.2 7.28 
2.30 45.6 6.S5 
1.58 84.0 16.4 



























TABLE 16. Ex~erimenta1 binding data for guinea pig 
brain NaK+-ATPase in the absence of K+ 
Glycoside 
Molarity 
1 x 10-8 
3 x 10-8 
1 x 10-7 
3 x 10-7 
1 x 10-8 
3 x 10-8 
1 x 10~7 
3 x 10-7 
1 x 10-8 
3 x 10-8 
1 x 10-7 




40 .. 0 
30 .. 5 














































b/u bound unbound 
CYlvfAROL 
12.9 8.4 1.00 
11.7 B .. 3 1.0B 
13.9 27.2 3.76 
10.0 25.2 3.60 
5.25 74.0 21.9 
4.32 83.4 23.1 
1 .. 22 164. 153. 
1.14 161. 167. 
DIGITOXIN 
2.50 4.6 0.84 
2.28 4.9 0.88 
1.94 14.2 2.88 
2.04 14.9 2.96 
1.76 46.5 12.0 
1.48 49.2 12 .. 7 
1.90 93.1 98.0 


























TABLE 17. Experimental binding data for guinea pig 
brain Na+K+-ATPase in the absence of K+ 
Glycoside 
Molarity 
1 x 10-8 
3 x 10-8 
1 x 10-7 
3 x 10-7 
1 x 10-8 
3 x 10-8 
1 x 10-7 
3 x 10-7 
1 x 10-8 
3 x 10-8 
1 x 10-7 






















































b/u bound unbound 
CThfAROL 
15.9 13.1 1.30 
14.5 12.7 1.42 
11.2 40.2 5.08 
9.95 39.4 5.50 
3.50 114. 31.9 
3.38 113. 32.2 
0.786 188. 192. 
0.723 186. 203. 
DIGITOXIN 
2.38 8.43 1.27 
2.31 9.08 1.28 
2.05 24.0 4.44 
2.02 24.0 3.47 
1.34 78.7 15.4 
1.34 83.3 17.4 
0.558 175. 94.6 



























TABLE 18. Experimental binding data for guinea pig brain 
Na+K+-ATPase in the presence of 0.625 mMK+ 
Glycoside 
Molarity 
1 x 10-8 
3 x 10-8 
5 x 10-S 
1 x 10-7 
1 x 10-8 
3 x 10-8 
5 x 10-8 
1 x 10-7 
1 x 10-8 
3 x 10-S 
5 x 10- 8 





























b/u bound unbound 
CThtAROL 
6.30 11.0 2.61 
6.98 11.0 2.86 
4.76 31.S 9.79 
4.64 32.1 9.87 
4.15 SIloS 16.6 
4.05 50.9 17.6 
2.08 60.0 32.6 
1.91 62.4 30.8 
DIGITOXIN 
1.75 7.68 1.43 
1.62 6.95 1.41 
1.50 25.1 4.77 
1.45 25.3 5.02 
1.26 43.7 . 8.64 
1.28 44.3 8.90 
0 .. 951 61.8 19.2 



























TABLE 19. Experimental binding data for guinea pig brain 
Na+K+-ATPase in the presence of 0.625 mM K+ 
28 
Glycoside 
Molarity bound unbound b/u bound unbound b/u 
CONVALLATOXOL CYMAROL 
1 x 10-8 13.8 2.05 6.73 11.3 2.41 4.69 
10-8 
13.1 2.00 6.55 11.8 2.41 4 .. 90 
3 x 42.6 7.21 5.91 35.2 8.41 4.18 
38.7 7.51 5.15 34.5 8.79 3 .. 92 
1 x 10-7 93.7 35.8 2.62 88.6 42.8 2.07 
91.1 45.1 2.02 
3 x 10-7 140 .. 231. 0.606 143. 226. 0.633 
150. 229. 0.655 147. 223. 0.659 
DIGOXIN DIGITOXIN 
1 x 10-8 8.49 4.89 1.-74 8.79 1.46 6.02 
7.97 5.18 1 .. 54 7.59 1.31 5.79 
3 x 10-8 26.2 16.9 1.55 23.5 4.52 5.20 
27.3 16.8 1.62 23.1 4.70 4.91 
1 x 10-7 54.3 62.3 0.872 67.9 24.4 2.78 
10-7 
61.5 63.3 0.972 80.0 24.0 3.33 
3 x 118. 237. 0.498 143. 93.1 1.54 
117. 244. 0.480 138. 138. 1.00 
1 x 10-8 9.6 7.32 1.03 
8.9 7.16 1.24 
3 x 10-8 29.1 23.7 1.23 
10-7 
28.6 24 .. 2 1 .. 18 
1 x 63.0 70.6 0.892 
62.8 72.6 0.865 
3 x 10-7 115. 270. 0.426 
114. 272. 0.419 
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TABLE 20. Experimental binding data for guinea pig brain 
Na+K+-ATPase in the presence of 0.625 mM K+ 
Glycoside 
Molarity bound unbound blu bound unbound b/u 
CONVALLATOXOL CYMAROL 
1 x 10-8 21.7 4.04 5.37 18.3 3.72 4.92 
10- 8 
21.5 3.60 5.97 17.5 3.68 4.76 
3 x 60.8 14.8 4.11 46.0 15.5 2.97 
57.5 18.8 3.06 48.0 1S.1 3.18 
1 x 10-7 102. 74.4 1.37 106. 65.6 1.62 
95.1 80.0 1.19 97.4 73.6 1.32 
3 x 10-7 136. 313 .. 0.43 140. 286. 0.490 
10-6 
138. 321. 0.430 146. 292. O.SOO 
1 x 184. 1100. 0.167 296. 1000. 0.296 
10-6 
160. 1120. 0.143 294. 984. 0.299 
3 x 189. 4252. 0.044 404. 3272. 0.123 
142. 3600. 0.039 347. 3384. 0.102 
DIGOXIN DIGITOXIN 
1 x 10-8 11.7 8.00 1.46 16.3 2.28 7.15 
11.8 8.00 1.48 17.1 2.56 6.68 
3 x 10-8 35.4 25.3 1.40 45.8 9.52 4.81 
33.1 26.2 1.26 44.0 9.12 4.82 
1 x 10-7 66.3 82.8 0.801 108. 50.0 2.16 
10-7 
63 .. 2 88.0 0.718 97.2 49.6 1.96 
3 x 122. 312. 0 .. 391 143. 211. 0 .. 678 
103. 322. 0.320 134. 213. 0.629 
1 x 10-6 164. 1064. 0.154 199. 828. 0.240 
186. 1056. 0.176 212. 816. 0.260 
3 x 10-6 160. 3544. 0.045 280. 2616. 0.107 
201. 3528. 0.057 224. 2568. 0.087 
OUABAIN 
1 x 10-8 14.9 7.96 1.87 
12.6 8.68 1.45 
3 x 10-8 36.5 27.5 1.33 
33.1 28.2 1.17 
1 x 10- 7 19 .. 6 126. 0 .. 156 
10- 7 
19.1 130. 0.147 
3 x 20.2 412. 0.049 
10-6 
20.7 424. 0.049 
1 x 28.6 1376. 0.021 
37.4 1352. 0.028 
3 x 10~6 46.1 4408. 0.010 
47.3 4224. 0.011 
Glycoside 
Molarity 
1 x 10-8 
3 x 10- 8 
1 x 10-7 
3 x 10-7 
1 x 10-8 
3 x 10- 8 
1 x 10-7 
3 x 10-7 
1 x 10-8 
3 x 10-8 
1 x 10-7 
3 x 10-7 
TABLE 21. Experimental binding data for guinea pig 
kidney Na+K+-ATPase in the absence of K+ 
bound unbound b/u bound unbound 
CONVALLATOXOL CYMAROL 
5.7 5.44 1.05 . 5. 7 - 3.32 
6.1 5.52 1.10 5.8 4.48 
17.7 17.5 1.01 16.6 14.4 
17.7 17.8 0.994 16.7 14.7 
47.4 66.0 0.718 48.4 64.0 
43.1 60.8 0.709 47.4 67.6 
73.7 258. 0.286 79.6 267. 
72.1 266. 0.271 80.0 272. 
DIGOXIN DIGITOXIN 
2.9 6.24 0.465 2.7 2.44 
2.8 6.48 0.432 2.9 2.64 
9.2 20.5 0.449 8.9 8.40 
9.0 20.8 0.433 9.2 8.48 
25.1 70.4 0.356 28.0 31.4 
25.6 76 .. 8 0.333 30.7 33.3 
46.0 276. 0.167 60.2 155. 
47.4 281. 0.169 54.7 153. 
OUABAIN 
3.8 6.64 0.572 
3.8 6 .. 84 0.556 
12.1 23.1 0.524 
11.9 23.2 0.513 
29 .. 2 72.0 0.406 
28.7 73.2 0.392 
61.6 270. 0.228 


















0 .. 358 
TABLE 22. Experimental binding data for guinea pig . 
kidney Na+K+-ATPase in the absence of K+ 
Glycoside 
Molarity 
1 x 10- 8 
3 x 10-8 
1 x 10-7 
3 x 10-7 
1 x 10-8 
3 x 10- 8 
1 x 10-7 
3 x 10-7 
1 x 10-8 
3 x 10-8 
1 x 10- 7 






















































b/u bound unbound 
CYMAROL 
1.21 6.04 4.32 
1.29 5.66 4.92 
1.75 18~3 14.9 
1.12 15.6 14.4 
0.802 51.9 54.4 
0.707 50.9 61.6 
0.306 78.9 278. 
0.319 78.8 278. 
DIGITOXIN 
0 .. 426 2.87 2.44 
0.493 2.87 2.28 
0.430 9.24 8.08 
0.431 9.74 8.48 
0 .. 381 27.6 31.4 
0.418 28.9 30.9 
0.217 59.7 159. 














1 .. 08 












TABLE 23. Experimental binding data for guinea pig kidney 
Na+K+-ATPase in the presence of 0.625 mrvt K+ 
Glycoside 
Molarity 
1 x 10-8 
3 x 10-8 
1 x 10- 7 
3 x 10-7 
1 x 10-6 
3 x 10-6 
1 x 10- 8 
3 x 10- 8 
1 x 10-7 
3 x 10- 7 
1 x 10- 6 
3 x 10-6 
1 x 10-8 
3 x 10-8 
1 x 10-7 
3 x 10- 7 
1 x 10-6 














































































b/u bound unbound 
CYMAROL 
0.479 3.43 7.41 
0.484 3.58 7.09 
0.450 10.3 22.1 
0.448 10.3 23.0 
0 .. 370 28.9 84.4 
0.331 33.1 81.3 
0.218 54.8 298. 
0.201 57.9 317. 
0.076 1135. 
0.089 58.5 1210. 
0.027 64.9 3909. 
0.032 68 .. 3 3774. 
DIGITOXIN 
0.270 2.48 3.56 
0.225 2.14 3.66 
0 .. 204 
0.206 7.33 12.2 
0.195 20.4 44.2 
0.187 23.0 48.5 
0.140 42 .. 0 177. 
0.130 42.9 174. 
0.062 163. 1271. 
0.061 276. 1379. 
0.020 311 .. 4628. 

































0 .. 128 
0 .. 200 
0.06 
0.062 
TABLE 24. Experimental binding data for guinea pig 
heart Na+K+-ATPase in the absence of K+ 
Glycoside 
Molarity 
1 x 10-8 
3 x 10-8 
1 x 10-7 
3 x 10-7 
1 x 10-8 
3 x 10-8 
1 x 10-7 
3 x 10-7 
1 x 10-
8 
3 x 10-8 
1 x 10-7 
3 x 10- 7 
1 x 10- 6 
3 x 10-6 
1 x 10-5 


































unbound b/u bound unbound 
CONVALLATOXOL CYMAROL 
7.24 0.790 5.99 6.16 
7.68 0.714 6.24 6.52 
25.7 0.591 15.7 22.0 
26.2 0.569 14.7 20.6 
78.4 0.372 31.4 86.0 
82.0 0.352 32.0 88.0 
289. 0.150 42.4 308. 
293. 0.149 40.6 301. 
DIGOXIN DIGITOXIN 
7.12 0.409 3.84 3.42 
7.24 0.398 3.71 3.27 
23.7 0.320 10.7 13.0 
23.5 0.326 11.1 13.4 
81.6 0.233 22.8 46.4 
86.0 0.219 25.0 47.2 
275. 0.105 36.1 184. 




































TABLE 25. Experimental binding data for guinea pig 
heart Na+K+-ATPase in the absence of K+ 
Glycoside 
bOWlda unboundb Molarity b/u bound unbound 
CONVALLATOXOL CYMAROL 
1 x 10-8 5 .. 68 8.72 0.651 5.22 7.68 
10-8 
4.63 8.80 0.526 4.84 7.60 
3 x 13.7 29.3 0.468 13.0 26.2 
14.0 29.9 0.468 12.8 25.5 
1 x 10-7 27.7 83.6 0.331 30.3 106. 
10-7 
27.8 93.2 0.298 27.8 97.2 
3 x 43.4 315. 0.138 35.6 348. 
42.2 318. 0.133 31.8 359. 
DIGOXIN DIGITOXIN 
1 x 10-8 2.34 8.52 0.275 3.42 4.20 
2.06 7.72 0.267 3.40 4.76 
3 x 10-8 5.57 27.6 0.2.02 8.68 15.3 
5.41 28.0 0.193 8.94 16.4 
1 x 10-7 14.1 90.4 0.166 27 .. 8 47.6 
17.1 97.2 0.176 17.2 57.6 
3 x 10-7 25.4 315. 0.081 
33.8 311. 0.109 29.9 212. 
OUABAIN 
1 x 10-8 2.36 8.76 0.269 
2.17 9.28 0.234 
3 x 10-8 6.67 29.8 0.224 
6.49 29.5 0.220 
1 x 10- 7 16.2 87.6 0.185 
17.2 95.6 0.180 
3 x 10-7 31.2 300. 0.104 
28.2 307 0.092 
a 





















1 x 10-8 
3 x 10-8 
1 x 10-7 
3 x 10-7 
1 x 10-8 
3 x 10- 8 
1 x 10- 7 
3 x 10-7 
1 x 10-8 
3 x 10- 8 
1 x 10-7 
3 x 10~7 
TABLE 26. Experimental binding data for guinea pig . 
heart Na+K+-ATPase in the· absence of K+ . 
bound unbound b/u bound unbound 
CONVALLATOXOL CYMAROL 
4.5 8.88 0.507 4.3 8.24 
4.6 10.6 0.434 
10.9 30.0 0.363 10.7 25.8 
11.S 29.5 0.390 10.7 26.5 
23.5 88.0 0.267 22.0 95.6 
23.1 96.4 0.240 22.3 100. 
35.0 314. 0.111 30.8 336. 
33.4 314. 0.106 35.0 327. 
DIGOXIN DIGITOXIN 
2.0 8.B4 0.226 7.1 4.44 
1.8 8.56 0.210 6.4 4.76 
5.2 28.1 0.185 
5.1 28.0 0.182 
12.4 91.6 0.135 22.3 56.0 
15.7 96.0 0.164 19.5 66.4 
21.5 314. 0.068 29.6 210. 
32.3 ·300. O.lOB 27.B 205. 
OUABAIN 
2.2 9.64 0.228 
1.9 9.52 0.200 
10.0 52.8 0.189 
9.6 53.2 0.180 
13.5 91.2 0.148 
13.6 94.0 0.145 
24.8 319. 0.078 


















1 x 10-8 
3 x 10-8 
1 x 10-7 
3 x 10-7 
1 x 10-8 
3 x 10-8 
1 x 10-7 
3 x 10-7 
1 x 10-8 
3 x 10-8 
1 x 10- 7 
3 x 10-7 
TABLE 27. Ex~erimental binding data for guinea pig 
heart Na K+-ATPase in the absence of 'K+ 
bound unbound b/u bound unbound 
CONVALLATOXOL CYMAROL 
3.6 7.20 0.500 3.6 6.36 
3.9 7.20 0.542 3.6 6.12 
8 .. 0 19.8 0.404 9.4 21.0 
8.7 23 .. 7 0.367 9.0 20.9 
20.6 70.8 0.291 19.8 68.8 
16.7 74.8 0.223 20.1 79.2 
30.7 253. 0.121 29.4 263. 
33.7 260. 0.130 41.5 274. 
DIGOXIN DIGITOXIN 
1.6 6.60 0.242 2.6 3.42 
1.6 6.72 0.238 2.5 3.60 
4.4 22.3 0.197 6.7 11.6 
4.6 23.2 0.198 6.5 11.9 
11.7 74.0 0.158 14.7 47.2 
11.5 79.6 0.144 16.8. 46.8 
18.0 256. 0.070 
18.6 272. 0.068 26.2 158. 
OUABAIN 
1.8 7.60 0.237 
2.0 7.60 0.263 
5.5 24.1 0.228 
4.3 24.6 0.175 
12.9 74.8 0.172 
13.8 77.2 0.179 
24.6 239. 0.103 




















1 x 10-8 
3 x 10- 8 
1 x 10-7 
3 x 10- 7 
1 x 10-8 
3 x 10-8 
1 x 10-7 
3 x 10- 7 
1 x 10-8 
3 x 10-8 
1 x 10-7 
3 x 10- 7 
TABLE 28. Ex~erimenta1 binding data for guinea pig 
heart Na K+-ATPase in the absence of K+ 
bounda unboundb b/u bound unbound b/u 
CONVALLATOXOL CYMAROL 
4.64 7.52 0.617 4.36 6.68 0.653 
4.50 7.96 0.565 4.40 6.84 0.643 
11.2 24.8 0.452 11.7 22.4 0.522 
11 .. 1 26.4 0.420 12.0 23.1 0.519 
24.1 79.6 0.303 24~8 82.4 0.301 
24.0 81.6 0.294 25.4 87.2 0.291 
36.1 266. 0.136 34.3 287 .. 0.120 
47.3 266. 0.178 36 .. 6 287. 0.128 
DIGOXIN DIGITOXIN 
2.03 7.68 0.264 3.40 3.53 0.963 
1.99 7.72 0.258 3.31 3.74 0.885 
5.23 23.8 0.220 8.17 12.8 0.638 
5.07 24.0 0.211 8.74 13.0 0.672 
13.1 77.2 0.170 20.0 45.2 0.442 
14.1 82.0 0.172 19.1 47.2 0.405 
22.5 270 .. 0.083 31.8 176. 0.181 
25.0 268. 0.093 31.2 184. 0.170 
OUABAIN 
2.43 8.20 0.296 
2.25 8.24 0.273 
6.05 26.7 0.226 
6.59 26.4 0 .. 250 
15.9 80.4 0.198 
16.4 82.0 0.200 
27.8 . 273. 0 .. 102 
31.3 276. 0.113 
37 
TABLE 29. Experimental binding data for guinea pig heart 
Na+K+-ATPase in the presence of 0.625 mM K+ 
Glycoside 
Molarity 
1 x 10-8 
3 x 10-8 
1 x 10-7 
3 x 10-7 
1 x 10-8 
3 x 10- 8 
1 x 10- 7 
3 x 10-7 
1 x 10-8 
3 x 10-8 
1 x 10-7 






















































b/u bound unbound 
CYMAROL 
0.414 3.77 7.88 
0.431 4.99 7.00 
0.425 8.00 27.8 
0.331 8.71 27.8 
0.233 44.4 87.6 
0.213 45.3 94.0 
0.170 57.8 327. 
0.188 58.5 326. 
DIGITOXIN 
0.243 
0.235 2.65 4.24 
0.192 5.88 13.8 
0.184 7.62 13.0 
0.161 35.6 55.6 
0.168 42.0 58.0 
0.149 59.5 187. 



























TABLE .30.. Experimental data for the binding of conval1atoxol to guinea 
pig kidney Na+K+-ATPase in the presence of ATP or inorganic phosphate 
Conval1atoxol 
Molarity bound unbound b/u bound unbound blu 
ATP H3P04 
1 x 10-8 6.62 1.19 5.56 5.65 0.905 6.24 
10-8 
6.43 1.13 5.69 5.65 0 .. 946 5.97 
3 x 19.6 3.96 4.95 19.2 3 .. 78 5.08 
18.9 3.98 4.75 18.4 3.95 4.66 
1 x 10-7 49 .. 3 17.8 2.77 40.6 16.4 2.48 
50.8 19.0 2.67' 41.5 16.0 2.59 
3 x 10- 7 90.7 83.6 1.08 79.2 85.9 0.922 
96.8 84.8 1.14 79.9 86.9 0 .. 919 
1 x 10-6 115. 319. 0.360 97 .. 6 283. 0.345 
110. 310. 0.355 95.0 266. 0.357 
3 x 10-6 112. 1102. 0.102 106. 1068. 0.099 
125. 1097. 0.114 lOB. 1101. 0.098 
1 x 10-5 131. 2278. 0.058 118. 2623. 0.045 
185. 2291. 0.081 159. 2700. 0.059 
3 x 10-5 200. 8834. 0.023 186. 8576. 0 .. 022 
252. 8726. 0.029 164. 8532. 0.019 
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TABLE 31. Rat Brain ATPase Activity 
as a Function of Time 
Time in Total Mg 
2+ a 
Minutes A660 Activity A660 Activity 
Study Ib 
2.5 .090 12.0 .038 5.0 
.081 10.8 .035 4.6 
5.0 .180 24 .. 0 .. 058 7.7 
.180 24.0 .052 6.9 
10.0 .342 45.5 .078 10.4 
.365 48.6 .068 9.0 
15.0 .50 66.6 .. 110 14.6 
.50 66.6 .109 14.5 
20.0 .62 82.5 .121 16.1 
.62 82.5 .138 18.4 
30.0 .80 106.5 .142 18.9 
.96 127.8 .142 18.9 
Study 2c 
2.5 .120 14.6 .. 025 3 .. 0 
.112 13.6 .025 3.0 
5.0 .210 25 .. 5 .039 4 .. 7 
.213 25.9 .. 041 5.0 
10.0 .380 46.2 .061 7.4 
.. 359 43.6 .063 7.7 
15.0 .47 57.1 .070 8.5 
.47 57.1 .070 8.5 
20.0 .. 61 74.2 .110 13.4 
.57 69.3 .110 13.4 
30.0 .75 91.2 .139 16.9 
. 75 91.2 .142 17.3 
a inhibited by 1 x 10- 2 ~1 Ouabain. 
b 1.16 A660 units/~mole Pi· c 1.27 A660 units/~mole Pi· 
TABLE 32. Rat ATPase Activities as 
Functions. of Enzyme Concentration 
111 Enzyme 
















a 0.045 mg Pro/SO ~l 
A 
. . b ctlV1ty 
11.6 










units/}11I101e p. 1.20 A660 1 
c 0.165 mg Pro/SO~l 
d 1.31 A660 units/llmo1e Pi 
III Enzyme 
1 


























































TABLE 33. Rat ATPase Activities as 





mM A660 Activity A660 Activity 
0.155 .132 17.7 .095 12.8 
.131 17.6 .089 11.9 
.140 18.8 
0.310 .. 161 21 .. 6 .093 12.5 
.165 22.1 .087 11.7 
0.625 .231 31.0 .090 12.1 
.230 30.9 .090 12.1 
.228 30.6 
1.25 .211 28.6 .093 12.5 
.221 30.0 .090 12.1 
.210 28.4 
2.50 .320 43.0 .100 13.4 
.327 43.9 .096 12.9 
.324 43.5 
5.00 .280 37.6 
.300 40 .. 3 .100 13.4 
.280 37.6 
10.00 .235 31.5 .102 13.7 
.239 32.1 .099 13.3 
.239 32.1 
20.00 .208 27.9 .093 12.5 
.209 28.0 .091 12.2 
.202 27.1 
a 1.20 A660 units/~mo1e Pi. 
b inhibited· with 5 x 10-4 M Ouabain. 













.310 19 .. 3 
.302 18.8 
.382 23.8 















TABLE 34. Inhibition of Rat Brain ATPase by Various 
Gardiac Glycosides at Several K+ Concentrations 
CONVALLATOXOL DIGOXIN CYMAROL 
Glycoside % % % 
Molarity A660 Inhibition A660 Inhibition A660 Inhibition 
2.5 ruM K+ a 
1 x 10-8 .420 - 10 .470 - 30 
10-8 
.415 8 .500 - 42 .435 - 16 
5 x .332 25 .420 - 10 .370 10 
.342 21 .450 - 22 .385 4 
1 x 10- 7 .440 - 18 .357 15 
x 10- 7 
.375 8 .445 - 20 .367 11 
5 .288 43 .340 22 .280 46 
.302 37 .330 26 .278 47 
1 x 10- 6 .272 49 .310 34 .265 52 
.302 37 .315 32 .257 55 
S x 10-6 .250 58 .239 63 .221 70 
.255 56 .249 59 .245 60 
1 x 10-5 .245 60 .221 70 .209 75 
.278 47 .230 66 .215 72 
5 x 10-5 .200 78 .121 110 .140 102 
.220 70 .130 106 .145 100 
0.625 mM K+ 
b 
1 x 10- 8 .235 - 11 .265 - 40 .247 - 22 
.254 - 29 .256 - 31 .250 - 25 
5 x 10- 8 .174 48 .235 - 11 .. 250 - 2S 
.199 24 .255 - 30 .222 2 
1 x 10- 7 .214 10 .235 - 11 .220 4 
.206 17 .245 - 20 .230 6 
5 x 10- 7 .183 40 .186 37 .182 40 
.185 38 .193 30 .190 33 
1 x 10-6 .174 48 .175 47 .170 52 
.185 38 .199 24 
5 x 10- 6 .165 57 .156 66 .IS5 66 
.lS5 66 .160 62 .175 47 
1 x 10-5 .153 68 .154 67 .161 61 
.164 58 .168 54 
5 x 10- 5 .125 95 .105 115 .145 76 
.126 94 .135 86 .. 130 91 
a 1.16 A660 units/~mo1e p ... Na+K+-ATPase S.A. - .395 A660 in absence of l' 
b 
glycoside. 
Na+K+-ATPase S.A. 1.16 A660 units/~mo1e p ... - .224 A660 in absence of l' 
glycoside. 
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TABLE 34 (continued) 
OUABAIN DIGITOXIN HELLEBRIN 
Glycoside % % % 
Molarity A660 Inhibition A660 Inhibition A660 Inhibition 
2.5 mM K+ 
1 x 10-8 .451 - 22 .490 - 38 .388 3 
.493 - 39 .470 - 30 .389 3 
5 x 10- 8 .409 5 .389 2 .304 37 
.419 - 10 .390 2 .312 33 
1 x 10-7 .385 4 .408 5 .271 SO 
.425 - 12 .380 6 .289 43 
5 x 10- 7 .297 39 .280 46 .210 74 
.303 37 .283 45 .226 68 
1 x 10-6 .. 290 42 .280 46 .218 71 
.. 325 28 .289 43 .221 70 
5 x 10-6 .249 59 .238 63 <.170 >90 
.272 49 .220 70 <.170 >90 
1 x 10-5 .227 67 .228 67 .170 90 
.233 65 .235 64 .181 86 
5 x 10-5 .187 84 .160 94 <.170 >90 
.220 70 .160 94 <.170 >90 
1 x 10-4 .153 97 
.161 94 
5 x 10-4 .135 
.135 
1 x 10- 2 .135 100 
.135 
0.625 mM K+ 
1 x 10- 8 .300 - 73 .218 6 .221 3 
.273 - 47 .221 3 .246 21 
5 x 10-8 .240 - 16 .192 31 .197 26 
.239 - 14 .202 20 .191 32 
1 x 10- 7 .233 9 .203 20 .180 42 
.254 - 29 .208 15 .176 46 
5 x 10- 7 .201 22 .170 52 .145 76 
.210 13 .170 52 .158 64 
1 x 10-6 .199 24 .172 SO .140 81 
10-6 
.210 13 .179 43 .167 55 
5 x .190 33 .146 75 .105 115 
.181 41 .145 76 .115 IDS 
1 x 10-5 .188 35 .. 159 63 .132 89 
.162 60 .. 135 86 
5 x 10-5 .159 63 .120 100 .097 122 
.186 37 .136 85 .103 117 
1 x 10-4 .148 73 
.148 73 
5 x 10-4 .120 
x 10-2 
.122 
1 .118 100 
.120 
4S 
TABLE 34 (continued) 
CONVALLATOXOL DIGOXIN CYMAROL 
Glycoside % % % 
Molarity A660 Inhibition A660 Inhibition A660 Inhibition 
20.0 mM K+ c 
1 x 10- 8 .308 7 .291 3 .328 - 19 
.307 6 .318 - 13 .326 - 18 
5 x 10- 8 .297 0 .301 3 .308 7 
.291 3 .296 0 .300 - 2 
1 x 10-7 .272 IS .286 6 .276 12 
.279 10 .288 5 .276 12 
5 x 10-7 .244· 32 .247 30 
.249 28 .247 30 
1 x 10-6 .217 48 .258 23 .227 42 
.219 46 .258 29 .218 47 
5 x 10-6 .165 79 .198 59 .164 80 
.177 72 .206 54 .167 78 
1 x 10-5 .155 85 .191 63 .157 84 
.147 90 .188 65 .150 88 
5 x 10-5 .137 96 .194 62 .139 95 
.139 95 .202 57 .139 95 
1 x 10-4 .132 99 .155 85 .138 95 
.128 101 .161 81 .136 96 
5 x 10-4 .122 105 .078 131 .. 126 102 
.. 129 101 .046 151 .123 104 
0.625 roM K+d 
1 x 10-8 .142 21 .163 7 
.153 6 .169 - 16 .139 25 
5 x 10-8 .140 24 .146 16 .112 62 
.142 21 .154 5 .128 40 
1 x 10-7 .122 48 .143 20 .118 S4 
.141 23 .143 20 .116 57 
5 x 10- 7 .128 40 .124 46 .108 68 
.129 39 .127 42 
1 x 10-6 .115 58 .121 50 .103 74 
.112 62 .125 44 .109 66 
5 x 10-6 .118 54 .115 58 .097 83 
.114 59 .115 58 .098 81 
1 x 10-5 .113 61 .098 81 .088 95 
.113 61 .100 79 .. 097 83 
5 x 10-5 .101 77 .077 110 .085 99 
.103 74 .095 85 .087 96 
c 1.20 A660 units/~mole p ... l' Na+K+ -ATPase S.A. - .296 A660 in absence 
of glycoside. 
d 1.27 A660 units/~mole Pi; Na+K+-ATPase S.A. - .213 A660 in absence 
of glycoside. 
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TABLE 34 (continued 
OUABAIN DIGITOXIN HELLEBRIN 
Glycoside 
Molarity A660 Inhibition A660 Inhibition A660 Inhibition 
20.0 mM K+ 
1 x 10-8 .318 - 13 .317 - 12 
.318 - 13 .306 - 6 
5 x 10-8 .298 1 .298 1 
.270 16 .299 - 2 
1 x 10- 7 .279 10 .291 3 .298 1 
10- 7 
.288 5 .296 1 .288 5 
5 x .260 22 .236 36 .234 38 
.260 22 .246 30 .235 37 
1 x 10-6 .253 26 .226 42 
.250 28 .224 44 .233 38 
5 x 10-6 .196 60 .176 72 .183 68 
.188 65 .178 71 .178 71 
1 x 10-5 .168 77 .164 80 .169 77 
.183 68 .166 78 .169 77 
5 x 10- 5 .140 94 .180 70 .146 90 
.143 92 .188 65 .143 92 
1 x 10-4 .156 84 .141 94 
.146 90 .153 86 
5 x 10-4 .133 100 .082 129 
.128 .083 128 
0.625 mM K+ 
1 x 10-8 .170 17 .170 17 .151 9 
.156 2 .170 - 17 .148 13 
5 x 10-8 .154 5 .160 - 3 .136 29 
.149 12 .162 . - 6 .138 27 
1 x 10-7 .141 23 .164 - 9 .128 40 
.141 23 .151 9 .135 31 
5 x 10- 7 .122 48 .135 31 .. 121 SO 
.. 132 35 .139 2S .. 116 57 
1 x 10-6 .142 21 .126 43 
.132 35 .126 43 
5 x 10-6 .122 48 .106 70 
.125 44 .108 68 
1 x 10-5 .117 55 .111 64 .105 72 
.119 53 .110 65 .107 69 
5 x 10-5 .090 92 .096 84 
.115 58 .088 95 .096 84 
1 x 10-4 .107 69 
.108 68 
5 x 10-4 .088 95 
.092 90 
TABLE 35. Ex~erimental binding data for rat brain 
Na+K -ATPase in the absence of K+ 
Glycoside 
Molarity 
1 x 10-8 
3 x 10-8 
1 x 10- 7 
3 x 10-7 
1 x 10-8 
3 x 10-8 
1 x 10-7 
3 x 10- 7 
1 x 10-8 
3 x 10-8 
1 x 10-7 






















































b/u bound unbound 
CYMAROL 
4.76 15.5 5.45 
4.28 16.1 5.01 
2.24 35.3 19.0 
2.30 35.5 20.1 
0.68 41.8 82.9 
0.66 40.5 89.3 
0.21 44.6 304. 
0.18 45.4 309. 
DIGITOXIN 
0.91 11.0 2.60 
0.82 10.8 2.33 
0.77 32.4 10.1 
0.69 . 32.1 11.6 
0.41 54.0 48.7 
0.49 70.3 44.0 
0.12 70.0 200. 
0.12 53.9 177. 
1.25 

























TABLE 36. Experimental binding data for rat brain 
Na+K+-ATPase in the absence of K+ 
Glycoside 
Molarity 
1 x 10-8 
3 x 10-8 
1 x 10- 7 
3 x 10-7 
1 x 10- 8 
3 x 10-8 
1 x 10-7 
3 x 10- 7 
1 x 10-8 
3 x 10- 8 
1 x 10- 7 













31 .. 0 




































b/u bound lUlbound 
CYMAROL 
6.74 11.7 2.02 
7.52 11.8 2.05 
4.80 34.3. 8.26 
5.14 35.6 7.53 
1.28 84.9 35.9 
1.22 90.8 39.6 
0.264 123. 269. 
0.256 131. 268. 
DIGITOXIN 
1.68 7.68 1.59 
1.43 7.99 1.72 
1.21 26.0 5.38 
1.36 27.0 5.38 
1.13 23.0 
1.04 80.8 25.8 
0.391 211. 122. 
























TABLE 37. Experimental binding data for rat brain 
Na+K+-ATPase in the presence of 0.625 rnM K+ 
Glycoside 
Molarity 
1 x 10- 8 
3 x 10-8 
1 x 10-7 
3 x 10- 7 
1 x 10-8 
3 x 10- 8 
1 x 10- 7 
3 x 10-7 
1 x 10-8 
3 x 10-8 
1 x 10-7 






















































b/u bound unbound 
CYMAROL 
3.57 10.8 6.44 
3.08 12.8 6.38 
1.61 27.1 22.6 
1.62 28.6 23.0 
0.634 39.7 86.1 
0.293 40.1 90.8 
0.163 45.7 318. 
0.167 37.5 311. 
DIGITOXIN 
0.551 10.4 3.16 
0.671 11.3 3.18 
0.495 28.9 11.7 
0.428 30.4 11.9 
0.253 56.6 46.1 
0.299 83.0 47.6 
0.198 97.8 180. 




























TABLE 38. Experimental data for rat brain Na+K+-ATPase/l x 10-8 M 


































TABLE 39. Experimental data for rat brain Na+K+-ATPase/convallatoxol 
binding in the presence of various concentrations of K+ 
Glycoside 
Molarity 
1 x 10-S 
3 x 10- S 
1 x 10-8 
. 3 x 10-8 
1 x 10-8 
3 x 10-8 
1 x 10- 8 































































b/u bound unbound b/u 
"0.625 ruM K+ 
10.8 23.4 4.36 5.37 
11.4 26.7 4.10 6.51 
34.2 34.5 4.52 7.63 
31.3 34.1 3.96 8.61 
5.77 70.5 16.6 4.25 
5.78 64.8 16.0 4.05 
5.83 75.7 20.8 3.64 
5.60 74.6 22.0 3.39 
2.5 mM K+ 
12.1 12.7 7.02 i.81 
11.6 13.3 6.80 1.96 
12.1 16.6 8.74 1.90 
11.5 14 .. 4 8.56 1.68 
4.85 33.6 23.4 1.44 
4.80 30.8 23.1 1.33 
4.67 
5.04 44.2 29.9 1.48 
20. 0 ITh\1 K+ 
0.96 2.42 10.1 0.24 
0.91 2.60 10.1 0.26 
1.08 
0.92 3.04 11.9 0.25 
0 .. 79 7.34 30.5 0.24 
0.72 6.82 30 .. 9 0.22 
0.66 7.72 39.0 0.20 
0 .. 71 8.36 39.6 0.21 
14.0 
12.7 
5 .. 67 
5.92 
52 
TABLE 40. Experimental binding data for the rate of as~ociation 



































































































1 .. 93 
1.9S 
1.93 
1.54 14.6 1.43 10.2 
1.31 12.6 1.30 9.69 
1 .. 24 11 .. 8 1.64 7.20 
1.32 12.0 1.68 7.14 
0.944 8.26 2.12 3.90 
1.07 9.22 2.27 4.06 
1.16 8.97 2.64 3.40 
0.903 7.58 2.26 3.35 
0.771 5.22 2.88 1.81 
0.758 5.72 2.54 2.25 
0.677 3.98 3.20 1.24 
0.716 3.95 3.57 1.11 
0.692 3.89 3.31 1.18 
0.568 2.48 3.60 0.689 
0.694 3.64 3.92 0.928 
TABLE 41. Experimental binding data for the rate of as'sociation 







































































































0.823 7.65 0.747 10.2 
0.710 7.37 0.796 9.26 
0.850 8.08 0 .. 928 8.71 
0.712 7.11 0.940 7 .. 56 
0.736 6.73 1.00 6.73 
0.698 6.34 1.20 5.28 
0.649 6.24 1.03 6.06 
0.654 6.18 1.01 6.12 
0 .. 601 5.86 1.11 5.28 
0.698 6.58 1.38 4.77 
0.596 5.40 1.10 4.91 
0.636 5.40 1.22 4.43 
0.553 4.74 1.18 4.02 
0.548 4.36 1.39 3.14 
0.542 4.47 1.39 3.22 
53 
TABLE 42. Experimental binding data for the rate of association 
of glycosides to guinea pig heart Na+K+-ATPase 
Time in 
Minutes bound unbound b/u bound unbound b/u 
CONVALLATOXOLa 
2.5 8.52 19.4 0.439 
7 .. 16 20.2 0.354 
5.0 6 .. 49 20.5 0.316 
6.64 20.1 0 .. 330 
10 .. 0 5.38 20.4 0.264 
5.64 21.5 0.262 
20.0 5.87 20 .. 8 0.282 
5.58 21 .. 8 0.256 
30.0 
5.04 21.2 0.238 
CONVALLATOXOLb 
2.5 4.28 8.60 0.498 2.69 9.20 0.292 
4.22 8.52 0.495 2.59 8.96 0.289 
5.0 4.41 8 .. 44 0.522 2.66 9.24 0.288 
5.16 8.20 0.629 2.70 ~ 9 .. 28 0.291 
15.0 
20.0 2.68 9.16 0 .. 292 
4 .. 45 8.36 0.532 2.71 9.44 0.287 
30.0 4.30 8.64 0.498 2.78 9.36 0.297 
4.02 8.24 0 .. 488 2.74 9.48 0.289 
OUABAINc 
2.5 4.75 22.6 0.210 
5.03 23.4 0.215 
5.0 ·5.45 22.9 0.238 
5.23 23.2 0.225 
20.0 6.08 22.5· 0.270 
5.43 22.4 0.242 
30.0 4.86 23.0 0.211 
6.62 24.1 0.275 
a 3 x 10- 8 M 
b,c 1 x 10- 8 M 
54 
TABLE 43. Experimental binding data for the rate of association of 












a 3 x 10-8 M· 











































TABLE 44. Experimental binding data for the rate of association and 
















































































4.28 14.6 2 .. 15 6 .. 79 
3.93 13.5 1.99 6.78 
4.04 12.4 2.92 4.25 
3.80 12.1 2.79 4.34 
3.96 11.3 4.06 2.78 
3.84 10.8 4.10 2.63 
3.54 9.46 4.88 1.92 
3.50 9.90 4.72 2 .. 10 
3.35 8.51 5.21 1.63 
3.42 8.85 5.33 1.66 
3.35 7.08 6.27 1.13 
2.72 7 .. 39 4.13 1.79 
58 
TABLE 46. Rat Heart ATPase Activity 
as a Function of Time 
Time in Total lvlg2+
a 
Minutes A660 Activity A660 Activity 
Study Ib 
2.5 .125 4.3 .026 0.9 
.126 4.3 .028 1.0 
5.0 .218 7.5 .050 1.7 
.192 6.6 .043 1.5 
10.0 .259 8.9 .050 1.7 
.272 9.3 .049 1.7 
15.0 .331 11.4 .090 3.1 
.320 11.0 .096 3.3 
20.0 .332 11.4 .100 3.4 
.340 11.7 .109 3.7· 
30.0 .45 15.4 .150 5.1 
.47 16.1 .150 5.1 
Study 2c 
2.5 .199 7.8 
.191 7.5 
5.0 .263 10.3 
.261 10.2 
10.0 .41 15.9 
.42 16.5 
15.0 .59 23.1 
.57 22.3 
20.0 .69 27.0 
.65 25.4 
30.0 .95 37.2 
.87 34.0 
a inhibited by 1 x 10-2 M Ouabain. 
b 1.27 A660 units/~mole Pi .. 
c 1.21 A660 units/vmole Pi-
Glycoside 
TABLE 47. Inhibition of Rat Heart ATPase by Various 
Cardiac Glycosides at Two K+ Concentrations 
CONVALLATOXOL DIGOXIN CYMAROL 
59 
Molarity A660 Inhibition A660 Inhibition A660 Inhibition 
20.0 roM K+ 
a 
1 x 10- 7 .50 1 
.55 - 23 
5 x 10- 7 .51 4 
.49 5 
1 x 10- 6 .50 2 .441 .422 36 
.50 1 .. 431 31 .452 21 
5 x 10-6 .49 5 .436 29 .427 33 
.49 5 .436 29 .442 26 
1 x 10-5 .45 24 .421 36 .422 36 
.47 15 .451 22 .417 38 
5 x 10-5 .47 15 .406 43 .403 45 
.46 20 .401 46 .406 43 
1 x 10-4 .45 22 .. 319 84 .414 39 
.49 5 .331 79 .427 33 
5 x 10-4 .43 34 .367 62 
.42 36 .387 52 
0.625 mM K+b 
1 x 10- 7 .474 3 
.4-89 . - 6 
5 x 10-7 .484 3 
.494 8 
1 x 10-6 .484 3 .42 32 .404 40 
.494 8 .42 32 .444 19 
5 x 10-6 .464 8 .. 370 59 .399 43 
.464 8 .370 59 .414 . 35 
1 x 10-5 .444 19 .350 70 .384 51 
.464 8 .350 70 .384 Sl 
5 x 10-5 .434 24 .265 116 .324 84 
.424 30 .267 115 .334 78 
1 x 10-4 .404 40 .344 73 
.404 40 .334 78 
5 x 10-4 .359 65 .324 84 
.359 65 .. 309 92 
a 1.23 A660 units/~mole Pi; Na+K+-ATPase 8.1; .50 A660 in absence of 
b 
glycoside. 
Na+K+-ATPase 1.23 A660 units/~mole p .. 7.1; .48 A660 in absence of l' 
glycoside. 
60 
TABLE 47 (continued) 
OUABAIN DIGITOXIN HELLEBRIN 
Glycoside % % % 
Molarity A660 Inhibition A660 Inhibition A660 Inhibition 
20.0 mM K+ 
1 x 10-6 .492 2 .433 . 30 .428 33 
10-6 
.527 - 14 .458 18 .438 28 
5 x .457 19 .453 21 .430 32 
.442 26 .443 26 .425 34 
1 x 10- 5 .436 29 .453 21 .400 46 
.452 21 .458 18 .418 38 
5 x 10-5 .412 40 .468 14 .390 51 
.422 36 .458 18 .380 56 
1 x 10-4 .402 45 .313 87 .380 56 
.402 45 .318 85 .380 56 
5 x 10-4 .352 69 .340 74 
x 10-3 
.342 74 .360 65 
1 .332 78 
.347 71 
5 x 10-3 .302 92 
.302 92 
1.2 x 10-2 .282 10.8 
.292 11.2 
0.625 mM K+ 
1 x 10-6 .444 19 .449 16 .429 27 
.454 13 .454 13 .444 19 
5 x 10-6 .414 35 .414 3S 
.414 35 .416 34 
1 x 10-5 .411 37 .384 51 .369 59 
.424 30 .394 46 .379 54 
5 x 10-5 .356 66 .294 100 
.360 64 .298 98 
1 x 10-4 .334 78 .329 . 81 
.344 73 .329 81 
5 x 10-4 .319 86 .299 97 
.324 84 .309 92 
1 x 10- 3 .334 78 
.314 89 
5 x 10-3 .294 100 
.324 84 
1.2 x 10- 2 .294 ·100 
.294 
TABLE 48. Experimental binding dfl:ta for the rates of association 




























































. 9.82 .0076 





TABLE 49 Experimental data for rat heart Na+K+-ATPase/convallatoxol 
binding in the presence of various K+ concentrations 
Glycoside 
Molarity bound unbound b/u bound unbound b/u 
o ~ 155 n1M. K+ 0.625 mM K+ 
1 x 10-8 .373 12.6 .0296 .290 11.8 .0246 
.235 11.8 .0199 .152 11.9 .0128 
3 x 10-8 .745 38.0 .0196 .538 38.4 .. 0140 
.800 38.9 .0206 .373 34.8 .0107 
1 x 10- 7 . 913 Ill . .0082 • 845 105 . .0080 
10- 7 
.744 109. .0068 . 304 108 . .0028 
3 x 
1.25 roM K+ 2.5 roM K+ 
1 x 10- 8 .193 12.3 .0157 .124 12.1 .0102 
.179 12.6 .0142 .110 11.8 .0093 
3 x 10-8 .359 37.7 .0095 .469 38.5 .0122 
.290 37.7 .0077 38.3 
1 x 10- 7 .220 109. . 0020 1.06 107 . .0099 
113. .456 114. .0040 
3 x 10- 7 351. 337. 
339. 344. 
5.0 roM K+ 20 ruM K+ 
1 x 10- 8 .248 11.7 .0212 .014 12.4 .0011 
.097 12.9 .. 0075 .925 12.0 .0771 
3 x 10-8 .483 37.5 .0129 .110 38.8 .0028 
10- 7 
.235 37.4 .0063 39.3 
1 x 111. 1.10 107. .0103 
10-7 
. 727 108 . .0067 .879 107. .0082 
3 x .355 342. .0010 349. 
.963 346. .0028 2.06 354. .0058 
Without K+ 
1 x 10-8 .455 12.2 .0373 
.331 12.4 .0267 
3 x 10-8 .649 38.1 .0170 
.566 37.9 .0149 
1 x 10-7 .068 107. .0006 
1.40 110. .0127 
3 x 10- 7 
TABLE SO. Experimental binding data for rat heart 




1 x 10-8 
3 x 10-8 
1 x 10-7 
3 x 10-7 
Study 2 
1 x 10-8 
3 x 10-8 
1 x 10-7 







• 781 105 . 
. 355 109 . 
• 014 328 . 










blu bound unbound 
OUABAIN 
.0176 .257 13.7 
.0095 .314 14.6 
.0138 .956 43.6 






.159 1.20 13.6 
.152 1.11 12.7 
.069 2.63 40.7 
.072 2.64 39.6 
.029 3.97 126. 
.026 4.24 131. 
.008 4.61 393. 















TABLE 51. Ex~erimental binding data for rat heart 
Na+K -ATPase in the absence of K+ 
Glycoside 
Molarity 
1 x 10-8 
3 x IO- B 
1 x 10-7 
3 x 10-7 
1 x 10-8 
3 x 10-8 
1 x 10-7 
3 x 10-7 
1 x 10-8 
3 x IO- B 
1 x 10-7 





















































b/u bound unbound 
C)llAROL 
.029 .11 B.78 
.028 .07 9.18 
.023 .27 2B.1 
.021 .25 29.3 
.016 0 94.5 
.014 .78 96.1 
. 001 1.59 302 . 
.002 4.57 304. 
DIGITOXIN 
.008 .. 20 6.41 
.012 
.. 009 .97 21.3 
.016 1.02 21.3 
4.01 64.5 
.028 7.52 63.8 
.0003 32.6 173. 























TABLE 52. Experimental binding data for rat heart 
Na+K+-ATPase in the presence of 0.625 mM K+ 
Glycoside 
Molarity 
1 x 10- 8 
3 x 10-8 
1 x 10- 7 
3 x 10- 7 
1 x 10-8 
3 x 10- 8 
1 x 10-7 
3 x 10- 7 
1 x 10-8 
3 x 10- 8 
1 x 10-7 






















































b/u bound unbound 
CYMAROL 
.023 0 8.72 
.011 0 9.22 
.. 011 .04 29.8 
.011 .07 30.2 
.011 0 91.4 
.005 .23 97.1 
0 321. 
.001 0 317. 
DIGITOXIN 
.004 .18 5.63 
.002 1.20 4.45 
.033 1.52 20.1 
.005 .96 20.8 
.007 2.36 49.1 
.011 4.58 58 .. 9 
.019 31.8 170. 
.015 17.8 198. 
.004 
.. 002 
.008 
.004 
.006 
65 
b/u 
.001 
.002 
.002 
.032 
.270 
.076 
.046 
.048 
.078 
·1.87 
.090 
